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SUMMARY
In this investigation in vitro systems were employed to study the biological effects o f transfer, 
metabolism, cytotoxicity and mutagenicity of one PAH, benzo(a)pyrene a known mutagen and 
carcinogen, in different physical states in association with various particles. The physical forms in 
which BP was studied were, particulate-adsorbed, microcrystalline and in a dissolved state (in an 
organic solvent dimethylsulphoxide (DMSO) and aqueous buffer (PBSA)). The particles onto which 
BP was adsorbed were alumina, TiÛ2 and Fe2 0 3 .
The Ames (bacterial mutagenicity) test gave a direct measure of the potential biological response of 
the particles themselves and associated with BP in its adsorbed and non-adsorbed states. Particulate 
adsorbed BP produced enhanced mutagenicity compared to BP alone, when dosed in PB SA. Alumina 
B (the high surface area alumina) produced the greatest mutagenicity.
The mutagenic effects of BP in the Ames test required metabolism to epoxides, diols, tetrols and 
quinones (See Section 1.8). The extent of this response was reflected by the availability o f BP from 
its various states to the biological systems (microsomes).
The physical state on the surface of the particle and the availability of the BP to the microsomal 
membrane bound enzymes was indicated by measuring the transfer of BP into the microsomes, by the
et aX
method described by Lakowicz ^(1979), which involved the fluorometric measurements of  
benzo(a)pyrenes. BP was found to be in both monomeric and exitomer (crystalline) states on the 
surface of the particles. The alumina B showed a prominent presence of monomeric BP compared to 
other particles and the greatest transfer rate.
The metabolic profile investigation was carried out using High Performance Liquid Chromatography 
(HPLC) and '^’C-radiolabelled BP. Examination of BP’s metabolite profile reflected the effects o f the 
particles on the various states of BP and its availability. Indication of favoured metabolism and 
inhibition of part of the cytochrome P-450 enzyme system was not seen. The extent o f metabolism
was indicative of the BP available, which was related to the BP transfer rates. BP coated alumina B 
was the most extensively metabolised of the BP coated particles.
In addition to these subcellular studies, the effects of the particles and BP adsorbed particles were 
investigated using an established macrophage-like mammalian cell line P388D1 (Dawe & Potter, 1957; 
Koren, 1975), and which has been used as a favourable model o f cytotoxicity index, of macrophage
et a l lb a l
function (Daniel^l980; Wright^l980 and Wade efc^r 1980) and hence that of possible lung toxicity. 
A comparison with mice peritoneal macrophages was also made.
A parallel assessment of cytotoxicity in a non-phagocytic cell line (CHO and V79) was also 
performed. The indices of cytotoxicity used were release o f Lactate dehydrogenase (LDH) and 
lysosomal enzymes (p-Gal, p-Gluc) and percentage of cell survival using Neutral Red and Kenacid 
Blue; as a result of exposure to particulate and BP associated particles. The limited cytotoxicity was 
observed with BP coated and uncoated particulates. The addition o f a metabolising system (S9) 
produced cytotoxicity, although this was only a tentative observation as limited testing was performed.
To compliment the in vitro work, an in vivo study based on the intratracheal instillation work of 
Saftiotti (1968 ,1972) and Henr^(1973) was performed. This involved a single intratracheally instilled 
dose of ferric oxide particles coated with BP (in a 1:1 proportion) into male Syrian golden hamsters.
et
Through a modification of the organ culture technique o f Placke (1987), a tritiated thymidine 
incorporation over a 12hr to 5 day time period, was performed. Although no unscheduled DNA 
synthesis was detected, large numbers of S-phase cells were seen; the majority being in the trachea, 
and the BP-FejOj dose having the greatest effect.
1. GENERAL INTRODUCTION
1.1 AIR POLLUTION
The Earth’s atmosphere is an envelope o f gases extending to a height of about 2000km made up of 
distinct layers; ionosphere, chemosphere, stratosphere and troposphere. The troposphere is a layer of 
about 20km and is the area of greatest significance since it contains the air we breathe and move 
around in. Normal unpolluted air contains mainly nitrogen, oxygen, water, carbon dioxide and noble 
gases and dispersed within it is an array of particulate matter made up of aggregate molecules; 
condensed water vapour, condensed and reacted forms of natural organic vapours, salt from sea spray, 
windbome organics, pollen, fimgi, bacteria, algae and particulates from landscape erosion, geological 
activity and volcanoes (Stem 84).
The arrival of modem man and his reliance on industry to produce his needs, has resulted in an 
increase in gaseous and particulate emissions, which has in turn changed the environment in ways that 
are threatening local biological equilibrium and has greatly increased the health risk to the human 
inhabitants. These harmful effects associated with the various constituents o f air pollution on humans 
and the biological environment have been the major reason for efforts to understand their respective 
biological effects and control their sources o f emission. The sources of air pollution are numerous but
e jta -2
can be put into two categories: stationary and mobile (Stem^l984).
1.1.1 Stationarv Sources
Combustion of fossil fuels - electric power stations
Industrial Processes - iron and steel production, cement production, stone cmshing and sand 
and gravel erosion.
Natural Processes - decay, volcanic activity and wind erosion.
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1.1.2 Mobile Sources
Motor vehicles : lawn mowers, cars, lorries, marine craft, trains and aeroplanes 
Aerosols : smoking, aerosol cans (hairspray, paints etc), crop spraying/hand spraying.
The main release sources for particulates and xenobiotics is the result of incomplete combustion. 
Associated with particulate emissions there are gaseous emissions of NO, NjG, CO and CO2 with
e,taZ
hydrocarbon and heavy metal contamination (Bond^l986, Cuddity 1983, McChellan 1987, Lewtas 
1985).
Once these particulates are released to the atmosphere their associated contaminants can undergo 
further transformation. This transformation is brought about by the action of atmospheric factors, such 
as ozone, free radicals and sunlight and the catalytic quality of the particulate surface (Stem 1984).
Most particulate matter that is expeUed into our atmosphere is combined with organic chemicals of 
several classes, which are o f prime interest because of their known carcinogenicity/mutagenicity (See 
Tables 1 and 2). These are: polycyclic aromatic hydrocarbons (PAHs), heterocyclics, aromatic 
heterocyclic amines, nitrosarenes, nitrosamines, chlorinated hydrocarbons, aflatoxins and mycotoxins. 
There are 4 areas o f probable exposure :-
1. Occupational exposure - workers
2. Indirect occupational exposure - worker community, communities living in the vicinity o f the 
plants
3. Para-exposure - using and living with these materials, e.g. asbestos building materials
4. Environmental exposure - through air, soil and water
2-
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TABLE 1.2. Concentrations of Organic Compounds Found in Air Samples Taken in Belgium.
Compound
CONCENTRATIONS ng/m^
Particulate
Samples
(P)
Gas Phase 
Samples 
(G)
Distribution
Factor
(P)/(G)
Aliphatic Hydrocarbons
n-Nonadecane 0.80 15.1 0.053
n-Eicosane 0.85 7.55 0.113
n-Heneicosane 1.08 4.12 0.262
n-Docosane 2.33 4.23 0.551
n-Triosane 4.75 3.38 1.41
n-Tetracosane 8.15 4.63 1.76
n-Pentacosane 9.50 5.74 1.66
n-Hexacosane 9.73 8.70 1.12
n-Heptacosane 11.1 9.03 1.39
n-Octasane 8.10 7.80 1.04
n-Nonacosane 15.8 7.32 2.41
n-Tricontane 5.75 4.87 1.18
n-Hentriacontane 11.2 3.99 2.81
Polyaromatic Hydrocarbons
Phenanthrene and 1.21 44.7 0.027
anthracene
Methylphenanthrene and 0.90 10.2 0.088
methylanthracene
Fluoranthene 2.22 8.52 0.261
Pyrene 3.17 3.36 0.488
Benzofluorenes 2.33 1.87 1.246
Methylpyrene 0.93 - P
Benz(a)anthracene and 12.2 3.87 3.15
chrysene
B enzo(k)fIuoranthene 23.1 2.01 11.5
and benzo(b)fluoranthene
Benzo(a)pyrene, benzo(e) 20.1 2.69 7.47
pyrene and perylene
Phthalic Acid Esters
Di-isobutyl phthalate 1.73 32.8 0.053
Di-n-butyl phthalate 101.0 353.0 0.286
Di-2-ethylhexyl phthalate 54.1 127.0 0.426
The above tables are taken from Stemn ^ 9 8 4 ).
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The dusts and their contaminants enter the human body predominantly via two routes: 1) uptake 
through the respiratory tract for those o f low aerodynamic diameter, and 2) the digestive tract, either 
directly by swallowing or indirectly via swallowing spittle coughed up fiom the lungs as the end result 
of normal respiratory clearance mechanisms.
1.1.3 Toxicological Aspects
The ultimate objective of industrial toxicology is the prevention of the health risks that may result 
from exposure to chemicals in the environment and workplace.
The way to prevent harmful toxicological effects o f these agents is to eliminate them from the 
environment. However, this is unlikely to occur because of political and economic reasons. So a 
compromise is reached in which the exposure is reduced to an acceptable level o f risk based on known 
toxicological data and practicality.
The acceptable level has to take into account the acute toxicity and the long term toxicological effects 
of the dust and hydrocarbons, which is very difficult to establish. As these dusts and hydrocarbons 
have individual effects, together they may cause effects that are additive or synergistic. This makes 
selection of a single component to monitor difficult, and unreliable.
Developing a means of evaluating the toxicological effects (carcinogenic potential and irritant effects) 
of airborne particulate components and their associated xenobiotics, requires the accumulation and 
validation of data from a broad base (epidemiological, in vivo and in vitro study), in relevant areas 
which will help to identify the potential hazard and estimate the potential risk. This will then allow 
’permissible’ levels of exposure to be set. Regular use o f ever developing models to assess the 
possible health risk associated with that exposure, will also help maintain the ’permissible’ levels.
-5 -
Single toxicants that produce immediate symptoms, usually respiratory irritation, are relatively easy 
to assess. In the case of cancer the considerable lag between exposure and expression makes 
assessment more difficult. The physical form of the airborne particulate fraction makes it difficult, 
not only to assess its composition but also its complex chemical interactions and its even more 
complex biological intra-actions (Phalen 1984), which makes risk assessment almost impossible. Table 
3 gives an indication of these influencing factors.
Thus there is a need for a battery o f in vitro, short term assays to assess the toxicological effects 
(carcinogenic potential and irritant effects) of airborne particulates (plus contaminants) which, wiU 
have to take into account the majority of these varied interactions. When a potential carcinogenic 
airborne fraction is detected, and its potential hazard is defined using additional information associated 
with the group most exposed to the hazard (genetic disposition, sex, age, nutritional state etc), route 
of exposure, duration, dose and protection (best practical management), an estimation of risk can be 
made. This risk can then be transposed into ’permissable’ levels of exposure with emphasis on 
monitoring areas o f possible health risk obtained from short-term assays.
However it must be borne in mind that the social-economic considerations, namely risk evaluation and 
its management, will have the most pronounced effect on the prevention of health risk.
The sections that follow, give an indication of the complexity and interplay of factors that have to be 
considered, when studying an area as complex as the respiratory tract. A brief outline o f its structure, 
with regard to particulate (asbestos and silica) and xenobiotic (benzo(a)pyrene) insult are summarised 
with reference to defence, both physical and metabolic, and resulting dysfunction.
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TABLE 1 3  Aerosol Particle Properties That May Relate To Their Biological Effects.
PROPERTY COMMENT
Chemical composition Will influence biological response in many ways.
Mass concentratioa
(mass particles per unit mass
size)
WEI influence total dose dqx)sited and hence biological response.
Aerodynamic size Will influence probability for inhalation and deposition pattern
Size distribution WEI influence aU of the above
Geometrical size WEI influence deposition pattern, clearance rate, dissolution rate, and sensory irritancy
Electrical charge WEI influence coagulation rates and depositim on chamber walls, animal fur, nares and nasal hairs.
Hygroscopidty WEI determine growth rates in respiiatoiy tract and hence deposition pattern
Surface area WEI determine amotmt of adsorbed gases carried on particles. WEI influence rate of dissolution in 
lung fluids. May influence interaction with macrophages and other lung ceEs.
Particle shape WEI influence deposition via interception mechanism and may influence phagocytic efficiencies.
Dissolution rate WEI determine persistence in lung fluids and tissues.
Water solubility WEI influence particle stability in respiratory tract.
Deliquescence WEI influence particle size in respiratory tract and hence deposition pattern.
Irritancy May influence breathing patterns and thus modify dose and dose distribution.
Specific gravity WEI influence deposition pattern and may influence clearance rates.
Number concentration 
(particles per imit voLair)
May influence deposition pattern and may influence clearance rates.
Antigenicity May influence irritancy, induce tissue responses and secondary influence clearance rates.
Odour May induce avoidance behaviour
Taste May induce avoidance behaviour
Radioactivity Can influence electrical charge and dissolution rate characteristics as well as toxicity to lung cells.
Surface character May influence the interaction with macrophages and other lung cells
Temperature Particle temperature wEl be simEar to surrounding gas which wEl influence deposition pattern.
NOTE : Many of these properties are interdependent. For example, for spherical particles, the
aerodynamic diameter is a function of geometric diameter and density (Phalen 1984).
1.2 THE LUNG
et tJ-
The sections that follow were taken from (Inchiosa 1983, Klaassen 1986, Tumer-Warwick 1978).
The lung can be split into three regions based on anatomical features and upon particle deposition and 
clearance phenomena that occur within each unit.
1. Nasopharyngeal (NP)
2. Tracheobronchial (TB - with the respiratory bronchioles (RB))
3. Parenchymal (P)
Figure 1.1 and Figure 1.2 shows a schematic representation of the various regions and major cell types 
associated with these regions.
1.2.1 Nasopharvngeal (NP)
The mammalian nose and its immediately post nasal cavities comprise an elaborate organ that provides 
for olfaction, detection of aiibome irritants, collection of noxious gases and particles, humidification 
and temperature adjustments of inspired air and disposal of fluids that drain from the eyes, sinuses and 
inner ears. The critical nature of these functions also makes the nasopharyngeal region an important 
target for airborne xenobiotics. It deals with air pollutants in the raw unfiltered state at ambient 
concentrations, and failure of any of its critical functions can lead to serious, even life threatening 
situations.
In humans, the nose contains two channel-shaped nasal cavities (entered by the nostrils) that are 
separated by a cartilaginous bony central septum. The anterior one third o f the nasal cavity is covered 
with skin much like that on the face and does not have an effective coating of mucus. However the 
remainder of the cavity is covered with mucus that moves backwards, driven by cilia to a point where 
it is swallowed. The anterior portion is covered by hair which traps large inhaled bodies. The nasal
8-
FIGURE 1.1 Schematic Representation of Lung Compartments
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FIGURE 1 .2 Schematic Representation of the Lung and Cell Type Locations
Goblet cell
Undifferentiated cell Seroas cell
Bronchioles
I
Alveolar
sacs
Kulchitsky
cell
— Trachea
Bronchus
Brush
cell
Basement
membrane
; nerve
Basal
cell
Ciliated cell
Basement
membrane
Basal Nerve \ \
cell Clara
cell
Type li alveol 
cell
Cross
section
Cilium
Undifferentiated
cell
Tight 
junction
Type I 
alveolar cel
Fused basements; 
membrane
[a(ia.p'te.ci'/<khr\
Surf actantLamell
Alveolus
Capillary 
lumen
/
Interstitium
endo­
thelial 
cell
— 10 —
turbinates line the central and rear portion of the nasal cavity stratifying inspired air, increasing 
humidification and warming (cooling) o f inhaled air.
At the rear, the nasal cavity narrows and turns sharply downwards. This area, the nasal pharynx, is 
the region of deposition of large particles that eluded previous capture. The nasal cavity and pharynx 
joins into the main body of the pharynx, which divides into the laiynx (trachea) and oesophagus. The 
pharynx is coated with mucus in the same fashion as that o f the nasal cavity.
The larynx causes great turbulence, which causes particulate matter to impact on the tracheal wall, 
which is coated with mucus and then is propelled upwards by the mucocilary escalator and swallowed.
1.2.2 Tracheobronchial Tree (TB)
The trachea is continuous with the larynx. It has U-shaped cartilage rings which prevent the trachea 
collapsing when breathing. The inner walls of the trachea are covered with mucus supplied by goblet 
cells and mucous glands. The trachea divides into primary bronchi. These bronchi enter the right and 
left lung and continue to divide for several generations (16 in man), before alveoli (air sacs) begin to 
appear in the bronchiolar walls opening into the lumen. This appearance of alveoli marks the end of 
the TB and the beginning of the RB region. Bronchi and bronchioles are roughly circular with smooth 
muscle and irregularly shaped cartilage plates situated outside of the smooth muscle. When the 
diameter of the bronchioles is less than 1mm the cartilage disappears. The bronchioles have mucous- 
secreting goblet cells but do not have mucous glands in the walls. The outermost layer o f the bronchi 
consists of a mixture of tough connective tissue and elastic fibres.
The inner lining of the bronchi is pseudostratified colunmar epithelium, having ciliated cells, mucus- 
secreting goblet cells and underlying mucus-secretory glands. Thus the TB tree possesses an active
- 11 -
clearance mechanism due to the propulsion of mucus towards the pharynx to a point where it is 
swallowed. The bronchioles are lined with ciliated columnar epithelium that is not pseudostratified.
The RB exhibits an increase in the number of alveolar opening. Between alveoli and the surface of 
the RB is ciliated epithelium, however within the alveoli, ciliated cells are not found and clearance of  
deposited debris is presumably by those mechanisms associated with deeper-situated alveoli.
1.2.3 Parenchvma OP)
Parenchyma is a term that relates to the primary functional tissues o f an organ as distinguished from 
its supporting framework as secondary tissues (connective tissue, cartilage). Parenchyma is therefore 
the respirable unit, consisting of many alveoli (alveolar ducts, sacs and capillaries, alveoli, pulmonary 
lymphatics).
The alveolar duct is a tubular structure, whose wall is completely covered with alveoli, which ends 
in the alveolar sacs (shape o f an incomplete polyhedron). The closed end of this sac is surroimded 
by a network of fine blood capillaries. Thus, atmosphere and blood are brought into intimate contact 
where equilibration of CO2 and 0% can take place. Fibres carried in inspired air can become embedded 
into the alveolar capillaries and connective tissue, after deposition in this area.
The action of the ciliated mucous-secreting tissues of the NP and TB (RB) compartments is 
responsible for sweeping the surfaces of the airway free of particulate contamination. This function 
depends upon the quality and quantity o f mucous and the quantity and synchronisation o f cilia.
The wall of the alveolus is mainly made up of very thin type I epithelial cells which lay on a basement 
membrane that is fused to the basement membrane of the blood capillary endothelial cells. In addition, 
there are thicker, roughly cube-shaped cells, the type II alveolar epithelial cells, which have a surface
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covered with protrusions (microvilli). These cells manufacture and secrete substances onto the surface 
of the alveolus. They are believed to be involved in the manufacture and secretion of surfactant, a 
surface-tension lowering agent that reduces the tendency alveoli have for collapsing. The two 
basement membranes of the alveoli and endothelium are separated by interstitium which is filled with 
both elastic and non-elastic fibres and cells called fibroblasts.
Macrophages are relatively large, nucleated cells which possess the ability to roam about and engulf 
foreign materials. This engulfing is called phagocytosis (incorporation of solid matter) or pinocytosis 
(incorporation of liquid droplets). Macrophages are found on the surfaces of the alveoli in the deep 
lung and are not a fixed part of the alveolar wall. They maintain the sterility of the lung surfaces by 
engulfing bacteria and fine particulate matter upon its deposition, within the alveoli.
1.2.4 Sites of Production of Antibodies
The main sites of production are the cells within germinal follicles and plasma cells within the 
reticulo-endothelial system, particularly localised lymph nodes, with additional production fi'om plasma 
cells lining the gut and respiratory mucosa mainly in the region of the bronchial glands. The 
production of antibodies for the defence of the upper respiratory tract, are produced by localised 
lymphoid tissue and particularly the tonsils.
The production of antibodies, usually follows specific antigen processing by the regional lymph nodes.
1.2.5 Ventilation
Under resting conditions, the average man inhales about 500ml of air per breath (the tidal volume). 
This volume is small in comparison to a total capacity of about 6 litres. The inspired air fills the nose 
and TB tree which has a cumulative total volume of about 200ml. Alveolar ventilation is about 300ml
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of this inhaled 500ml. The 300ml mixes with air that is already resident. Exhaled air consists o f the 
200ml of unchanged air from the TB and 300ml of mixed alveolar air. Thus, pollutant gases or 
particles that are inhaled into the alveoli region may be washed out over several successive breaths. 
The time available for deposition and uptake o f inhaled materials in the bronchial tree is 6 seconds 
(the time it takes to breathe), while residence time for deposition in the alveolar region can be in the 
order of tens of seconds (or even minutes).
Increase in ventilation rate and volume of breath effectively increases the amount o f xenobiotics 
inhaled. In exercise, there is often a shift from nasal to orinasal (combined mouth and nose) breathing. 
The air breathed in through the mouth bypasses nasal scrubbing o f large particles and pollutant gases, 
tending to lead to an increased impaction of xenobiotics, in the deeper areas o f the lung.
An additional factor is the reflex changes in breathing patterns due to sensory irritation. In general, 
these reflex actions appear to be protective in that the changes in breathing patterns serve to limit or 
prevent exposure o f the respiratory tract These reflexes included coughing and sneezing, bronchial 
constriction, reduction in ventilation rates and volume and excess secretion of mucus.
1.2.6 Distribution. Detx)sition. Excretion and Clearance
Particulates with an aerodynamic diameter of less than 10pm are more likely to affect public health 
because they can reach all regions of the respiratory tract including the alveolar regions. This size 
range represents the greatest proportion of airbome material and is mostly derived from industrial 
processes (Broddin et al 1977, Albagli et al 1974). The deposition and subsequent removal of 
particulates and xenobiotics in the respiratory tract are dependent on physiochemical forces (Phalen 
1984) and biological factors such as; anatomy, metabolic capacity and clearance and defence 
mechanisms. The clearance and distribution and eventual elimination of substances deposited in the
14-
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respiratory tract may take place by a combination of several mechanisms (Klaassen^l986). A 
schematic representation of these mechanisms is illustrated in Figure 1.3.
FIGURE 1.3. Distribution of Inhaled Materials.
NASOPHARYNGEAL
me
TRACHEO­
BRONCHIALo
u .
me/m
w
a/m
ALVEOLAR
t/m
LYMPH
Bile
Feces
KIDNEYS
LIVER
MUSCLE
ORGANS
BONE
FAT
Schematic diagram of routes of deposit ion , aborption, d is tr ib u t io n  
and excretion o f  inhaled agents (modified from Klaassen
FIGURE LEGEND
e
m
me
t
t/m
a/m
s
me/m
Non-particulate material such as solutes, may be absorbed directly into the 
plasma along the entire surface of the respiratory tract.
Elimination (excretion in urine and faeces)
Phagocytic activity o f macrophages 
Mucociliary escalator system
Lymphatic drainage of the alveoli also represents a direct clearance 
mechanism which can be utilized by macromolecules and particles.
Particles ingested by macrophages pass with these cells into the lymphatic 
system.
Lytic enzymes contributed by macrophages may directly aid in the dissolution 
of particles resulting in products that can be absorbed.
Swallowing materials removed by coughing and mucociliary escalator. 
Contribution of both macrophage and mucociliary escalator.
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Particles having a diameter greater than 5jxm (5-30pm) are principally deposited in the nasopharyngeal 
region by impaction. Particles of l-5pm in diameter deposit along the tracheobronchial tract by 
sedimentation, with the smallest particles reaching the region approaching the alveoli. Particles less 
than 1 tun in diameter, which reach the alveoli, are deposited primarily by diffusion.
Particulate deposition in the nasal pharyngeal regions is removed as a result of coughing, sneezing 
and swallowing. A prime clearance mechanism for particulate deposition is the efficient mucociliary 
escalator system which raises particles to where they may be expelled or swallowed. The mucous 
layer that particulates and non-particulates are entrapped in, which is propelled by the mucociliaiy 
escalator, coats the entire surface area o f the respiratory tract. It is an effective barrier against 
infection and all xenobiotics must pass into and through it when cleared from the respiratory tract 
The phagocytic activity o f macrophages is another important mechanism for the clearance of 
particulates deposited in the tracheal bronchial tree and alveoli. The lytic enzymes contributed by the 
macrophages may directly help in the dissolution of particles, resulting in direct absorption into the 
circulation. Ingested particles may pass into the lymphatic circulation. The lymphatic drainage o f the 
alveoli also represents a direct clearance mechanism which can be utilised by macromolecules,
e2ro2.
aggregates o f macromolecules and particulates of appropriate size (Klaassen ^ 1986). Finally non­
particulate material may be absorbed directly into the plasma along the entire surface area o f the 
respiratory tract (which is related to its lipid solubility).
1.3 METABOLISM OF XENOBIOTIC CHEMICALS
Every day humans are exposed to thousands of different chemicals. Of these, most are encountered 
in minute amounts. Many are introduced into the diet (food additives, preservatives, pesticides, 
herbicides, drug residues, water (nitrates, pesticides, herbicides) and the air we breathe, which is laden 
with noxious chemicals in gaseous or particulate form.
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Regardless of the sources of xenobiotics, the body has to have a successful strategy to detoxify and/or 
eliminate these chemicals from the body. Only water soluble (polar) xenobiotics can be excreted 
easily from the body, those that are lipophilic (non-polar) have to be metabolised to more polar 
derivatives prior to elimination. The enzyme systems that catalyse these processes must be relatively 
non-specific to deal with the wide range o f xenobiotics.
Metabolism, in the case of polycyclic aromatic hydrocarbons, usually involves the introduction of an 
oxygen atom into the non-polar molecular structure which may produce very reactive electrophilic 
species capable o f binding to endogenous nucleophilic species - protein and DNA, causing destruction 
of vital metabolic proteins and disruption o f the integrity o f DNA structure.
There seems to be no common structural feature between carcinogens, although most require some bio­
transformation into reactive electrophilics.
The general strategy of mammalian metabolism is the same. However, there are differences between 
species, age, sex, hormonal state and disease and differences in the extent of favoured metabolism 
which produce different toxicological effects (Sipes & Gandolfi 1986).
Metabolism in the classic text, is divided into two phases (Sipes & Gandolfi 1986). Phase I involves 
the modification of a non-polar molecule to that o f a more polar entity (Table 1.4) which can then 
undergo Phase U reactions involving conjugation with endogenous polar molecules (Table 1.5) such 
as sulphate or glutathione. Glutathione conjugates are subsequently converted to mercapturic acids, 
prior to excretion.
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TABLE 1.4. PHASE I
TYPE OF REACTION FUNCTION GROUP AFFECTED
OXIDATION 
Aliphatic hydroxylation 
Aromatic hydroxylation 
N-Dealkylation 
O-Dealkylation 
S-Demethylation 
Oxidative deanuration 
N-Oxidation
S-Oxidation
Epoxidation
R-CH3 
R-Ar -
R-NH-CH3 
R-O-CH3 - 
R-S-CH3 -
RCHjOH 
-  R-Ar-OH
R-NH2 + HCHO
RCHNH2-CH3 
R-NH-R’ ------
R-OH + HCHO 
^  R-SH + HCHO 
 > R-COCH3
R-NOH-R'
R
R ’
R
R
SO,
R’
R
\ \
C -H CH
C -H
-  I > 0  
CH
/ /
R^  (unstable)
REDUCTION 
Nitro-reduction 
Azo reduction 
Dehalogenation
NÛ2-Ar-R -  
Ar-N=N-Ar^ 
RCCI3 -------
NH2"Ar-R 
—> Ar-NH2 + NH2-Ar
RCHCL+HOa
HYDROLYSIS 
Deesterification 
Deamination 
Epoxide hydrolysis
(+ H2O)
RC00CH2R^----------» RC00H+H0CH2R^
RCONHR^--------------  RCOOH+HjNR^
R C
R C
R C O H
I
R C O H
R - hydrocarbon chain 
Ar - Aromatic ring e.g.
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The most common type of Phase I reaction is oxidation. The mixed function oxidases or mono­
oxygenases are families of NADPH dependent enzymes concentrated in the endoplasmic reticulum of 
the cell. These enzymes catalyse a number of hydroxylation, epoxidation and other oxidation reactions 
using O2 as the oxidising agent An iron atom in the haemoprotein cytochrome P450 binds molecular 
oxygen and activates it for reaction with organic substrates. The exact nature of the iron oxygen 
species is not completely understood, but is extremely reactive and can insert into C-H, N-H, S-H and 
C=C bonds.
The cytochrome P450 systems are inducible, in that enzymic levels and metabolic activity increases 
in response to certain environmental and dietary factors and many carcinogens are inducers o f this 
system (Okey^l986).
Generally oxidation results in detoxification. However, occasionally reactive intermediates (usually 
electrophilic or free radicals) are produced from Phase I reactions. Rather than undergoing conjugation 
(Phase II) reactions they escape the detoxification system to react with essential cellular molecules and 
disrupt the nonnal functions of the cell (Parke 1987).
1.4 METABOLISM IN THE LUNG
The lungs are a prominent target organ for numerous types of chemically-induced pathological changes 
(Witschie2û27?7^.They are situated in a primary site for exposure to xenobiotics both externally by
inhalation and internally by circulation. It has been well demonstrated that respiratory tissue contains
ti«L <3:ol .
enzymatic activity to metabolise many xenobiotics (Hook^l976; Gram 1980,^1986). Metabolism of
certain compounds is critical for the onset of cellular damage (Boyd 1980bpiUette^l974). Activation
of these xenobiotics to electrophiles and activated nucleophiles enable them to react directly with
cellular components, typically alkylation of macromolecules. Other species produce free radicals that
are able to reduce molecular oxygen to activated forms which in turn initiate cellular damage.
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Although several factors could be responsible for the apparent differential susceptibility o f the 
respiratoiy tract tissue to carcinogens (e.g. intra-organ distribution of carcinogen), an important factor 
is metabolism.
Many reports have been focused on PAH metabolism and indicated that the respiratory tract is not 
homogeneous in its metabolising ability. This would not be surprising as the respiratory tract contains 
over 40 different cell types, with possible unique ’activating’ and inactivating capabilities. In most 
instances the interaction of cytochrome P450 with xenobiotics, results in biological inactivation and 
increased rates o f clearance from the body. However, in some instances xenobiotics are themselves 
converted to highly reactive intermediates that form adducts with vital cellular macromolecules (DNA, 
RNA, protein, lipids). These interactions may lead to a variety o f detrimental biological consequences 
including cellular necrosis, mutagenicity and malignant transformation.
Other studies emphasise that the lungs contain defence mechanisms against reactive intermediates
<2aL iit(- «îaZ.
(Boyd^l982; Forman^l981; Dunbar J981). Ultimate toxicity could be expected to reflect the balance 
between activation and deactivation within the lung cells. However, factors such as accumulation and 
clearance rates for a xenobiotic are important. An increase or decrease in enzyme activity may 
compensate for the adverse effects o f the xenobiotic, due to an increase in biological anabolism and 
catabolism brought about by the xenobiotic insult, not to mention the genome defences that must be 
breached.
1.4.1 Phase I Pulmonarv Metabolism
The formation of reactive electrophiles and nucleophilic intermediates is commonly mediated via 
oxygenation of the xenobiotic by cytochrome P450 oxidase-reductase systems.
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Respiratory P450 mono-oxygenase can metabolise a wide variety of PAHs (Warren et al 1982) to 
highly reactive electrophiles. Work by Devereux^(1979) and Serabjit-Singh et al (1979) showed that 
the non-ciliated bronchiolar cell (Clara) is the major site of pulmonary P450. Consequently many 
potent alkylating agents specifically damage the terminal bronchioles in vivo (Boyd^l980cïjWarren et 
al 1982).
Wolf et al (1979) and Slaughter gf al (198 P) showed that the majority of rabbit pulmonary P450 is 
comprised of two isoenzymes, 2B4 (P450n) and 4B1 (P450%). They demonstrated the specificity of 
2B4 (P450n) for 4-ipomeanol and could explain its toxicity, as it was detected only in non-ciliated 
epithelial cells. 4B1 (P450i) was found in Clara cells, while both forms were present in alveolar type 
II cells. BP can be metabolised in rabbit lungs by the 2B4 (P45Qn) isoenzyme, which results in 
covalent binding of BP to DNA (Wolf et al 1979). In contrast the potent mutagens 2AAF and 2AA 
are activated by 4B1 (P450j) (Robertson et al 1981).
Additionally prostaglandin synthetase has been reported to activate BP via pathways dependent on the 
presence of arachidonic acid (Sivarajah et al 1978) to produce the intennediate 7,8-diol-epoxide 
capable of DNA binding (Sivarajah et al 1981). Significant activity of this system has been reported 
in human lung (Sivarajah et al 1981). Again specific cell-type toxicity has been shown by Ryan and 
Ryan (1974), showing its localization mainly in the alveolar-capillary bed, being associated to alveolar 
type n  and macrophages, while in the bovine, being associated with endothelial cells (Ryan et al 
1978).
Flavin-containing mono-oxygenase is present in most mammalian species, respiratory activity being 
between 50-100% of hepatic activity in rabbit (Uehleke 1973) and hamster (Ziegler 1980) and almost 
200% in male mice (Duffel et al 1979). Notable exceptions are the dog and human (Ziegler 1980), 
being 2 0 % that o f liver.
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The production of superoxides via the NADPH-cytochrome P450 reductase system, produce their 
toxicity through Og intermediates that interact with macromolecules, which disrupt cellular integrity 
(mainly membranes) or cause critical depletion of cellular reducing equivalents. Keeling et al (1981) 
demonstrated the selective damage of alveolar type I and II cells by low doses of paraquat In addition 
to the O2 effects, a specific transportation mechanism for paraquat has been postulated (Forman et al 
1982). Dee et al (1980) found that in rats P450 reductase was located in the bronchi and bronchioles.
efc«2.
Serabjit-Singh^(1980) reported its presence in terminal bronchioles of rabbit and Rister et al (1976) 
found significant activity in alveolar macrophages of guinea pigs.
Thus, the site-specific toxicity o f some respiratory toxins may be the consequence o f localised 
accumulation in the lungs as opposed to localised enzyme activity.
1.4.2 Phase II Pulmonarv Metabolism
An important substance for the protection of lung (and other organs) against reactive intermediates 
(electrophiles and activate nucleophils) is reduced glutathione. Glutathione has several functions in 
the maintenance of cellular integrity, including :-
1. Protection of essential catalyte -SH groups : which involves neutralisation of xenobiotics that 
may deactivate these -SH groups or regenerate -SH groups that have been oxidised.
2. Conjugation with xenobiotics or their metabolites.
3. Detoxification of endogenous peroxides and reactive oxygen species.
The proposed mechanism that may be involved in the activation of inert chemicals to reactive 
intermediates within the lung and their subsequent deactivation by glutathione is represented 
schematically in Figure 1.4.
Electrophiles are conjugated with glutathione through the enzyme activity of glutathione-S-transferases.
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Several studies have shown that respiratory toxins that generate reactive organic species also perturb
ttoL
the glutathione balance within the organ. Work by Smith^(1981) and Steele etal (1981) have shown 
that BP-4,5-oxide forms conjugates with glutathione in perfused lung preparations.
The nucleophiles do not appear to react with cellular macromolecules under normal physiological 
conditions, but their effects are mediated through metabolism. As can be seen from Figure 1.4, 
glutathione is active in the dispersing of peroxides formed from the reduction of molecular oxygen. 
In these reactions the disulphide form of glutathione ("oxidised glutathione") is produced and can be 
subsequently reduced back to free glutathione at the expense o f NADPH. This oxidation-reduction 
turnover of glutathione may produce additional stress on the reducing equivalents of the cell.
This additional stress on the cell may be a possible mode of toxicity. Dunbar et al (1981) reported 
changes in the reduced/oxidised ratio of glutathione and its leakage fmm the tissue after toxic insult 
Devereux et al (1981) found that isolated rabbit type II cells contained 5.5nmol/mg while Clara cells 
contained only 2.6nmol/mg. However, the method used also measured low molecular weight 
sulphydryl compounds and the effect of the isolation methods on cellular glutathione content is 
unknown.
Conjugation with glutathione could be expected to protect against lung damage initiated by alkylating 
agents. If glutathione conjugation was preferred then a threshold level for onset o f tissue alkylation 
would be equivalent to a critical reduction in the cellular glutathione. This would allow reactive 
metabolites to reach ’target’ molecules in sufficient concentrations to initiate cellular-damage. A 
decrease in glutathione by any of the routes previously mentioned may direcüy involve cellular 
damage.
Although glutathione transferases are important in the detoxification of electrophilic compounds, there 
are occasions, when the action of these transferases may enhance the toxicity o f an inhaled compoimd.
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For example, in the production of the glutathione conjugate of dibromomethane (Inskeep & 
Guengerich 1984) a S-[(2-N^-guanyl)ethyl] glutathione adduct was formed, through the formation of 
an electrophilic group based on the sulphydryl group.
The lungs contain a specific energy dependent transport process for ascorbic acid which permit the 
accumulation of the vitamin from plasma (Wright et al 1981). In the whole lung, approximately 30% 
of the respiratory ascorbate is associated with the lining of the alveolar space (Willis et al 1974). The 
main cells of this region that accumulate ascorbic acid are alveolar type II cells and macrophages 
(Castranova et al 1982). Ascorbic acid reacts with activated oxygen species rendering these 
intermediates non-toxic. Furthermore it reacts with electrophiles and various alkylating agents (Lake 
et al 1981; Edgar 1974). Additionally Kallistratos et al (1980) showed how vitamin C in rats inhibited 
BP carcinogenesis.
A number of studies investigating molecular oxygen have demonstrated that the lung contains specific 
enzymes designed to protect the cells from various oxygen species (superoxide dismutase, catalase and 
glutathione peroxidase).
The distribution of superoxide dismutase varies considerably within the lung (Stevens et al 1977).
Adult rat macrophages, alveolar type II and interstitial cells showed equivalent concentrations of
1^ 0.1
superoxide dismutase, which were higher than that o f type I (Forman^l981). Additionally Ody et al 
(1980) demonstrated that mutase activity was present in endothelial cells.
Catalase is associated with specific micro-peroxisomes. Peroxisomes have been found in the lungs 
of mouse, rat, pig, rabbit and monkey (Petiik 1971; Goldenberg et al 1978; Schneeberger 1972), 
located mainly within the alveolar type II and bronchiolar Clara cells.
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Forman and Fisher (1981) found that alveolar type II cells isolated from rat lungs contained 
substantially higher peroxidase activity than whole lung. Impaired performance by these enzyme 
systems would result in an increase in cellular damage.
1.5 THE LUNG AS A TARGET ORGAN
The lung is developed from the foregut pouch and has some features in common with the gastro­
intestinal tract. It is uniquely vulnerable to invasion by noxious agents for two reasons. Firstly, even 
at rest, it is exposed to some 9000 litres of air every 24 hours; an environment containing all manner 
of contaminants, including inorganic particles, smoke fumes and organic material such as animal and 
vegetable products contained in dust, pollen and moulds. Secondly, the lung is the only organ to 
receive the total cardiac output, resulting in maximum opportunity for circulating agents (xenobiotics, 
antigens or immune complexes) to reach the pulmonary capillary beds.
The lung has only a limited range of responses to damaging agents (Menzel and Amdur 1986). This 
is because the final common path of inflammation and repair involves a fairly limited range o f cells. 
Thus a wide range o f initiating agents cause damage to host cells in a much more limited number of 
ways.
1.5.1 Pulmonarv Response to Toxic Insult
The types of toxic response shown by the lungs are briefly discussed below.
1.5.2 Irritation
One of the most immediate signs o f irritation is the reflex action of coughing, with bronchial 
constriction of the upper respiratory tract reducing the volume of ventilated air. The irritation may
-27
affect cells such as the secretory ducts to over-produce bronchial secretions in an attempt to dilute the
offending agent. However this over-production can lead to complications, producing localised
blockage, confounding ventilation and leading to localised hypoxia.
1.5.3 Lining-cell Damage
Damage to cells lining the airways and alveoli may lead to an increase in permeability, proliferation 
and necrosis. The main types of responses are :-
1. Pulmonary oedema
2. Pulmonary emphysema
3. Fibrosis
1.5.4 Pulmonarv Oedema
This is generally described as an excessive extravascular accumulation of fluid within the lungs, caused 
by a hydrodynamic imbalance across the capillary wall and increased permeability.
The tightly fitting junction of the epithelial and endothelial basement membranes are separated by the 
interstitial space containing fine elastic fibre bundles of collagen, elastin and fibrin. Contained within 
this are fibroblasts and macrophages. The connective tissue breakdown via enzymic attack due to 
cellular dysfunction or death from toxic insult, causes dysfunction of the co-operation between the 
connective tissue/ceUular barrier which can produce marked changes in the localised environment. 
These changes can lead to possible accumulation of fluid causing disruption of the structural integrity 
of the lung in which the structural compartments are separated.
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1.5.5 Pulmonarv Emphysema
Emphysema is the permanent enlargement of the respiratory passages or air spaces to the terminal 
bronchioles. This enlargement is caused by the breakdown of connective tissue by an increase in 
activity of endogenous proteolytic enzymes. This increase in activity can be the result o f excess 
secretion by localised irritation, release from damaged cells, the results of monocyte stimulation or by 
reduction of natural inhibitors. The condition is perpetuated by the normal breathing process and 
exasperated by coughing and bronchitis.
1.5.6 Pulmonarv Fibrosis
Particulate fibrogenesis is the result o f fibroblast proliferation, with an increase in collagen synthesis 
(Richards et al 1973). This laying down of collagen and cellular proliferation leads to an invasive 
aggregation of lung tissue and loss of structural function, producing a stiff non-elastic structure. The 
growth of fibroblasts, may be the result of release of cellular components or mediators from the 
epithelium or macrophages (Allison 1973). Additionally the particulates may provide a solid support 
of suitable size and stimulus to produce fibroblast growth (Marondus 1973).
All the above are inter-related, aU having a common route of initiation through the effect o f the 
xenobiotic on the local respiratory environment, cellular compounds and specific cell types (secretory 
cells, monocytes). The presence o f particulates only acts to recruit more cells and to activate them 
(Bowden and Ad-àr^oa, 1984 b), This increase in recruitment increases oxygen metabolites (superoxide 
anions, hydroxyl radicals and hydrogen peroxide), these agents can cause additional damage (e.g. 
cellular membrane, essential metabolic enzyme). They may reduce the activity o f endogenous 
macromolecules. It is conceivable that a chronic inflammatory state, characterised by persistent 
increases in macrophages may contribute to cancer by this mechanism.
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1.5.7 Immunological Damage
From the immunological standpoint the lung may be considered in two major compartments. (1) The 
mucosal lined airways contain mucus, secretory and ciliated cells, smooth muscle and in part cartilage. 
These structures have specially adapted systems for clearance o f particles and possess a special local 
system for antibody production. (2) The gas-exchanging parts of the lung, composed of alveoli having 
an extensive air/blood interface. In this region, the cellular and humoural responses in normal 
individuals are derived almost entirely from the circulation (Tumer-Warwick 1978).
There are fov^ r types of response :-
Type I - anaphylactic - this involves an antibody reaction with localised immunological cell (mass) 
causing degranulation and release of endogenous factors that leads to vasoconstruction.
Type n  - reaction of complement via the attach immuno-complex.
Type m  - Arthus reaction - caused by a precipitation of antibody/antigen (immune complex) in the 
interstitial space of lung which causes localised tissue damage via complement and phagocyte 
lysosomal leakage from engulfed immunocomplex. Additionally soluble immunocomplex may lead 
to the triggering of oedema.
Type IV - no antibodies are involved in this type. Macrophages, after processing the antigen, 
stimulate lymphocytes to produce soluble factors (leukotriens), which are responsible for the delayed 
response of hyper-sensitivity.
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1.5.8 Pulmonarv Cancer
Many different materials produce tumours on inhalation (e.g. asbestos, PAHs and cigarette smoke). 
These xenobiotics cause their affects via genetic and epigenetic mechanisms. Most organic xenobiotics 
require metabolic activation to mutagens/carcinogens via the mono-oxygenase system of the lungs 
(Benford and Bridges 1986, Parke 1987), which is present in high activity in various types o f cells 
(Clara, Type 1 and II) (Devereux et al 1979, Serabjit-Singh et al 1979, Wolf et al 1979, Slaughter et 
al 1980, Benford and Bridges 1986). These xenobiotics are activated to varying degrees (See Section 
1.4), which act directly on the nuclear and cellular macromolecules of the lungs. Inorganic 
components can facilitate the affect of these organic compounds by direct cellular disruption or 
Stimulation of endogenous factors (Pantalone^l977).
1.6 PARTICLES
Particles have an affect on the biological environment into which they are introduced. The most 
studied particulates, which demonstrate the diversity of interaction, are silicon and oxygen based; 
namely asbestos and silica. These particulates are made up mainly o f silicon oxide with various 
impurities which give them unique and useful properties. Silicon dioxide exists in crystalline (quartz, 
coesite), crytocrystaHine (flint) and amorphous (diatonite) forms, the abundant mineral o f most interest 
being quartz. Asbestos is silica dioxide in filamentous layer, bound together by a variety o f cations 
Mg^ "^ , Ca^ "^ , Fe^ "^ , N a \ Ni, Co, Cr, etc) in many complex ways. This hydrated silicate exists in two 
main fibrous crystalline states, serpentine (chrysitUe) and amphibolic (cacodolite, amosite).
Both types of particle cause pulmonary fibrosis. In the case o f quartz silicosis, this is mainly localised 
in the respiratory bronchioles, which develop nodules that contain the entrapped particles. Asbestosis 
however, is more diffuse with the fibrosis spreading throughout the structure o f the lung and possibly 
invading the parenchyma (which can enclose normal lung tissue).
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The development of fibrosis is related to the amount of particulate dose received. However the 
particulate types differ in their biological interaction which results in this fibrosis.
The activity of silica seems to be related to its chemical functionality expressed at its surface; siliconal 
and ionized siliconal groups. These groups bind membrane proteins of the cell membranes. The 
particle size expressed surface area, thermal history, preparation and trace metal content are 
variables that alter the nature and number of the expressed functions at the surface (Nolan gfa/1981; 
1983, Beck et al 1973, Schlipkotter 1974 & Lebouffant 1980). The interaction with cellular 
membrane, changes their permeability to hold contents, releasing cytoplasmic and lysosomal contents, 
that affect the biological environment they are released into. Release of cellular stimulatory factors 
(leukotrienes) encourage localised fibroblast proliferation (Brown 1980) and production of collagen
état eàoL
(Poole^l985), with further monocyte recruitment (Bowden and b, Beck^l982).
The biological interaction in the case of asbestos seems to be related to the trace cation Mg^ '^  that is 
released into the media, which binds with the salic acid residues of the glycoproteins causing changes 
in membrane fluidity leading to penneability changes, thus causing cellular leakage. The particles 
themselves interact with the epithelium causing local scarification and irritational inflammation (Little
t t  d
1978, S h am y982i).
In the case o f asbestos, the particle’s fibre length and diameter have a significant contribution to 
biological activity. Fibres of sufficient length to be only half digested by macrophages, cause 
macrophages to leak cellular components.
Although there is no reliable evidence of increased prevalence of pulmonary carcinoma in man with 
silicosis, exposure to asbestos carries a peculiar liability to mesothelioma of the pleura and peritoneum. 
The Stanton hypothesis (Stanton and Wrench 1972; Stanton and Layard 1978), based on the fibre 
length and diameter, predicts that tumour development will probably reside with particles of lengths
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greater than Spm and less than 2.5pm diameter, the more present the greater the incidence of  
mesothelioma developing. Apart from the physical characteristics of the particles, associated trace 
metals such as nickel, cobalt and iron, are equally active in the animal host (Harrington and Roe 1965A 
Wagner et al 1973).
Ultimately the procedures used in this study would be applied to environmental samples such as; coke 
oven dust, freshly isolated coal dust, metal oxide with adsorbed decomposition products derived from 
the foundry industry, blasting operations, automobile emissions and adsorption of cigarettes smoke 
onto various metal oxides . The work carried out in this study was to optimise, validate and calibrate 
the procedures. Environmentally isolated samples can be variable. In the case of automobile 
emissions, the fuel used, engine cycle and ambient air conditions, all contribute to the overall 'product 
emission'. For this reason a model sample, with distinct measurable and reproducible components was 
desired. Ideally the particulates of choice could be easily characterized, obtain commercially and the 
coating with BP (the chosen carcinogen(see section 1.7 for details)) should be controlled.
The particulates selected were alumina, titanium dioxide and ferric oxide (for details of suppliers, 
surface area and size distribution see table 3.1 (page 91)). Alumina and ferric oxide were chosen as 
the laboratory has previous experience working with these materials. Titanium dioxide was selected 
as it is used as a negative control in in vivo and cell culture studies (Davies 1980). These materials 
have been use in in vitro (Lakowicz et al 1980) and in vivo (Stenback et al 1976) studies in 
combination with BP, in its various states (adsorbed, in an aqueous microcrystalline suspension and 
as a positive control dissolved in an organic solvent such as DMSO or acetone).
These materials have a variety of uses in the manufacturing industry. Metallic oxides are used in 
diverse products such as paints and dyes, in welding rod coatings, ceramics, inks, plastics, abrasives 
and chromatographic packings and as a source of the pure metal.
The occupational exposure of these materials can produce various pathological conditions, such as
fibrosis, oedema, emphysema and cancer (Kilbum 1984, Jett et al 1983). The occupations most at risk
are manufacturing workers, smelter workers, foundry workers, welders and miners (Kilbum 1984).
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1.7 BENZO(A)PYRENE
1.7.1 General Metabolism
The polycyclic aromatic hydrocarbon (PAH) chosen for this project was benzo(a)pyrene, a known 
mutagen/carcinogen.
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The choice of BP as the model carcinogen was for the following advantages:-
1. It is widely distributed in the environment and is likely to be relevant to cancer in man.
2. It is invariably formed when organic matter is burnt and is therefore a useful indicator o f
industrial pollution.
3. It is readily detected and quantitated by its fluorescence, so its toxicology can be studied.
4. It has proved to be a potent carcinogen in many species tested.
5. Its chemistry, metabolism and carcinogenicity are well documented.
The major enzymes involved in the activation/detoxification of BP are the cytochrome P450 dependent 
mono-oxygenases (MO), the activity o f which is often determined by the arylhydrocarbon hydroxylase 
(AHH) assay, and also prostaglandin synthetase (PS). These produce substrates for further metabolism 
by epoxide hydrolase (EH), epoxide reductase (ER), and quinone reductase (QR). The following 
section gives a brief outline of BP metabolism and its biological interactions. A schematic summary 
is shown in Figure 1.5.
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FIGURE 1.5 Summary of Benzo(a)pyrene Metabolism
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Metabolism of BP takes place in two phases:-
Phase I.
Conversion to oxidised derivatives (epoxides, phenols, diols, tetrols, quinones), is performed by 
oxidative enzymes and epoxide hydrolase associated with endoplasmic reticulum.
The MO introduce an oxygen atom across an aromatic double bond to form various epoxides.
4, 6EpOXld»
S,dEpoDdd9
8,1OEpadd0
These epoxides may undergo spontaneous rearrangement to produce phenols, in the case o f BP the 
major ones are 3-OHBP and 9-OHBP.
OH HO
30HBP 90HBP
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In addition, the epoxides are further metabolised to dihydrodiols by the action of epoxide hydrolase 
(EH), producing a variety of dihydro-diols, the major ones o f interest being 7,8-, 9 ,10 - and 4,5-diol.
HO
HO,
■OH
OH
HO
OH
r.edioiBP
These dihydrodiols are further metabolised by MO (and PS) systems to produce epoxide-dihydrodiols. 
The (+) 7,8-diol-9,10-oxide and (+) 9,10-diol- 7,8-oxide are mainly responsible for the biological 
action of the parent compound. These diol-epoxides are rapidly hydrolysed in aqueous media to 
produce triols and tetrols.
HO'
HO HD
HO, OH
HO
HO
HO
- _ \  It is believed that
the attack of water on a radical cation is involved, in which 9-OHBP is formed via the 9,10 expoxide 
BP and 3-OH from 2,3 epoxide BP ' However 60HBP is unstable in
solution and is converted rapidly into the 60X 0B P radical and then probably into cations, that are 
easily hydrolysed at the l-,3-, and 12-positions to form three hydroquinones. These hydroquinones
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can be oxidised spontaneously to form 1,6-, 3,6- and 6,12- quinones in the presence of oxygen (Lesko 
et al 1975 and Lorentzen er al, 1975). The action of QR keeps these quinones present in the 
hydroquinone form; isolation of each metabolite in air produced the quinones. Additional quinones 
are produced through oxidation of the 1,3 di-hydroxy BP.
O
Phase n. 1,6 quinone BP
These moderately polar metabolites are conjugated with sulphate, glucuronic acid or glutathione by 
enzymes mainly present in the cytosol, to give substances which are sufficiently soluble in water to 
be excreted. This process is generally believed to be the true detoxification and the conjugated forms 
are eliminated firom the biological system.
The glucuronic acid conjugation is catalysed by a membrane bound UDP-glucuronosyl transferase.
COOH COOH
+ HO-BP
UDF
0-B P 
+ UDP
Most of the hydroxylated metabolites of BP are conjugated (Nemoto and Gelboln 1976) as are the 
diols (Moore and Cohen 1978). The major metabolites are 30HBP and 90HBP, and to a lesser extent
4,5-, 9,10-, 7,8-diols and their relevant tetrols with (Marshall et al 1979; Cohen et al 1977; Nemoto 
and Gelboln 1976) traces of hydroquinones (air isolated), oxidised production of quinones.
Sulphate conjugation involves a two stage enzymic reaction, between a sulphotransferase and an 
activated sulphate ion in the form of 3’phospho-adenosine-5’-phospho-sulphate (PAPS).
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The 30HBP metabolite seems to be the major sulphate conjugate isolated fiom human lung (Cohen 
et aU 1976), hamster lung (Moore & Cohen, 1978). In addition BP-dihydrodiol, tetrol and other 
phenol sulphate conjugates have been detected (Burke et al 1977; Moore & Cohen 1978; Autrup et 
al 1978a), Work by Nemoto et al (1977; 1978, ) demonstrated that l-,3-,4-,6-,8-,9- and 12- OHBP and
1,6-, 3,6- quinones were good substrates for sulphotransferase. 2-OHBP and lO-OHBP and 4,5- 
epoxide, 4,5-diol, 7,8-diol and 9,10-diol were also conjugated, but to a much lesser extent.
The glutathione conjugates are formed through action of the glutathione-S-transferases. These catalyse 
the conjugation of reduced glutathione with epoxide metabolites, followed by the sequential removal 
of glutamate and glycine and N-acetylation of the resultant cysteine derivative to form a mercapturic 
acid which is excreted through bile and urine (Sims & Grover 1974). BP 4,5-epoxide is known to be 
a good substrate (Plummer et al 1980) and 9,10- and 7,8-epoxide are poor substrates (Waterfall & 
Sims 1972). However the diol-epoxide derivatives (BP 7,8 -diol-9,10-epoxide) are good substrates for 
the glutathione-S-transferase system.
■OH
GtydnoV  Xr «-eHj-CH.COOH 
DP4MreflpfajricfK(d
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1.8 BIOLOGICAL ACTIVITIES OF BP AND ITS DERIVATIVES
BP has been shown to produce tumours in many species (mouse, rat, hamster, guinea pig and rabbit) 
following different administrations including oral, skin and intratracheal routes (lARC 1973). 
Following oral administration tumours were produced in the forestomach and oesophagus (Neal & 
Rigdon 1967; Waltonberg & Leong 1970; Huggins & Yang 1962). Skin application o f BP in organic 
solvents have produced carcinomas and papillomas in Swiss mice (Wynder & Hofônan 1959), rat 
(Nakano 1937) and rabbit (Wynder et al 1957). The intratracheal administration of BP in saline and 
as a colloidal suspension produced a number of forestomach secondary sites throughout the respiratory 
tract (Yanisheva 1971; Saffiotti et al 1972 :).
1.8.1 Mutagenicitv of BP Metabolites
The ultimate carcinogenic metabolite o f BP is thought to be the 7,8-diol-9,10-epoxide BP.
(+) DP-7,8-oMd»
(•) trens-BP-73-dIhydfOdlol
Y
(+) ontiBP-7,8-dioI.9,10-8poxjdo
However, several other metabolites o f BP are mutagenic both with and without further metabolic 
activation. The tables (Tables 6-10) below present a brief review of some metabolites tested in the 
Salmonella typhimurium Ames test (Ames^l973) and Chinese Hamster V79 cell mutagenicity test of 
Chu and Mailing (1968).
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1.8.2 Reaction of BP Derivatives with Cellular ComTX)nents
The evidence so far points to one of the trans-enantiomers of BP-7,8 -diol 9,10-oxide as the main 
metabolite involved in reactions with nucleic acid and which may therefore be the ultimate carcinogen 
derived ftom BP. Much woik therefore has been done on the effects o f the anti and s ^  metabolites 
on nucleic acid (DNA, RNA and homopolymers) and protein. The metabolites seem to react with 
exocyclic amino groups (LARC 1983).
TABLE 1.6. Phenols of BP tested in vitro
Phenols Ames V79
-S9 +S9 -S9 +S9
1-OHBP i + + U NA
2 - + i+ ++
3 u + u NA
4 u - u NA
5 - - + NA
6 ++ + u +
7 i + - u NA
8 - - 1+ NA
9 i + - u NA
1 0 - - >L+ NA
11 - - NA
12 ++ + >1+ NA
Source of information Wood et al 1975, Wislocki et al 1976 
Huberman et al 1976 (See Table 10 for Key).
e/f-
, Clatt and Oesch 1976, Chang 1979 and
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TABLE 1,7. Epoxides of BP tested in vitro
Epoxides Ames V79
+S9 ±S9
4,5-oxide ++ ++
7,8 1+
9,10 U
11,12 i+ ++
Source o f information Wood et al 1975, Wislocki et al 1976 and Jeiina 1976 (See Table 10 for 
Key).
TABLE 1.8. Dihydrodiols o f BP tested in vitro
Dihydrodiols Ames V79
+S9 -S9 +S9 -S9
4,5 diol i+ - -
7,8 + 1+ + -  .
9,10 i+ i+ - -
11,121 u u NA NA
Source o f information Wislocki et al 1976 - and Huberman et al 1976 (See Table 10 for Key).
TABLE 1.9. Diol-Epoxides of BP tested in vitro
Diol-Epoxide Ames V79
+S9 ±S9
*7,8-diol-9,10-oxide + +
*9,10-diol-7,8-oxide i +
9,10-epoxide-7,8,9,10 tetra hydro BP +(-) NA
Source o f information Newbold and Brookes 1976, Marquardt et al 1976 and Nagao et a/1978 (See 
Table 10 for Key).
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TABLE 1.10. Other derivatives (quinones, triols and tetrols) of BP tested in vitro
Derivatives Ames V79
+S9 -S9 +S9 -S9
* 1 ,6 -quinones - -
* 3,6-quinones - -
* 6 ,1 2 -quinones - -
4,5-quinones - -
1 1 ,1 2 -quinones -
7,8-quinones - - -
7/8,9-triol -
7,9/8-triol -
7,8/9-triol -
9,10/8,9-tetrol -
7/8,9,10-tetrol -
7,9/8,10-tetrol -
7,9,10/8-tetrol -
Source o f information Wislocki 1976, \ ' " Wood et al 1977 and Huberman 197^. 
KEY TO TABLES
+
++
+
*
Positive 
Strong positive 
Weak positive 
Negative
Conflict of results (both + and -)
Produced by autooxidation of metabolite 6 -PHBP (Lorentzen et al 1975). 
Highly cytotoxic
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1.8.3 Reactions with Exocyclic Amino Groups
Protein. The exact nature of the exocyclic amino group interaction is not known, but the electron rich 
amino acids such as tyrosine, histidine and trypan are vulnerable targets. It is believed that epoxides 
are able to alkylate protein, as shown by Nemoto (1986) who demonstrated the ability of 4,5 oxide 
to alkylate proteins m v/rro.
RNA. BP-7,8-diol 9,10-oxide reacts with the exocyclic amino groups of guanine and adenosine (and 
cytocine to a lesser extent) at the C-10 position to the diol-epoxide. There is little or no detectable 
reaction with uracil and thymine. However inhibition of protein synthesis through modification of 
mRNA has been demonstrated (Grunberger et al 1980).
DNA. Osborne et al (1976) showed a major association with a guanine derivative and a minor 
adenosine derivative against the C-10 position of the diol-epoxide. Osborne et al (1978) also detected 
the N-7 guanine diol-epoxide. There is however some controversy over the existence of a diol-epoxide 
derivative that reacts with the phosphate backbone of nucleic acid (Moore et al, 1977; Shooter et al, 
1977).
1.9 EXPERIMENTAL MODELS FOR RESPIRATORY TRACT CARCINOGENS
Table 11 gives a brief summary of experimental models that are available for studying various aspects 
of pulmonary carcinogenicity. As shown, there are a variety of experimental methods and models 
available, the method chosen however, is dependent on the specific needs of the research project 
Table 12 shows some of the advantages and disadvantages of these systems. The tables were compiled 
from information obtained from Nettesheim and Griesemer (1978).
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In addition to these tables, consideration has to be made regarding the inter-laboratoiy variations 
through techniques and chemical resources and animal husbandry.
1.10 PRO.TECT AIMS
In this investigation in vitro systems were employed to study the biological effects o f transfer, 
metabolism, mutagenicity and cytotoxicity in bacterial and primary and established cell lines, of one 
PAH, benzo(a)pyrene a known mutagen and carcinogen in different physical states, in association with 
various particles. The physical forms in which BP was studied were, particulate-adsorbed, 
microcrystalline and in a dissolved state (in an organic solvent (DMSO) and water). The particulates 
onto which BP was absorbed were alumina, ferric oxide and titanium dioxide.
To compliment the in vitro work, an in vivo-in vitro study was performed using BP coated ferric 
oxide, which was intratracheally instilled into hamsters, and through an organ culture technique, 
radiolabelled thymidine incorporation was measured.
It was hoped that these investigations would give a better understanding of the BP coated particle state 
and contribute to development o f the basis of a short term in vitro test that could be used as a 
biological index o f potential hazard for environmentally isolated samples.
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2. MATERIALS AND METHODS
Chemicals. Media and Equipment Used
All chemicals used were AnalaR grade and were obtained from BDH Limited, Poole, England, except 
where stated. AU solutions used were sterile.
Materials Used For This Study
7 -Hydroxycoumarin (Sigma)
7-Tritiated Styrene oxide (Amersham)
Absolute Alcohol 100 (Hayman)
Acetone (Fisons)
AmpiciUin (Sigma)
Bacto-Agar (Difco)
Benzo(a)pyrene BP (Aldrich)
Biotin (Sigma)
Bovine serum albumin (Sigma)
Cacodylate (BDH)
Crystal violet (Sigma)
Dimethyl Sulphoxide(DMSO)(BDH)
Dipotassium hydrogen orthophosphate (BDH)
Disodium hydrogen orthophosphate (BDH)
EDTA (BDH)
Epoxyresin (Taab)
Ethoxycoumaiin (Aldrich)
Ethylacetate (May & Baker)
Foetal calf serum (Gibco)
Folin and Ciocalteau's phenol reagent (BDH)
Glucose (BDH)
Glucose-6 -phosphate (G6P)(Sigma)
Glutamine (Sigma)
Glutaraldehyde (Flow)
Histidine hydrochloride (Sigma)
Kanamycin (Sigma)
Kenacid blue dye (BDH)
Magnesium chloride (BDH)
McCoys 5A(Mod)
Methanol (May & Baker)
Methyl Umbelliferone conjugates (Glucuronide ,Galactoside , N -A cety l-g lw co ^ «4 e (Sigma) 
Neutral red (Sigma)
Nicotinamide adenine dinucleotide (NADP)(Boehringer-menheim)
Nitrogen(oxgen ffee)(air Products)
Nutrient broth (Oxoid)
Osmic acid (Taab)
Pentane (May & Baker)
Petroleum spirate (May & Baker)
Phosphate buffered saline (PBSA)(Flow)
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Potassium dihydrogen phosphate (BDH)
Potassium Chloride (BDH)
Reduced nicotinamide adenine dinucleotide (NADH)(Sigma) 
Sodium hydrogen carbonate (BDH)
Sodium hydroxide (BDH)
Sodium carbonate (BDH)
Sodium chloride (BDH)
Sodium dihydrogen orthophosphate (BDH)
Sodium Potassium tartrate (BDH)
Sodium Pyruvate (Sigma)
Sodiunm thiosulphate (BDH)
Styrene oxide (Aldrich)
Sidphuiic acid (BDH)
Thiobarbituric acid (Sigma)
Trichloroacetic acid (BDH)
Triethylamine (BDH)
Tris buffer 7-9 pH (Sigma)
Triton X-100 (BDH)
Tryptan blue (Searle diagnostics)
Trysin/EDTA (Gibco)
List o f Suppliers Used
BDH Ltd, Dorset, England 
Boehringer, Mannheim, Sussex, England 
Difco Ltd, Surrey, England 
Flow Laboratories, Irive, Scotland 
Gibco Ltd, Paisley, Scotland 
May & Baker, Dagenham 
Nunc Kamstruprej 90 Kampstrup Denmark 
Oxoid Ltd, Basingstoke, Hamphier England 
Sigma Chemical Co., Dorset, England 
Taab laboratories, Derkshire England
2.1 PREPARATION OF SIZED PARTICLES
The particles were prepared by Mr T McDonald of the Analytical Unit of the Robens Institute 
(McDonald 1984) using a fluidized bed system. This system allowed the production of a dynamic 
atmosphere of the particles with larger particles being trapped in the bed. This atmosphere was then 
passed through a second size system using a cyclone to give a size cut off at the desired upper size 
range. These particles were then collected using a 0.2pm membrane filter system.
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The fluidized bed had a continuous feed system that fed a mixture of particles 5 (w/w) in ballotine 
(lead glass 125-150pm) into the bed. The bed was fluidized by air passing through it at 10 l/min. 
The cyclone attached was designed to pass respirable dust filtering the curve at 10 1/min flow rate.
The feed stock material used for alumina A and ferric oxide contained only small quantities of the 
desired particle size, so the material was milled to reduce the size. The milling was carried out using 
an ultra-filtered distilled water carrier. After 15 min grinding the slurry was allowed to settle for one 
week, the water then removed and the particles dried in a rotary evaporator under reduced pressure. 
These particles were then used as the feed particles for the fluidized bed.
The size distribution was determined using scanning electron microscopy (SEM). A portion of the 
particles was mounted on double sided sellotape, attached to a glass coverslip, which in turn was 
mounted to a SEM stub. The stub was then coated with a thin film of metal (gold splatter coated). 
Photographs were taken and the size of the particles measured manually using the longest axis of each 
particle as its diameter.
2.2 PREPARATION OF BP MICROCRYSTALS
Benzo(a)pyrene (Aldrich) was recrystallised from a methanol: water (40:60 v/v) solution. A 0.6mg/ml 
solution of BP in methanol was prepared. A series of tubes were prepared as follows:- A 4ml volume 
of BP in methanol was added to a test tube together with 6ml of double distilled water while vortex 
mixing. The tube and contents were centrifuged at SOOOrpm for 15 minutes to pellet the precipitated 
BP. The supernatant was decanted and the pellet vortex evaporated at 60°C imder reduced pressure 
(25-30 mm Hg) until dry (until no further weight change was recorded). The final BP sample used 
was pooled from all the tubes prepared.
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2.3 PREPARATION OF BP COATED PARTICLES
A method of nucléation was used, which involved the evaporation of solvent from a BP solution, 
causing the BP to precipitate over the particles that were present (Lakowicz 1979; 1980).
2.3.1 Method I - Coating of samples used for Ames Tests.
Approximately Ig of particles was placed in a 100ml round bottomed glass flask containing varying 
concentrations o f BP in pentane. This mixture was then stoppered and sonicated for 15 minutes to 
equilibrate and then attached to a rotary evaporator. The samples were evaporated to dryness at room 
temperature (21°C), under a partial vacuum (25mm Hg) rotating at 90rpm. A list of coating 
concentrations achieved can be seen in Table 3.2 and 3.3. To produce the various BP coating 
concentrations on Ig of particles varying volumes of BP in pentane (lOOjig/ml) were added to the 
particles and made up to a final volume of 2 0 ml with pentane.
To determine the amount o f BP coated onto the particle surface, a standard curve using the original 
BP pentane solution was prepared. A 1ml aliquot was taken and the pentane evaporated to residue 
under a steady stream of oxygen-free nitrogen. The BP residue was resuspended in methanol at 
various dilutions to produce a standard curve. For details of particulate sample preparation see section
2.5.
2.3.2 Method II - Radiolabelled Coating using BP.
The particles were coated at approximately 2mg of BP per gram of particles. A 250 pi aliquot of 
[7,10-^''C]-BP (Amersham International pic) in toluene at 50pci/ml specific activity, 228|xCi/mg) was 
added to a 10ml round bottomed flask. The toluene was evaporated under a steady stream of oxygen 
free nitrogen until the BP was precipitated onto the flask. To this was added approximately 125mg
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of particles and 2.5mls o f BP in pentane (lOOpg/ml). The sample was sonicated for 15 minutes, to 
equilibrate the BP. The sample was then placed in a rotary evaporator and evaporated to dryness 
under partial vacuum at room temperature (as previously described in section 2.3.1).
To determine the radiolabel and BP coated concentrations, a known weight (approximately 5mg) of 
the radiolabeUed BP coated particles was added to 4ml volumes of Picofluor scintillant, a 1 in 10 
dilution was performed and the measured by liquid scintillation counting. The concentration of 
BP coating was determined by method described in section 2.5. The results were expressed as pCi/|Xg 
of particles.
2.3.3 Method III - BP Coating for Intratracheal Dosing.
2.3.3.1 Preparation of Particulates FejOa-BP
Acetone was chosen as a more suitable solvent, due to BP’s higher solubility in it. FezOg was coated 
at a 1:1 proportion by nucléation of BP from acetone (20mg/ml) on to the surface o f FejOa particles, 
using a rotary evaporator, under vacuum and at a temperature of 40°C (Henry et al 1973; Saffiotti et 
al 1968).
2.3.3.2 Preparation of Particulate FejOj
FCzOg was subjected to the same procedure as the FejOj in acetone, omitting BP. Both Fe^O -^BP and 
FejOs were left in petroleum wax beU jars under vacuum to remove any residual acetone.
2.3.3.3 Determination of BP and Ferric Oxide Ratio
A known weight o f ferric oxide coated BP was placed in a pre-weighed capped test tube. 3ml of 
DMSO was added and the solution sonicated for 5 minutes. The tube was centrifuged to precipitate 
the particles and the DMSO and extracted BP were decanted. This process was repeated until no 
fluorescence could be detected in the decanted DMSO. The DMSO extracts were pooled and the BP
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content determined by comparison of an aliquot against a standard curve of BP in methanol. The 
dried particles and tube were then weighed to determine the particulate weight.
2.4 FLUORESCENCE EMISSION SPECTRA OF BP ON SURFACE OF PARTICLES
An emission spectra for a fixed amount of BP, coated to particulates was obtained using a method 
proposed by Lakowicz et al (1979) which involved suspending BP coated particulates in 39 buffer (see 
section 2.8.4 for details) at a final concentration of O.Spg of BP/ml. After vortex mixing the sample 
for 1 minute, an emission spectrum was performed between 350nm and 580nm at X ex 296nm.
2.5. DETERMINATION OF BP CONCENTRATION COATED ON PARTICULATE 
SURFACES.
A known weight of coated particulates (approximately lOmg) was mixed with 3ml DMSO. After 
mixing and sonicating for 5 minutes, the sample was centrifuged at 3000rpm for 5 minutes to 
precipitate the particles. A lOOpl aliquot of the supernatant was then added to 3.9ml o f methanol.
The fluorescence was measured at Ex 296nm and Em 405nm. A plot of emission intensity at 405nm 
as a function of concentration was used to determine the amount of BP extracted from the particulates.
2.6 DETERMINATION OF BP SOLUBILITY IN VARIOUS AOUEOUS MEDIA
2.6.1 Determination in Water (and Buffer)
The aqueous solubility limit of BP was determined by adding lOpl aliquots of BP in DMSO, ranging 
in concentration between O.ljig/l and 250|ig/l, to 10ml of aqueous media. These samples were 
incubated in a shaking water bath at 37°C for a minimum of 16 hours. The fluorescence emission 
spectra between 350nm and 580nm was detemiined for each sample at an X ex o f 296nm in quartz
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cuvettes. A plot of emission intensity at 405nm as a function of concentration was used to determine 
the solubility limit (Lakowicz^l979).
2.6.2 Determination in S9 Mix
A concentration range of S9 mix (0.05-0.9mg protein/ml) was prepared in O.IM phosphate buffer, 
pH 7.4 containing KCl (33mM) and MgQj (8mM). To this was added lOOpl of BP (20pg/ml) in 
DMSO, which gave a final concentration of 0.5}xg/ml BP and 2.5% DMSO (yjv) in medium.
Each S9 mix concentration was heated to 55°C for 30 minutes in a water bath (this was to ensure that
eJt «2
maximum amounts of BP were dissolved in S9 mix fraction (Lakowicz^l979)), then cooled to 37°C 
and the fluorescence o f BP measured at an excitation wavelength of 296nm and an emission 
wavelength of 405nm. A series of blanks (which contained no BP) were also run in parallel. The 
fluorescence was plotted against microsomal concentration. A point at which the fluorescence reached 
the plateau was selected as a suitable microsomal concentration, for future experimental use, indicating 
that aU the BP present had been dissolved by the microsomal suspension.
2.7 DETERMINATION OF S9 VESICLES BINDING TO PARTICULATES
A lOOpl aliquot of particles in PBSA, giving a dose range of 1 to lOmg/ml final concentration, was 
added to 2ml of S9 mix (0.3mg of protein/ml). The mixture was vortex mixed and then incubated 
at 37°C with continuous shaking for 20 minutes in a flat bottomed conical flask. After incubation the 
sample was decanted into a glass centrifuge tube and centrifuged for 5 minutes at 1500rpm to 
precipitate the particles and any bound S9 vesicles. A 0.5ml aliquot of the supernatant was added 
to 1.5ml of 3% v/v carbonate in 0.1m NaOH, and its protein concentration was determined by the 
method of Lowry et al (1951). A microsomal standard without particulates was treated in the same 
manner as that of the samples (Lakowicz^l979).
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2.8 PREPARATION OF S9 FRACTIONS
2.8.1 Induction of Cytochrome P45Q in Rats Using Aroclor 1254
Male Wistar rats (200-250g) of University o f Surrey stock were dosed with Aroclor 1254 (a mixture
liaL
of polychlorinated biphenyls which induce multiple forms of P450 (Ames,1973)(Monsanto Ltd) at 
500mg/kg in Mazola com oil (CPC Products Ltd, UK). A single intraperitoneal injection of 
0.25ml/100g body weight, of a 200mg/ml mixture of Aroclor 1254 was administered 4 days before 
sacrifice (Ryan 1982).
2.8.2 Preparation of S9 Fraction
The S9 fraction was prepared from rat liver (Ames^l973) (3ml buffer/g wet liver weight in 1.15% KCl 
in O.IM sodium phosphate buffer) and homogenised using a Potter-Elvehjem homogeniser, attached 
to a Black and Decker driU, model 520 on a stand, at a drill speed of 2400 rev/min. The resulting 
homogenate was then centrifuged at 9000g for 10 minutes. After centrifugation, the layer of fat that 
had formed on top of the supernatant was carefully removed using a pasteur pipette. The supernatant 
was decanted and the pellet discarded. The supernatant was diluted to a final protein concentration 
of 30mg/ml.
The S9 fraction was then stored in liquid nitrogen in 2ml vials until use.
2.8.3 Monitoring o f S9 Fractions
2.8.3.1 Protein Determination
Adapted from the method of Lowry et al (1951), a lOpl and 20pl aliquot of sample (1/10 dilution of 
original) was added to sodium carbonate solution (3% v/v sodium carbonate in O.IM sodium 
hydroxide) to a volume of 500pl. Two ml of copper tartrate (9.2ml carbonate solution, 0.4ml 0.4%
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w/v sodium potassium tartrate and 0.4ml 2% copper sulphate) was added and left to stand at room 
temperature (21®C) for 10 minutes. To each sample was added 200pl of a 1:2 dilution of Folin- 
Ciocalteu’s reagent. The resulting solution was vortex mixed and left to stand for a further 10 minutes 
to develop the colour, which was then read at 660nm. Suitable controls and standards (lOpg - 150pg 
of protein BSA Img/ml) were run in parallel. A standard curve was plotted and the sample protein 
concentration extrapolated and expressed in mgAnl.
2.S.3.2 Cytochrome P450 Determination
Cytochrome P450 is determined in 39 fraction by the spectrum of the CO-complex of dithionite 
reduced P450, minus the non-reduced CO-complex spectra (Esterbrook 1972).
A 1ml aliquot o f 39 fraction (30mg protein/ml) was added to 5ml of O.IM sodium phosphate buffer, 
pH 7.4. The sample was gassed for 5 minutes with carbon monoxide. A baseline was recorded 
between 520 and 400nm. The cytochrome P450 in the sample cuvette was reduced by the addition 
of 2-3mg of sodium dithionite (Na23204), mixed by inversion and left to stand for 1 minute, after 
which the spectrum was recorded.
Calculation
An excitation co-efficient of lOOmoles' c^m"  ^ was used for the difference between 450 and 520nm.
Peak height = difference between absorbance at 450nm and 520nm 
P450 content = Peak height x 6  = }xmole/mg of protein
100 X  mg of protein = (pmole/mg of protein)
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2.8.4 Preparation of S9 Mix (and Buffer)
A 2ml vial o f S9 fraction was thawed at room temperature and placed on ice. To each 1ml volume 
of S9 fraction was added the following: 5ml of 0.2M sodium phosphate buffer, at pH 7 .4 ,1ml MgClj 
(80mM), 1ml KCl (330mM), 1ml NAD? (40mM) and 1ml G6P (50mM). The resulting S9 mix was 
kept at 4°C before use for a maximum of 3 hours. The S9 mix buffer used in experimentation did not 
contain any S9 fraction or cofactors. The volume was made up with distilled water.
2.9 DETERMINATION OF ENZYME ACTIVITY OF S9 FRACTION WITH/WITHOUT 
PARTICULATES
2.9.1 Ethoxvcoumarin-O-Dealkvlation
The assay is based on the 0-deethylation of 7-ethoxycoumarin to the highly fluorescent 7-
zt
hydroxycoumarin (umbelliferone) (UUrich^l972).
A 50pl aliquot o f microsomal fraction (0.375mg of protein) was added to 0.8ml of O.IM phosphate 
buffer, pH 7.4 and 0.2ml of ImM ethoxycoumaiin in (0.4pmol) which had been preincubated at 37°C. 
The sample was then hand mixed and preincubated in a heated cuvette holder at 37°C for 2 minutes. 
A range of particulate concentrations were added in PBSA (0 .5 ,1 ,5 , lOmg/ml) and made up to a final 
volume of 1.25ml. The reaction was initiated by the addition of 20pl of 20mM NADPH (200nmols), 
vortex mixed and incubated with continuous shaking at 37° for 5 minutes. Suitable controls and 
standards (0.5-5nmole of 7 -hydroxycoumarin) were run in parallel.
The reaction was terminated with 1.25ml methanol to precipitate the protein. The sample was then 
centrifuged at 1500rpm for 5 minutes to pellet the protein and the fluorescence of the supernatant was 
measured at X ex 370nm and X em 450nm. The results were expressed in nmoles/min/mg of protein.
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2.9.2 Epoxide Hydrolase
7-^H-styrene oxide is converted by microsomal epoxide hydrolase to the product 7-^H-styrene glycol. 
Unmetabolised styrene oxide is extracted into petroleum ether and discarded. The styrene glycol 
formed is extracted into ethyl acetate and the amount of radioactivity present is determined.
lOOjil of 0.5M Tris-HQ buffer pH 9 and 60ul (using a positive displacement pipette) of 2mg 
protein/ml microsomal suspension were mixed in a Sovirel tube with 210pl distilled water (given a 
total incubation volume of 380ul). The tubes were preincubated for 20 minutes in a 37°C shaking 
water bath. The reaction was initiated with the addition of 20ul of working substrate (0.76mg 7-^H- 
styrene oxide (specific activity) added to 4.04mg cold styrene oxide in 1ml o f acetonitrile, giving
1.31pCi/mg) and mixed. The reaction was terminated after 5 min by the addition of 9ml petroleum 
spirit (boiling range 40-60°C) and the tubes mixed for 10 minutes. The tubes were centrifuged 
(lOOOipm X  3 minutes) and separation of the aqueous and organic layers was accomplished by freezing 
in a cardice/industrial methylated spirits bath. The organic layer was discarded.
This procedure was repeated twice with fresh petroleum spirit, after which 2ml o f ethyl acetate was 
added and the tubes mixed for 10 minutes and centrifuged for 5 minutes at 2000rpm. Using a positive 
displacement pipette, duplicate 0.5ml aliquots were removed and added to 4.5ml Picofluor 30 
scintillant (Packard Instrument Co Ltd) and dpm counted on a LKB scintillation counter (LKB beta 
rack counter).
Included with this assay was a blank containing S9 which were boiled in screw capped Sovirel tubes 
for 20 minutes and then treated as other samples. A dose range of particulates was used (0.5, 1, 5, 
lOmgAnl ). An aliquot of particulate suspended in buffer was added in place o f water, maintaining 
the final volume of 380ul. In addition to the blank the dpm of 6  x 20ul aliquots of the working 
substrate were determined.
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Calculation of Activity 
nmole/min/mg protein =
rCdpm of sample) - (dpm of blank)! x 4
mg of protein x incubation time x specific activity used (min)
Specific activity o f =
dpm/2 0 ul stvrene oxide working
substrate solution 800 (nmol of styrene oxide in 2 0 ul)
2.9.3 Arvlhvdrocarbon Hydroxylase
The AHH activity was determined by measuring the production of 30HBP by the method of
e-t
(Dehnen^l973)
To 0.9ml of S9 mix (0.3mg protein/ml) was added lOOpl o f particles in PBSA to give a final 
concentration of 0.5, 1, 5 and lOmg/ml. The sample was vortex mixed and preincubated for 
20 minutes at 37°C with continuous shaking. The metabolising reaction was initiated by the addition 
of 25pl o f BP in DMSO (O.lpmol) and incubated for 5 minutes with continuous shaking. The 
reaction was terminated with 1ml of ice-cold acetone, while vortex mixing. The sample was 
centrifuged at 3000ipm for 5 min, at 4°C. The resulting pellet was discarded and 0.5ml o f supernatant 
was added to 2.5ml of triethylamine (7.5% v/v), mixed and the fluorescence measured at Z, ex 467nm, 
X em 518nm. On each occasion the sensitivity of the Perkin Elmer LS5 fluorometer was adjusted to 
100 fluorescent units, using a quinine sulphate standard (Ipg/ml) in O.IM sulphuric acid at X ex 
350nm and X em 450nm. A standard curve of the fluorescence of 30HBP (0 to 1.5nmol/ml) was 
prepared at the same settings for quinine sulphate. In this way all assays could be related to a single 
standard curve.
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Calculation
nmol 30HBP x 1ml = nmole 30HBP/mg/min 
time X protein mg
2.10 DETERMINATION OF BP TRANSFER FROM THE BP COATED PARTICLE 
SURFACE INTO MICROSOMAL LIPID BILAYER
2.10.1 Method for BP transfer in Aqueous Media (buffer)
To determine the solubilisation of BP into the 89 from the aqueous particulate adsorbed state, an 
increase in fluorescence at X ex 296nm X em 405nm associated with monomeric (dissolved) BP was 
measured (Lakowicz^l979).
BP coated particulates were suspended in aqueous media at a final concentration of 0.5pg BP/ml (final 
volume of 4ml). This was sonicated for 5 minutes, then placed in a quartz cuvette with continuous 
mixing and left to equilibrate at 37°C for 5 minutes, at which point the initial fluorescence (I„) was 
measured. The transfer reaction was initialised by the addition o f lOOpl of microsomal fraction with 
a protein content o f 12mg/ml (given a final concentration of 0.3mgAnl). At various time points the 
fluorescence (IJ was measured (2.5, 5, 10, 15, 20, 25, 30 minutes). After the last time point the 
suspension was heated to 55°C for 30 minutes. The suspension was then re-equilibrated at 3T C  for 
5 minutes and the final fluorescence measured (Io«).
2.10.2 Method for BP transfer in aqueous media with solvent (DMSO)
A final concentration of 0.5|XgAnl of BP (using BP coated particles) was used in the presence of 2.5% 
v/v DMSO (final concentration) in S9 suspension. This was achieved using a 20mg of particulate/ml
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of suspension of BP coated particulates in DMSO. An aliquot o f particulates with 2pg of BP was 
added to a test tube. Additional volumes of DMSO were added where necessary to make up a final 
volume of lOOpl DMSO. With the addition of 3.9ml of buffer the suspension was sonicated for 5 
minutes and treated in the same manner as the aqueous sample (see section 2 .1 0 .1).
Calculation
I = I, - I, X  100
2.11 PREPARATION OF THE AMES (BACTERIAL MUTAGENICITY) ASSAY
it <0-
Methods taken from Ames (1973).
2.11.1 Bacterial Culture Preparation and Maintenance
2.11.1.1 Preparation of Overnight (0/N ) Culture.
2 0 ml of nutrient broth (Oxoid 2.5g in 1 0 0ml) was pipetted in 100ml conical flasks containing 20ul 
of 1% v/v histidine (Ig in 100ml). This broth was then inoculated with a colony of TA98 taken from 
a master plate, and incubated in a shaking water bath at 37°C for 12-16 hours (o/n).
2.11.1.2 Checking of Bacterial Cultures
Each culture was checked for the following
Pre-existing mutants (mutants that are already histidine independent revenants). lOOpl o f o/n culture 
was plated onto a minimal glucose-biotin plate and incubated overnight at 37°C, after which colonies 
were counted.
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Spontaneous Mutants (mutants that are histidine independent produced due to experimental 
conditions). lOOul of o/n culture was pipetted into 0.5ml O.IM sodium phosphate buffer and 2ml of 
soft agar supplemented with histidine-biotin added. This was vortex mixed and plated out on minimal 
glucose plate, then incubated inverted for 48-72 hours at 37°C, after which colonies were counted.
Crystal Violet (testing for the loss o f capsule). lOOul of o/n culture was spread on a nutrient agar 
plate. A filter paper disc with lOul of crystal violet (Img/ml in H2O) was added, and the diameter of  
growth inhibition measured after 48 hours.
Ampicillin (AMP) Resistance (testing for the pklOl plasma that infers ampicillin resistance). lOOul 
of an overnight culture diluted 1 in 10® was plated out on nutrient agar plates containing lOpg/plate 
of ampicillin (Sigma) and colonies counted after 18 hour incubation at 37°C.
Number of Viable Cells. lOOul of a 1 in 10® dilution was plated out on a nutrient agar plate and 
visible colonies were then counted.
Criteria for Culture Used in Testing
No of Revenants
Pre-exiting Spontaneous Viable AMP CV
TA98
0.4 10-75 50-500 50-500 1 .2 cm
The above table represents ranges of acceptability that cultures fell within for experimental use.
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2.11.2 The Ames Test
t i aZ
Ames testing was performed by standard procedures using strain TA98 (Ames^l973). S9 fraction 
(0.15mg protein) in 0.5ml of O.IM sodium phosphate buffer ph 7.4, supplemented with KCl (33mM) 
and MgCl2 (8mM) containing the NADPH-generating system (4mM NADP and 5mM G-6 -P) was 
added to culture tubes in triplicate. To these was added BP in its various forms and concentrations, 
followed by the addition of 0.1ml of an overnight culture of TA98 (5x10® cells). Culture tubes were 
vortex mixed and incubated at 37°C for 20 minutes. Soft agar containing histidine (Sigma) and biotin 
(Sigma) (0.6g Difco bacto agar and 0.5g NADP in 100ml H2O, with 10ml o f 0.21g histidine and 0.2g 
biotin in 1 0 0 0 ml H2O) was added and vortex mixed with the contents of the culture tubes and poured 
onto minimal glucose media agar (20ml, 20% glucose [20g in 100ml], 50ml 25 x vogel bonner salt 
ph 7 .4 ,7.5g Difco agar in 430ml of H2O) plates. Plates were allowed to solidify for 10 minutes, then 
incubated inverted at 37°C for 48-72 hours, after which revenant colonies were cotmted and 
backgroimd lawns o f bacteria examined.
2.12 DETERMINATION OF METABOLITE PROFILE OF BP WITH PARTICULATES
Determining the profile of metabolites produced from "^^ C-BP coated to particles was accomplished 
using standard S9 mix and "^^ C-BP coated particles (see 2.8.2 Preparation of S9 Fraction for details), 
and high performance liquid chromatography (HPLC) (Selkirk 1974).
The radiolabeUed [7,10-14C] BP coated particles were added in PB SA and DMSO (for concentration 
see Tables 4.3 and 4.4) to the S9 suspension and incubated for 20 minutes at 37°C (as described for 
the Ames test (see section 2.11.2). The metabolising reaction was then terminated with an equal 
volume of cold acetone. The BP and any resulting metabolites were extracted using three successive 
washes with ethylacetate, which were then pooled. This ethylacetate phase was then evaporated to 
residue, under a constant stream of oxygen free nitrogen gas. The residue was then resuspended in
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methanol (lOOpl) and injected into the HPLC fitted with a 25cm C18-spheiisorb column with an 
elution flow rate of 1.8ml/mia The diol metabolites were eluted using 50% methanol:4% 
ethylacetate:46% water (v/v) for 30 minutes, followed by 70% methanol:4% ethylacetate:26% water 
(v/v), to elute the remainder of the BP metabolites and any unmetabolised BP. The progress of 
metabolite elution was monitored using a fluorescence detector at ex X of 264nm with an em A. cut 
off filter of 400nm.
Fractions were collected every 0.2 minutes in scintillation vials. 4.5ml of Picofluor scintillation fluid 
was added and the radioactivity was determined by scintillation counting.
2.13 P388D1. CHO and V79 CELL CULTURE MEDIAS
e ta ?  e i
Cell culture techniques adopted from Brown (1980) and Tan (1982).
2.13.1 Acid Treated Serum
Foetal calf serum (Gibco) was acid treated by addition o f O.IM H Q  until pH 3 was obtained. The 
acidified serum was left for 3 hours at 4°C, then restored to its original pH with the addition o f O.IM 
NaOH and stored frozen until required. The acid treatment of the serum removed the residual LDH 
activity.
2.13.2 Complete Culture Media
The main culture (complete) media consisted of 500ml o f McCoys 5 A (modified) supplemented with 
50ml acid treated foetal calf serum, 5ml (200mM) glutamine and 5ml kanamycin (10000 u/ml), which 
was stored at 4°C and pre-warmed to 37°C in a water bath before use.
- 65
2.13.3 Crvopreservation Media
The cryopreservation media was prepared immediately before use by gradually adding an equal volume 
of DMSO to complete media (which was kept on ice) with continuous agitation.
2.14 PREPARATION OF P388D1 CULTURES
2.14.1 Maintenance and Subculture
The medium was removed from the tissue culture flask (Nunc), leaving only the attached cells, and 
replaced with 5ml o f fresh culture medium. Using a siliconized rubber policemen (a piece of 
siliconized tubing over a bent glass rod), the cells were gently scraped from the bottom of the flask. 
The resulting suspension was aspirated to homogeneity. The suspension was then centrifuged at lOOg 
for 2 minutes in a bench top MSB centrifuge adapted for reproducible low speeds, by means o f a 
voltage regulator. The pellet was resuspended in 5ml of fresh media, the viable cell number 
determined by trypan blue exclusion and the cells were then plated out at a density of 2 x 10® cell/ml 
in tissue culture flasks. The flasks were incubated at 37°C in a humidified atmosphere with 5% CO2 
for 3 days before the next subculture.
2.14.2 Freezing for Crvopreservation
The cells were resuspended at a density of 3.25 x 10®/ml in culture media. This suspension was mixed 
with cryogenic preservation media at a ratio of 4 parts cell suspension in medium to 1 part cryogenic 
preservation medium. The cryogenic preservation medium was added dropwise, with gentle hand 
mixing. 1ml of the resulting suspension was aliquoted into 2ml volume cryotubes. The cells were 
then gradually frozen in liquid nitrogen vapour. This was done by progressive descending steps using 
a hand-freeze freezing tray (Union Carbide, Cryogenic Equipment) into liquid nitrogen, where they 
were stored until required.
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2.14.3 Thawing of Cells for Culture
The frozen cell suspension, while in its cryotube, was quickly thawed by immersion into a 37°C water 
bath, with gentle agitation. The thawed suspension was pipetted into a 20ml universal tube and 5mls
of fresh media was added, drop wise, with gentle agitation to promote mixing. The cell suspension 
was then centrifuged and the pellet was resuspended in fresh culture medium and plated out as 
described for subculturing (see section 2.14.1).
2.15 PREPARATION OF CHO AND V79 CELL CULTURES
2.15.1 Maintenance and Subculture
The medium was removed from the flask (leaving only the attached cells) and replaced with 5ml of 
PBS A, which was gently swirled to wash the cells free of medium. The PBS A was removed and 
replaced with 5ml trypsin/EDTA (Q.05%/0.02%) in PBS A at 37°C. The trypsinated flask was 
incubated for 1 minute, with gentle hand agitation, after which 5ml of fresh medium was added. The 
resulting medium and cell suspension was gently aspirated to produce an even cell suspension and then 
centrifuged at lOOg for 2 minutes to precipitate the intact cells. The supernatant was removed and 
discarded and the cell pellet was resuspended in fresh media and a viable cell count determined. The 
cells were then seeded at 2.5 x 10^  ceU/ml in flat bottomed Nunc culture flasks. The flasks were 
incubated at 37°C in a humidified atmosphere with 5% COg for 3 days before the next subculture.
2.15.2 Freezing and Thawing (Method previously described under P388D1)
Cells were subcultured to a seeding density of 1.25 x 10® ceU/ml before freezing.
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2.16 DETERMINATION OF VIABILITY TRYPAN BLUE EXCLUSION
A 250)01 aliquot of trypan blue was placed in a test tube. To this was added lOOjol of ceU suspension. 
This sample was then gently agitated. A small aliquot was then pipetted on to a haemocytometer then 
viewed through a microscope. Viable cells appeared straw coloured and non viable cells appeared 
blue. A total count of viable and non-viable cells were made.
Calculation
Total cells/ml = number of cells counted (straw and blue in colour) X 3.5x10^
% viability = straw coloured cell count X 100 
Total cell count
2.17 DETERMINATION OF CYTOTOXICITY
2.17.1 Cvtotoxicitv Assav Using Lactate Dehvdrogenase
Lactate dehydrogenase (LDH) is a cytosolic enzyme which leaks out o f cells with damaged 
membranes. The LDH activity is measured in the cell medium and in the solubilised cells. The 
activity in the medium is expressed as a percentage o f the total activity (medium plus solubilised 
cells). The reaction is pyridine-linked and can be followed by the reduction of NADH which has an 
absorbance maximum at 340nm that distinguishes it from the oxidised form (Bergmeyer 1974).
The P388D1 cells (Penarth Pneumoconiosis Unit) were plated at a density of 0.5 x 10®/ml, Iml/weU 
in 12-well plates (Nunc). The cultures were incubated at 37°C in a humidified 5% CO2 incubator 
overnight (16-18hrs). The medium was removed from the cells, which were then washed with PBS A 
leaving only attached cells. To these cells was added 2ml of acid treated serum culture medium, 
containing the appropriate concentration of particles. After an 18hr exposure period (at 37°C in a 5% 
CO2 humidified atmosphere) the culture media was decanted into LP4 tubes which were centrifuged
at 3000 rpm for 5 minutes to precipitate any debris (cell and particulates). The resulting supernatant 
was then decanted. To each culture well was added 2ml of solubilising agent (0.6g NaCl, 0.1 g Triton 
X-100 and O.lg bovine serum albumin (BSA) in 100ml of distilled water). The attached cells were 
scraped into suspension using a rubber policeman. These solubilised cell lysates were then added to 
the cell pellets, vortex mixed and then centrifuged.
From each sample tube 200ul of medium or solubilised ceU lysate was mixed with 3ml o f substrate 
buffer (3.5g K2HPO4, 450mg KH2PO4 and 31mg sodium pyruvate in 450ml distilled water) at 37°C. 
To initiate the reaction 50ul of NADH (42mg in 4.5ml 1% NAHCO3) was added and the loss of 
NADH was monitored over a 2 minute period at 340nm.
Calculation of Leakage and Enzvme Activitv 
Optical density min'  ^ (CD)
CD medium Leakage % = x 100 
CD medium + CD cells
Medium containing acid treated serum was used as a blank which was subtracted from all other 
medium readings.
2.17.2 Determination of cvtotoxicitv using Methvl-Umbelliferone Substrates
Enzyme activities determined were N-acetyl-p-Gjvco^ ar/MAiJL(üe. (NAG), p-Glucuronidase (Glu) and p- 
Galactosidase (Gal). These enzymes are associated with the lysosomes, which are particularly 
numerous in phagocytic cells.
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The detection of the enzymes in the medium indicates damage of the lysosomal membrane and plasma
membrane. The product produced by the catalytic activity of the appropriate enzyme was 4-methyl-
eJ~^
umbelliferone, a highly fluorescent compound in an aqueous alkaline environment (Verity^l967).
The cells were cultured and treated in the same manner as previously described for the LDH assay. 
From each sample tube lOOpl of media or solubilised cell lysate was mixed with 1ml o f substrate 
buffer. The substrate buffer for NAG and Gal was citrate phosphate buffer (0.2M, 8 .8 g citrate and
11.7g disodium hydrogen phosphate in 500ml of water buffer to pH 4.5) and G/u was acetate buffer 
(0.2M, 6.15g sodium acetate in 400ml of HgO, buffered to pH 4.0 with glacial acetic acid, then made 
up to 500ml). A solution of ImM in water of each substrate was prepared (4-Methylumbelliferone 
glucuronide,4-MethylumbeUiferone galactoside, 4-Methylumbelliferone N-acetyl-glucosaminide). The 
substrate and buffer were diluted 1:1 before use. The samples were then incubated at 37°C in a 
shaking bath. Glue 10 min, NAG 30 min and Gal 60 min.
The reaction was then terminated with 1.5ml of 0.2M carbonate buffer at pH 10.4 (11.6 g of sodium 
carbonate [anhydrous] and 3.4g of sodium hydrogen carbonate in 500ml of water). The samples’ 
fluorescence was then measured at X ex 385nm and X em 435nm.
Calculation
Leakage % = Fluorescence o f Medium (FM) x 100 
FM + Fluorescence o f cell lysate
2.17.3 Neutral Red Uptake
Neutral red is believed to enter the cell by non-ionic diffusion and accumulates in the lysosomes of 
viable intact cells. The amount of dye taken up by cells in culture can be used as an index of viability 
(Nemes et al, 1979). The method used was that of Borenfreud and Puemer (1985).
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A 2% (w/v) stock solution of neutral red was made up in double distilled water, which was filter 
sterilised (using Gelman acrodiscs, pore 0.22pm) and stored at 4°C. A 250pl aliquot of the 2% stock 
solution was added to M l culture media to give a final concentration o f 50pg/ml and incubated to 
37°C before use.
Cells were cultured in 24 well plates (Nunc) and treated with test particulates for 3 days. The culture 
medium was removed and the attached cells washed with PBSA and incubated with 1ml of neutral 
red culture medium per well, for 3 hours at 37°C in a humidified 5% CO2 atmosphere. After 
incubation the wells were washed with PBSA to remove any unabsorbed dye. The cells were 
destained using 1ml per well of destain (1% acetic acid in 50% v/v ethanol) for 20 minutes with 
continuous mixing (Luckman Rocker). The absorbance was measured at 540nm within 1 hour using 
a microelisa mini-reader (MR520, Dynatech Labs, Virginia, USA), which had been previously blanked 
on the destain solution and the results were expressed as a percentage o f untreated controls.
2.17.4 Kenacid Blue Staining
Kenacid blue dye hydrogen bonds with the protein of cells in a neutral alcoholic environment, that can 
then be liberated when the environment is made acidic. The method used was that o f Knox et al 
(1986).
This method was combined with that for neutral red. The neutral red destain solution was sufficient 
to fix the cell to the culture wells. This solution was removed and the attached cells were washed with 
PBSA to remove all traces of neutral red. A 1ml aliquot of Kenacid blue stain prepared just before 
use (12ml glacial acetic acid added to 88ml of a stock solution of 0.4g Kenacid blue (BDH) dissolved 
in 250ml ethanol and 630ml distilled water and filtered through Whatman No 1 paper) was added to 
each well and left mixing for 20 minutes at room temperature on a Luckman rocker. The stain was 
then removed and the plates were washed with destain solution (10% v/v ethanol, 5% v/v glacial acetic
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acid and 85% v/v water) until the washes no longer appeared blue in colour. Exactly 1ml of desorb 
solution (1ml potassium acetate in 70% ethanol) was added. The plates were agitated for a further 30 
minutes and the absorbance of the released dye was measured at 570nm using a microelisa mini reader 
within 1 hour. A well incubated with medium only, was used as a blank after treating in a similar 
manner to that of the cultured cells. Its absorbance was subtracted from the test readings and the 
results were expressed as a percentage of untreated controls.
2.18 PREPARATION OF SAMPLES FOR ELECTRON MICROSCOPY
The methods were adopted from AUen (1983), Boyde (1978) and Brunk^(1980).
2.18.1 Method I. Sample Preparation for TEM of Monolaver Cultured Celts.
The culture medium was removed, leaving only attached cells at the bottom of the plates. The 
attached cell layer was washed with 2ml of PBSA, which was then removed and the cells were then 
fixed with 1ml of 4% v/v glutaraldehyde in O.IM cacodylate buffer. At the end of the fixation time, 
the cells were washed in O.IM cacodylate buffer for at least 1 hour but no more than 18 hours. The 
cells were then counter-fixed in 1% (v/v) osmic acid in O.IM cacodylate - HNO3 pH 7.4 buffer for 
2 hours at room temperature. After completion of this second fixation the cells were dehydrated, in 
increasing concentrations of ethanol (25,50,75,96 and 100% v/v), with each progressive step having 
two changes of at least 1 0  minutes each.
The cells were then embedded in epoxyresin, by washing the cells and gradually increasing the 
concentrations of epoxyresin in ethanol (25%, 50%) until 100% resin was obtained. The last 100% 
resin was drained off and fresh resin added. This preparation was left to stand for 48 hours at room 
temperature and then heated to 60°C for a further 48 hours to aid polymerisation of the resin.
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When hard, the samples were cut between 0.5-1.0pm, mounted on copper grids and stained with 
uranium acetate and viewed under a Joel lOOB electron microscope.
2.18.2 Method n .  Sample Preparation for SEM of Monolaver Cultured Cells.
The cells were cultured and treated on glass coverslips for the required time, then fixed and dehydrated 
as for cell sample preparation for TEM.
After the fixation and dehydration steps the coverslips with cells were transferred into 100% 
dehydrated acetone (containing excess anhydrous NazSOJ by progressive increases in percentage of 
acetone (25,50,75 and 100% v/v).
The sample was then "critical point dried" and splatter coated with gold before viewing in a Joel 200x 
electron microscope.
2.18.3 Method m .  Sample Preparation for TEM of Bacterial/Microsomal Svstem.
The sample was prepared using the Ames mutagenicity test soft agar overlay. The soft agar overlay 
contained 2ml of soft agar, S9 (1.5g o f protein in 0.5ml o f 0.1 phosphate buffer at pH 7.4, with the 
NADPH generating system), bacteria (lOOpl o f overnight TA98 culture) and the particulates (5mg, 
added in either 50jil of DMSO or PBSA).
The soft agar was added to the microsomes either straight away, or after a 20 minute pre-incubation, 
in a shaking water bath at 37°C.
The resulting soft agar overlay was vortex mixed and a lOOpl aliquot was then pipetted into ice chilled 
phosphate buffer, to produce agar ’worms’. These ’worms’ were then prepared for TEM following
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the method for cultured cells. The sample was cut to 0.5-1.0pm; mounted on copper grids and stained 
with uranium acetate before viewing on the Joel lOOB electron microscope.
2.19 PREPARATIVE METHOD FOR TRACHEAL INSTILLATION
Animal Groups and Samples Dosed
ANIMALS DOSED NUMBER OF ANIMALS
TIME (KILL) POINTS 12HR 1 DAY 3 DAY 5 DAY
Saline 2 2 2 2
FeiOa 2 2 2 2
BP 2 2 2 2
BP-Fe^Og 2 2 2 2
A minimal number of animals were used for practical reasons. The method used was taken from 
Henry et al (1973) and Saffiotti et al (1968).
2.19.1 Preparation of Sample for Instillation
The sample was made up in saline, then mixed and sonicated for 5 minutes, before loading the syringe 
with 0.25ml of the suspension, the sample was vigorously mixed by hand. The effective dose volume 
expelled from the syringe was 0 .2 ml.
2.19.2 Surgical Method for Instilling in Hamsters
The animals were anaesthetized using a short-acting barbiturate (Sagital) given intraperitoneaUy 
(0.1ml). The hamster was then suspended vertically on a suitable animal support board by a rubber 
band, which was placed under the upper incisor teeth.
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The larynx was illuminated from above by a bright light. The ’tip’ o f the larynx was seen to be a 
white disc (like a polo).
The test material was drawn up in a syringe and delivered through a 19 gauge blunt needle. The 
insertion of the needle was facilitated by pre-bending it slightly (6.0cm long, bent at about 135°C at 
4.6cm from its tip).
The needle was inserted through the larynx under direct visualisation and passed down the trachea (this 
was felt through the blunt needle by its passage over the cartilage rings). The site of deposition was 
predetermined by the length of the needle (in young adult hamsters the tracheal bifurcation is 
approximately 5.5cm from the incisors).
The inoculum was expelled from the syringe during inspiration (with a little air). The animals were 
then left to recover naturally, noting any regurgitation. Animals in similar dose groups were kept 
together.
2.19.3 Culturing of Lung with Tritiated Thvmidine
The method was adopted from Placke and Fisher (1987) and Doolittle et al (1984).
Animals were sacrificed by CO2 suffocation, the thorax was opened to expose the heart, lungs and the 
trachea. Two ligatures were tied, one on the right bifurcation of the bronchiole and the other loosely 
about the trachea, a cut was then made through the larynx. A cannula was then inserted into the 
trachea and the inoculum of 2ml of 1% agarose (2% agarose, sterilised by autoclaving at lOpsi for 10 
minutes and kept at 40°C before use, when mixed in a 1:1 proportion with supplemented MEM (see 
section 2.19.3.1 for details)). It was then instilled and the ligature tied off.
An ice pack was then applied to facilitate the setting of the agarose for a few minutes. The heart and 
lungs were then removed and placed into ice cold media. The right lung was removed for preparation
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of the microsomal fraction and stored in liquid nitrogen for assaying later. The left lung which 
contained 1% agarose with supplemented MEM was cut into strips transversely and the bronchiole and 
trachea cut into rings (2-3mm thick). These strips were then incubated for 4 hours at 37°C in CO2 
incubator in tritiated thymidine supplemented MEM. The tritiated thymidine supplemented MEM was 
the same as the media for instilling but without the agarose and contained lOpCi/ml [methyl-®H] 
thymidine (Amersham International, Amersham; specific activity 40CiMM).
After this time the strips of lung tissue were collected into 10% buffered formalin and were left to fix 
for 48 hours before embedding in paraffin wax and preparing serial sections (5pm). Sections were 
taken for autoradiography and differential cellular staining with haematoxylin and eosin for histological 
observation.
2.19.3.1 Medium required for lung culture
With MEM at final concentration of Ix the following supplements were added, glutamine (lOmM), 
kanamycin (lOOjXgAnl), fimgazone (5|Xg/ml), sodium hydrogen carbonate (3.75mg/ml), hydrocortisone 
(l.OpM), insulin (2.5pg/ml), retinoic acid (30ng/ml).
2.19.4 Autoradiographv
Once the sections were cut and mounted, the slides were placed in a 60°C oven overnight, which 
helped to remove the majority of paraffin wax and fix the samples more permanently to the slides.
These slides were then washed initially in xylene and through graded alcohol washes into distilled 
water and left to air dry. The slides were then dipped into Hford K2 emulsion (Ilford, Knutsford, 
Cheshire) under darkness and were then transferred to a light-proof container and allowed to dry for
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3 hours. The light-proof container was wrapped in tin foil and stored at 4°C for 14 days for 
development (Ashby et al 1985).
After the time period, the slides were dipped in Kodak D19 (Kodak, Hemel Hempstead, Bucks) 
developer at 19-21°C for 5 minutes, then washed in distilled water for 1 minute. The slides were then 
transferred to Ilford Hypam fixer for 5 minutes and washed in running tap water for 10 minutes ready 
for staining.
2.19.4.1 Preparation of Haematoxylin and Eosin Autoradiographed Slides 
The autoradiographed slides were stained as follows :-
1 . Distilled water 2 min
2 . Haematoxylin lOmin
3. Running tap water 2 min
4. 1% acid alcohol 30sec
5. Tap water Imin
6 . Scott’s water Imin
7. Tap water Imin
8 . Eosin 3min
9. Running tap water 2 min
1 0 . 70% alcohol Imin
1 1 . 90% alcohol Imin
1 2 . 1 0 0 % alcohol Imin
13. 1 0 0 % alcohol 2 min
14. Xylene Imin
15. Xylene 2 min
Slides were then drained and mounted in DPX for viewing.
The above procedure lightly stained the nucleus and cytoplasm enabling effective grain counting.
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2.19.4.2 Grain Counting
The slides were scored through a x 100 objective under oil emersion and the grains were counted by 
a Biotran III computerised image analyzer. After calibration an area equal to the size o f the nucleus 
was used to coimt the grains in the nucleus and cytoplasm.
The net nuclear grain count was obtained by subtracting the cytoplasm count from the nuclear count.
To count the S-phase cells, the slides were viewed through a x 10 objective and all cells viewed in 
the objective field were counted and the S-phase cells. The % S-phase was established by the 
expression :-
S-phase x 100%
Total cells
The S-phase cells were recognised by a heavy label presence.
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3. BACTERIAL MUTAGENICITY
3.1 CARCINOGENESIS
The induction of cancer is believed to be a multistep process (Barrett 1987). However, 
experimental carcinogenesis has usually been broadly defined as initiation, promotion and progression 
(Pitot 1986, Farber 1984,^1987). These are not exclusive stages, but a loose framework, as genetic 
events that constitute initiation in one tumour may be promotional or progressional steps in another. 
The boundaries between the various stages are not always definable.
Initiation is generally considered to result from an irreversible genetic alteration, which is insufficient 
in itself to induce tumorigenesis. Promotion may be defined as the clonal expansion o f the initiated 
cell into a benign or preneoplastic focus. Progression involves the events necessary for the conversion 
of the preneoplastic or benign population to the malignant stage.
The final expression is based on the somatic mutation theory of cancer, in which a tumour is produced 
by clonal origin from a single aberrant cell that has acquired a number of heritable alterations (Wolf 
1974; NoweU 1976).
The nature of chemical carcinogenesis may be broadly categorised as foUows:-
1. Genotoxic
2. Epigenetic
3. Oncogenes/Suppressor Genes
However, the development o f the final tumour may result from a combination of these categories.
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3.1.1 Genotoxic
Agents that are genotoxic, cause their effects through direct action with DNA and its processing which
falls into the following categories:-
1. Covalent binding - resulting DNA adducts are not removed, the resulting lesions can produce 
mutations or chromosome aberration.
2. Interference with DNA replication, resulting in reduced template fidelity, mis-matching of 
bases and inhibition of precursor synthesis.
3. Radical cleavage - short-lived free radicals (O^, OH) reacting with the DNA backbone leading 
to mutations through chromosome breakage (rearrangement and deletion).
4. Interference with DNA repair
5. Interference with DNA segregation
3.1.2 Epigenetic
Agents that are epigenetic may cause the following effects through modulation of DNA or DNA
lesions:-
1. Acting as a hormone - directly with DNA and/or through the secondary messenger system, 
causing over-stimulation or repression of nonnal processes.
2. Interaction with growth receptors and factors - reduction and/or increase in cellular turnover,
activating neoplastic or pre-neoplastic cells to propagate.
3. Interactions causing detrimental effects on cell differentiation processes, leading to restrictive 
growth and membrane structure, causing inflammation and cytotoxicity.
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3.1.3 Oncogenes/Suppresser Genes
The oncogene is viral DNA that has become incorporated into the host genome. The simplest model 
relating to the involvement o f oncogenes in the evolution of a tumour cell is thought to occur through 
a series of oncogene activations, each of which is necessary and contributes to the full malignant 
phenotype (Weinberg 1989). The tumour suppressive genes, anti-oncogenes or receive oncogenes, are 
nonnal cellular genes that act as negative regulators of tumour cell proliferation and must be lost, 
inactivated or mutated for neoplastic transfomiation to occur (Weissman et al 1987). Thus, chemicals 
could cause modulation of these genes leading to the stimulation of neoplasia.
The initiation event is believed to be a mutational event, supported by studies in mouse skin 
carcinogenesis in which an irreversible event induced by a single exposure to a carcinogen is caused 
(BoutweU 1974, Loehoke et al 1983). This mutational event may occur within an oncogene (Brown 
et al 1986, Sukumar et al 1983) or may cause the modulation of gene groups (Alleles), so as to vary 
their expressional contribution, producing a change in cellular regulation (Bos^l987, Foirester et al 
1987).
The distinction between routes of carcinogenesis via genetic or epigenetic events may not be distinct 
The promotion and progression of carcinogenesis, may involve epigenetic as well as genetic factors. 
Farber et al (1987) and Barnett and Thomassen (1985) suggested that focal proliferation (or clonal 
expansion) was an essential part of promotion. However the mechanism by which it is achieved may 
be varied and includes differential growth stimulation, decreased terminal differentiation or altered 
balance between stimulation of cell growth and death in hypeiplasic foci.
Thus, there may be many mechanisms of malignancy and each may have many complex steps before 
its eventual expression. It is therefore likely, that a cell has to undergo a number o f changes to
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become malignant and overcome the immuno-surveillance mechanisms for continued expression. As 
man is made up of many billions of cells, cancer cells are therefore rare events.
3.2 CARCINOGENICITY AND MUTAGENICITY
Testing for potential carcinogens in vivo has proved to be expensive and time consuming. In recent 
years there has been an increasing reliance on the use of in vitro methods. These in vitro methods 
involve measuring genotoxic changes, covering areas such as mutagenicity, chromosomal damage and 
repair and cell transformation.
In vitro gene mutation assays are conducted in bacteria, lower eukaryotes such as yeast and fungi, 
mammalian cells in cultures, insects and plants. The most widely used short-term test for gene
mutation is the Salmonella assay developed by Ames. The bacterial mutagenicity assay (Ames test)
deil
is usually performed in a plate incorporation assay or a preincubation modification (Ames^l973). 
Chemicals, with or without metabolising systems (usually 89 fraction of rodent liver, after pretreatment 
with agent [generally Aroclor 1254] for non-specific induction of metabolising enzymes) and a strain 
of Salmonella with mutations to detect frameshift or base pair substitution, which is mixed in a soft 
agar overlay and plated. The revertant would grow into distinct colonies (for more detail see section 
3.4).
The cell types chosen for gene mutation in mammalian cell culture include the mouse lymphoma 
L51787, Chinese Hamster Ovary cells (CHO) and Chinese Hamster Lung cells (V79). In aU cases 
cells are exposed to the test substance for a suitable period of time and then subcultured to determine 
cytotoxicity and to allow phenotypic expression prior to mutant selection. Exposure to the test agent 
could be done in the presence or absence of a metabolising system (usually S9).
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The determination of mutant phenotype is through the resistance of the cultured cells to the presence 
of nucleotide analogues. Mutation results in loss of key enzymes involved in the conversion of these 
analogues to nucleotides that are lethal to the cell.
Tests for chromosomal damage include assays for chromosomal aberrations (both numerical and 
structural) and sister chromatid exchange (SCE) formation in mammalian cells in culture (including 
human cells). In vitro tests for chromosomal damage are performed using continuous cell lines or 
strains (CHO, V79), rodent or human peripheral lymphocytes in primary culture, or any cell type with 
a defined chromosomal structure. Metabolic activation systems are routinely included (S9). The 
structural changes in the chromosome are observed by microscopic examination of the metaphase stage 
of mitosis.
Tests for DNA damage and its subsequent repair included bacterial tests and tests for unscheduled 
DNA synthesis (UDS) in mammalian cells. Bacterial tests involved the use of repair proficient and 
repair deficient strains of bacteria (E. coli and B. subtilis). The tests do not measure DNA damage 
or mutation, but are more indicators of chemical interaction with DNA. Chemicals that are effective 
at killing deficient organisms are presumed to be more genotoxic.
The mammalian cell UDS tests are commonly performed in primary cultures o f rat hepatocytes (due 
to their inherent metabolic capabilities). DNA synthesis is induced as a result of repair o f damage at 
any point on the genome. Since it was believed that disrepair or incomplete repair may result in a 
permanent alteration of DNA, these tests may be an indication of premutational or precancerous 
events.
Cellular transformation assay (proposed as an assay for carcinogenesis and mutagenesis) involves 
treating cells with a chemical which induces morphological transformation to produce foci o f cells with 
visibly different growth patterns against a background of untransformed cells.
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There have been several attempts to systematically evaluate the ability o f short-term tests to predict 
carcinogenicity (McCann et al 1975, Purchase 1976, Green 1980, Tennant 1987, Zeiger 1990).
Four widely used in vitro assays for genetic toxicity were evaluated for their ability to predict the 
carcinogenicity of selected chemicals in rodents. These assays were mutagenic in Salmonella and 
mouse lymphoma cells, chromosome aberration and sister chromatid exchanges in CHO cells. The
test results showed a significant difference in individual concordance with the rodent carcinogenicity,
„  ttat
based on long-term rodent carcinogenicity studies (Tennant^l987, Zeiger 1987).
The concordance o f each assay was approximately 60%. No battery o f tests constructed from these 
assays improved substantially the overall performance of the Salmonella assay.
There is a good correlation between carcinogenicity and mutagenicity when one uses the bacterial
d a l
mutagenicity assay (Ames test) as a means of validation (Tennant 1987, Zeiger 1987).
The use of the mutants of Salmonella typhimurium, which respond to chemical mutagens either by 
directly or upon activation by a crude enzyme preparation (S9) from rat liver cells, showed a good
correlation, 87.7% were mutagenic, most of which required metabolic activation (Ames^l975; McCann
e^tal
and Ames 1976; Tennant^l987, Zeiger 1987). The compounds tested were known carcinogens and 
non-carcinogens o f varied chemical group classifications (PAH, nitro-amines, nitrosamines and 
polychlorinated biphenyls (PCB)).
Additionally, epigenetic carcinogens cannot be detected in mutagenicity assays (saccharin, sairole, 
chloroform, CCI4). A qualitative correlation between the result o f short term assays and carcinogenic 
potency should not be expected. It is predictable that a process in animals which usually requires 
multiple treatments with an agent and many months of biological development to produce tumours 
would not be mirrored in a mutagenic effect in a relatively simple bacterium.
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The ‘truth’ against which short-term assays are compared, involve studies in at least one sex o f rat or 
mice, and these carcinogenic assays are rarely repeated because of time and cost considerations.
Conflicts between rodent species carcinogenicity data and its concordance to humans wiU have an 
inherent error in correlation. Short-term tests would not be expected to be 100% in concordance if 
carcinogenicity data does not agree.
e,i dl
The results and analysis presented by the NTP study (Tennant^ 1987, Zeiger 1987) supports the 
conclusion that a positive Salmonella mutagenicity can be used to infer carcinogenicity in rodents but 
a negative response cannot be used to infer non-carcinogenicity.
For the purpose of this study the Ames test seemed to best suit our needs, giving a measurable index 
of biological effects that may be caused by BP in its various states, in the presence and absence of 
particulates under test.
3.3 ASSESSING AIRBORNE MUTAGENS/CARCINOGENS
Measuring the hazard and determining its risk to man mainly relies on extrapolation from animal data 
and the identification of the carcinogen. Ambient air is filled with hundreds o f toxic chemicals, and 
to measure each would be a monumental task. Determination of their interactions would be an even 
greater task.
Chronic exposure to low levels o f mutagens and carcinogens in the air occurs because o f everyday 
releases from exhaust fumes o f vehicles, incineration, chemical manufacturers, consumer products (coal 
and wood) and building materials.
85-
The highest risk pollutants are found in the particulate products of incomplete combustion (Katz et al 
1976, Perera 1981, Eiceman^l983). However, even though present in small quantities they may be 
potent carcinogens, and synergistic effects in hazard assessment are not fuUy understood.
A well known case of synergism involves smoking and exposure to asbestos. Both pre-dispose people
to lung cancer, but individuals who both smoke and are exposed to asbestos have an increased
dal
incidence of a lung cancer. From the epidemiological studies by Selikoff (1964,1968,1980) regarding 
the incidence o f lung cancer among workers who were occupationally exposed to asbestos, it was 
concluded that asbestos increased the risk o f death from bronchiogenic carcinoma in cigarette smokers 
by 8 fold and that asbestos workers who smoked had a 92 fold increased incidence, compared to non- 
smokers without occupational exposure to asbestos. Individual testing o f asbestos and cigarette smoke 
would not have shown up this potential risk. In addition many potential carcinogenic mixtures will 
be missed with individual testing.
3.4 AMES TEST FOR MUTAGENICITY
The Ames bacteria are derived from Salmonella typhimurium LT  ^ strain which was developed by
dal
Ames for mutagenicity screening (Ames^1973 and 1975). There are five main strains TA98,
TAIOO, TA1535, TA1537 and TA1538, containing a mutation resulting in a growth dependence on 
histidine. The mutation is detected as a reversion to histidine independence (his* his^)
These strains all have additional mutations which make them more susceptible to the mutagenic effect 
of chemicals. These are :-
1. Elimination of the excision repair system for DNA which also included the gal and bio region 
resulting in an absolute requirement for biotin.
86 -
2. Loss of lipopolysaccharide coat (down to the keto-deoxyoctanoate-lipid core) that encapsulates 
the bacteria.
3. The addition of the pkmlOl plasmid (TA98, TAIOO) which contains an error prone DNA 
repair system and which also confers ampicillin resistance on the bacteria.
The strains TA1537, TA1538 and TA98 (TA1538+pkl01) are frameshift (f) mutation specific while 
TA1535 and TAIOO (TA1535+pkl01) are base (b) substitution specific. These mutations take place 
at the engineer histidine mutation site of repeating -C-C-(f) or -C-G-(b) units.
In practice the test chemical and bacteria (which is unable to synthesize histidine (his')) is added in 
a soft agar overlay containing enough histidine and biotin for a few generations of growth, during 
which initial DNA damage may either be repaired or become a mutation. The mutations are then 
expressed as a function and gene product. When the histidine is exhausted, only mutants can grow. 
The overlay may also contain a selected homogenate of mammalian liver, which is usually obtained 
from rat (however, it can be human lung, liver, kidney etc), so detecting mutagen/carcinogens that 
require metabolic activation.
The overlay is added to a petri dish containing hard agar, with buffered salts and minimal glucose. 
This plate is then incubated, usually inverted, for 48-72 hours.
If the test chemical is a mutagen then a number of bacteria will revert to histidine independence (his^ 
wild type), these bacteria grow up to visible colonies. The increase in the number of revertants over 
the spontaneous background revertants is an index of the potency o f the chemical as a mutagen. 
Additionally the added histidine allows a "background lawn" of bacterial cell growth, that can be 
viewed under a light microscope. This lawn by its appearance or absence can give valuable toxicity 
information that can supplement the observed mutagenicity.
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3.5 AMES TESTS AS A SCREEN FOR CARCINOGENIC PAH/PARTICULATES
In evaluating air samples, the main aim is to identify which ’active’ ingredient(s) (or fractions) may 
be responsible for increasing the risk o f pulmonary cancer, or initiating i t  Once this has been 
established the removal can be accomplished or the reduction of the ingredient(s) monitored to 
establish an acceptable risk.
Animal bioassays are too expensive and time-consuming for routine screening. Chemical testing alone 
is not feasible because of the complexity of the air mixtures and the practical difficulties involved.
The Ames test offers a useful technique for looking at synergy and antagonism that chemical analysis 
alone cannot do, as the Ames test detects the mutagenicity of the total sample. It would however be 
possible to systematically investigate interactions between groups o f chemicals (those isolated in air 
samples), but this would be very time consuming.
The wide acceptance of the mutagenesis bioassay using Salmonella typhimurium developed by Ames 
(1975) and the sensitivity of this assay, has lead it to be extensively used for the detection o f mutagens
eioL S^ aL
in complex environmental samples (Van Houldt ^1989, Barale^l989, Walker J982). A number of 
approaches to sample preparation have been used for the mutagenicity studies of environmental 
samples using the Salmonella/microsome assay. The basic steps involved the collection, extraction 
concentration and mutagenicity. The sample collection usually involved vacuum pumps drawing 
measured volumes of air over filters or through solvent reservoirs. This isolated sample would then 
be further extracted or fractionated. The solvents of choice were usually organic (methanol, 
cyclohexane, ethylacetate or benzene). Modifications to the solvent enabled the extraction of various 
classes of compounds (basic, acidic, aliphatic, polyaromatic or oxygenated). Once concentrated in a 
suitable solvent vehicle (DMSG) they can be plated out in the SahnonellaAnicrosome assay.
3.6 FACTORS AFFECTING MUTAGENICITY
The main factor affecting the mutagenicity in the bacterial mutagenicity assay is availability of 
mutagen to interact with the bacterium.
BP is not mutagenic in the bacterial mutagenicity assay without metabolic activation (Glatt^l977). The 
activation is usually provided by a metabolising system (89), enabling the parent compound to be 
metabolised to a variety o f hydroxylated derivatives, via aryl hydrocarbon hydroxylase (AHH), these 
derivatives included phenols, dihyrodiols, quinines and diol epoxides, which have been shown to be 
mutagenic and carcinogenic and capable o f reacting with nuclei acid and protein (previously discussed 
in Section 1.8).
The modulation of enzymic activity would have a marked effect on metabolism and the observed
etaZ
mutagenicity. Lesia (1981) showed that, inhibition of the AHH activity can markedly reduce the 
mutagenicity o f 2AAF. The addition of epoxide hydrolase inhibitors greatly increased the 
mutagenicity (Bentley et al 1977), while the addition of EH to the Ames test microsomal fraction can 
reduce the observed mutagenicity of BP (See Section 1.8.2). The modification of activity and 
mutagenicity may also be associated with the bacteiial-microsome-particulate interactions.
3.7 AREAS OF INVESTIGATION
With these points in mind the following studies were made:-
1. Mutagenicity of BP coated particles.
2. The binding of S9 vesicles to the particulates.
3. Particulate effects on activity o f selective enzymes involved in the production o f mutagens o f  
BP.
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4. Electron microscopic observations were performed to assess the interactions between the
particulates, microsomes and bacterium in the agar overlay.
3.8 RESULTS
For particulate details (source, size and surface area) and BP loading concentrations per gram of 
particles used in these experiments see Table 3.1-3.3. Batch 11-13 were prepared to cover a 
concentration range o f up to 2mg of BP per gram of particulates. Batch 16-19 were prepared so that 
the concentration range overlapped and exceeded the previous samples, up to a concentration o f 5mg 
of BP per gram of particulate.
A high dose of lOmg of BP/gram of particulate was prepared for alumina B (AI2O3B) due to its 
surface area being much larger than the other particulates. The concentration ranges covered different 
coating natures of the BP on the particulates (monolayer to crystalline BP).
3.8.1 Mutagenicitv
The mutagenic effects o f BP coated particles suspended in DMSO orPBSA compared to BP in DMSO 
(BPd) and microcrystalline BP suspended in PBSA (BP^) are shown in Figures 3.1 - 3.4. The 
concentration of particulates used for each dose point was 2.5mg/plate. The effects of AI2O3B particles 
in both PBSA and DMSO were very similar to BP^ (Figures 3.1-3.4).
The lower loadings of BP (90-2300}ig) coated titanium oxide(Ti0^and ferric oxide (FejOa) suspended 
in DMSO produced similar responses to BP^ (Figure 3.2) while alumina A (AI2O3A) gave a lower 
response. In the higher loading of BP (399-lOOOOjxg) coated AI2O3A and Fez0 3  suspended in DMSO 
produced similar responses to BP^ (Figure 3.4) while TiOj gave a lower response.
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TABLE 3.1 Particulate Details
Particulate Surface* 
Area (mVg)
Percentage Size^(pJh) Source
0-3.0 3-5.99 6-8.45
Alumina A 
(Al^Os) 5.2 89.4 8 .8 1 .8
JMC-345 
Spec pure
Alumina B 
(AI2O3) 124.8
-
43.0 57.0
Sperisorb
(PhaseSep)
Titanium
Dioxide
(TiOg)
11.3 Sfc
BDH
Ferric
Oxide
(FC203)
13.6 60.0 22.9 17.1
JMC-
Puratonic
BP(m) - Aldrich
^Difficult to determine due to agglomeration, but particulate less than l|im
“ - Determined by Manufactures Specification (McDonald 1984)
 ^ - Determined by Electron microscopy.
Alumina A - High Surface Area 
Alumina B - Low Surface Area 
BP(m) - Benzo(a)pyrene microcrystals
c The size distribution of these particles was difficult to determine. However the larger 
particles were approximately 5pm in diameter as determined by electron microscopy 
(McDonald 1984),
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TABLE 3J1 BP Coating Concentrations on Particulate
Batch 11 12 14 13
Date of 
preparation
12.7.85 12.7.85 12.7.85 12.7.85
Particulate Alumina A Alumina B Ferric Oxide Titanium
Dioxide
BPpg/g of 
particles
121.7 124.6 90.1 104.7
216.1 318.3 227.0 375.2
258.2 739.5 487.7 389.4
328.2 839.0 505.7 736.0
513.7 1249.1 837.5 1018.7
755.6 1958.0 858.5 1415.4
1105.8 2281.4 1120.3 2246.3
BP concentrations were measured by HPLC against standards. Results are expressed as an average 
of a single experiment o f duplicate samples (McDonald 1984).
TABLE 3 3  BP Coating Concentrations on Particulate
Batch 16 17 18 19
Date of  
preparation
19.11.85 18.11.85 25.2.86 28.2.86
Particulate Alumina A Alumina B Ferric Oxide Titanium
Dioxide
BPpg/g of 
particles
476.3 1045 399.4 809.3
686.7 2279.1 551.8 1666.6
1649.9 3554.8 1694.6 3349.2
2764.7 5430.7 2218.9 3402.6
4756.0 9439.5 2949.9 5438.6
BP concentrations were calculated firom solvent extraction and extrapolation from standards. Results 
are expressed as an average of two separate determinations o f duplicates samples.
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With the exception of AI2O3B the coated particles suspended in PBSA produced similar responses, a 
much lower response than in DMSO, but higher than the BP micro-crystals in PBSA (BP^) (Figure 
3.1 and 3.3).
The uncoated particles showed no mutagenic activity with metabolic activation (Table 3.4) or without 
metabolic activation (results not shown).
3.8.2 S9 Binding of Particles
At concentrations o f particulates between 0.05 - 2mg/ml AI2O3B and Fe203  showed very similar 
binding, which was lower than AI2O3A, while Ti0 2  showed increased binding over all the particles. 
At concentrations above 2mg/ml the binding of S9 protein to particles was in the order Ti0 2  > AI2O3B
> AI2O3A > = Fe203  (Table 3.5). The binding order does not correlate with surface areas. However 
there was a partial correlation for the percentage of particulates less than 3pm in size; Ti0 2  > AI2O3A
> Fe20 3 , the exception being AI2O3B. This may be explained by the fact that AI2O3B did not have 
particles of this size range.
3.8.3 Effects o f Particles on Enzvme Activities
The effects of the particles on the microsomal metabolising enzymes were investigated by the effects 
on 7-ethoxycoumarin 0-deethylase, epoxide hydrolase and aryl hydrocarbon hydroxylase activity. 
There was no indication of inhibition of these enzymes by the particles (Table 3.6).
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TABLE 3S  S9 Microsomal binding
Particulate
(mg/ml)
Mean percentage o f bound S9*
AI2O3 A AljOjB TiO;
0 0 0 0 0
0.05 6 ± 1 1 ± 4 .6 1 ± 1.7 3.7 ±  9.6
0 .1 6.7 ±  1.5 2  ± 2 .6 2.3 ± 1.2 7.3 ±  5.9
0.5 7.3 ± 1.5 7.3 ± 1.5 1.3 ±  0.6 13.3 ±  8.1
1 .0 7.3 ±  2.1 6  ± 8 .7 5 ± 3 .5 17 ±  7.5
2 .0 8.3 ± 1.5 7 ± 9 .8 5 ± 3 .5 35.3 ±  1.5
5.0 13.7 ±  1.5 20.3 ±  3.5 9.7 ± 7 54 ±  7.8
1 0 .0 24.7 ±  0.6 28.3 ± 1.2 20 ± 7.9 61 ±  5.8
* Determined by the amount o f protein remaining in the supernatant, after the removal by 
centrifugation of the particulate and bound S9 microsomal vesicles.
The results are expressed as mean ± standard deviation of three separate experiments o f duplicates.
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TABLE 3.6 Enzyme Activities of S9 Microsomal Fractions in the Presence of Particulates
Particulate
(mg/ml)
Activity nmoles/min/mg
Ethoxycoumaiin
0 -deethylase
Epoxide
Hydrolase
Aryl Hydrocarbon 
Hydroxylase
AI2O3 A
0 4.9 ± 0 .4 2 1 .5  ± 1 0 .2 0.181 ±  0.06
0.5 4.6 ± 0.6 2 1 .9  ±  15.3 0.182 ± 0.05
1 4.3 ± 0.7 18.1 ± 4 .1 0.177 ± 0.05
5.0 4.1 ± 1.3 26 ± 17.4 0.175 ± 0.07
10 4.3 ± 1.0 23.9 ± 13.7 0.179 ± 0.06
AI2O3 B
0 4.6 ± 1.2 20.4 ± 9.1 0.204 ± 0.08
0.5 4.6 ± 1.0 25.4 ± 1 1 .2 0.204 ± 0.07
1 4.4 ± 0.8 21.9 ± 7 .1 0.213 ±  0.09
5 4.7 ± 0.5 23.1 ± 14.9 0.191 ±  0.06
10 4.5 ± 0.6 21.1 ± 8 .7 0.189 ± 0.05
FG2O3
0 4.7 ± 1.4 18.6 ± 5.2 0.181 ± 0.06
0.5 4.2 ± 1.3 20.7 ± 7.6 0.181 ± 0.063
1 4.3 ± 1.4 19.9 ±  5.8 0.183 ± 0.06
5 4.4 ± 1.4 18.4 ±  4.7 0.182 ±  0.05
10 4.0 ± 1.5 19.5 ± 5.4 0.187 ± 0 .0 6
TiOg
0 5.3 ± 0.8 20.9 ± 6.2 0.224 ± 0 .1 4
0.5 5.5 ± 0.7 20.2 ±  2.9 0.23 ±  0.14
1 .0 5.1 ± 0.8 19.7 ± 2.4 0.23 ± 0 .1 4
5.0 4.9 ± 0.9 17.7 ± 0.94 0 .2  ±  0 .1 1
10 4.2 ± 0.8 19.6 ± 1.53 0 .2 1  ±  0 .1 2
Activity was detennmed using Aroclor induce S9 microsomal fraction at a concentration o f O.Smg of 
protein/ml. The results are expressed as mean ±  standard deviation of three experiments using 
duplicate samples.
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LEGEND FOR FIGURES 3.1 - 3.4
A Alumina A
B Alumina B
F Ferric oxide
T Titanium dioxide
BPd - BP added in DMSO
BPm - BP microcrystals added in PBSA
} These doses were added to each 
} figure for comparison 
}
Particulates were dosed at 2.5mg/plate
Results are expresssed as % + SD of duplicate experiments of triplicate sample points.
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FIGURE 3.1 Ames Test with Metabolic Activation of Particles Suspended
in DMSO (90-2300pg/BP/g of Particles)
/V/o.
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FIGURE 3.2 Ames Test With Metabolic Activation of Particles Suspended
in PBSA (90-2300jJg/BP/g of Particles)
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FIGURE 3.3 Ames Test With Metabolic Activation of Particles Suspended
in DMSO (399-1OOOOpg/BP/g of Particles)
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FIGURE 3.4- Ames Test with Metabolic Activation of Particles Suspended
in PBSA (399-1 OOOO^jg/BP/g of Particles)
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3.8.4 Electron Microscopy
The cut samples were standard Ames soft agar overlays. The number of bacteria observed per sample 
(single cut) was small, in the range of 2-4.
The association between S9 and bacteria (Plates 3.1 and 3.2) showed that the S9 (seen as vesicular 
structures) existed in discrete ’pockets’, evenly distributed throughout the sample, hi all samples 
observed with vesu les  and bacteria, the. adhered to the bacteria forming a very close
association. However, no membrane union was however observed.
The bacteria themselves were evenly distributed throughout the soft agar media, but clumping was 
observed when S9 vesicles were present. The S9 vesicles seemed to act as an adhesive. When 
particles were added, the S9 vesicles adhered to the surface o f the particle, coating it in a similar 
fashion to that observed with the bacteria (Plates 3.3 - 3.6).
On all particulates encountered the microsomes coated their surfaces, as either single vesicles or as part 
of a large ’clump’. However with TiOg the association was such that, the S9 vesicles seemed to 
encapsulate individual TiOg particles and coat TiOg particulate aggregates (Figure 3.6 and 3.7).
The three-way close proximate association o f bacteria and particulate, with t k t  5 9 as the adhesive 
was observed (Plates 3.7 and 3.8). When particulates were added to the soft agar overlay in a PBSA 
or DMSO solvent vehicle, with or without a pre-incubation step o f 20 minutes, no difference was 
observed in aggregation and coating of particles or bacteria with microsomes.
The plates 3.1 - 3.8 are cuts of a 20 minute pre-incubation step after soft agar was added, after which, 
samples were fixed.
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Plate 3.1 Bacterial and S9 vesicles association
* marks a ’clump’ of 89 vesicles.** shows a bacterium with its cytoplasmic and nucleoplasmic features, with its encapsulating membrane 
(M ->). In close association with the bacterium membrane are 89 vesicular ’clumps’ (V ->) (30k magnification).
0
Plate 3.2 Bacterial and S9 vesicles association
Shows a bacterium with close microsomal association(-»). The vesicular membranes remain intact and touch the bacterial membrane 
(120k magnification).
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Plate 3.3 S9 vesicles and alumina A association
Shows the 89 vesicular-paniculate association with an AljOj A particulate(*) which is surrounded by 39 vesicles (—>),with accompanying 
39 vesicluar ’clumps’ (C ->) (20k magnification).
Plate 3.4 S9 vesicles and alumina B association
Shows the 39 vesicular-particulate association with an AI2O3 B particulate (*) which has distributed around its surface edge in discreet 
pockets, ’clumps’ of 39 vesicles and surrounding area is dotted with 39 vesicle ’clumps’ (10k magnification).
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Plate 3.5 S9 vesicles and ferrie oxide association
Shows the aggregated Fe^Oj particulate (*) associated with 89 vesicles (V -») (20k magnification).
Â
- y
Plate 3.6 S9 Vesicles, bacterial and titanium dioxide close association
Shows the aggregationai nature of the TiOj particulates (*). Associated and mixed in with the TiO% aggregates are ’clumps’ of S9 vesicles 
(V -»)(30k magnification).
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Plate 3.7 S9 vesicles, bacterial and titanium dioxide association
Shows the three way Particulate-S9-vesicles-bacterial association. The dark 'clumped dotes’ (*) are aggregated TiO% particulate, surrounded 
by S9 vesicles (V -^). The bacterium (B) show a heavy coating of S9 vesicle ’clumps’. The three way close association (particulate-vesicles- 
bacteiium) is present, but there is some distance between the bacteiial-vesicle grouping and the particulate-vesicle grouping 
(10k magnification).
*
Plate 3.8 Three way close proximate association
Shows the three way close proximate association (Particulate-Vesicles-Bacterium) (-»). In this instance the bacterium and the particulate share 
the same S9 vesicles. (30k magnification).
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3.9 DISCUSSION
The mutagenicity o f BP coated Al^O^B in PBSA was similar to BP in DMSO. This suggested that 
the bioavailability of BP coated onto AI2O3B was high. In the higher loading, the effect o f BP coated 
TiÛ2 particles in PBSA was similar to the BP in DMSO up to 3pg/plate of BP. FejOj and Al^OgA 
BP coated particles in PBSA had similar responses but lower than the Ti0 2  and AI2O3B but above that 
of BP microcrystals (all BP coated particles had higher mutagenicity than BP microcrystals). In the 
lower loading doses AI2O3A, Fe2Û3 and Ti0 2  in PBSA were veiy similar to each other.
When BP was adsorbed (coated) onto the particles, enhanced mutagenicity was observed in an aqueous 
phase. When the coated particles were suspended in DMSO before adding to the aqueous phase, there 
was little difference in mutagenicity compared to BP dissolved in DMSO. Observations by Bevan 
(1985) and Szyba^(1983) were similar, in that an increase in mutagenicity was associated with BP- 
adsorbed (coated) particles (asbestos and Fe203) compared to BP microcrystals. The coating process 
used was nucléation via solvent ' evap^ r^a-Éba.
This effect is unlikely to be explained by the modulation of enzyme activity, as no effects o f the  ^
particles were detected on the enzymes tested. From the inhibition of these enzymes one would expect 
a change in the observed mutagenicity, as the production of mutagenic metabolites and their 
subsequent removal would be reduced (Bentley et al 1977). However, inhibition o f AHH, 
ethoxycoumarin 0 -deethylation and epoxide hydrolase by particles (Fc20 3  and asbestos) has been noted 
by Bevan (1985) and Kandaswani^(1983). Although significant inhibition was observed, this was not 
reflected in the metabolic profile or the extent of metabolism, as similar percentage o f metabolism was
Q.tal
observed (62%) between BP-particulate solvent and BP coated paniculate states (Bevan^l985).
ei'pl
BP in acetone with Fc203  showed only slight inhibition of AHH activity (Bevan^l985). There was 
a significant difference in mutagenicity. This was unexpected, when compared with BP in acetone and
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BP acetone with chrysotile, in which the chrysotile dose showed a lower AHH activity. It would have 
been expected that the BP in acetone with FejOj would have had greater mutagenicity.
Bevan suggested that the observed biological effects may have been the result o f BP transfer into the 
microsomal vesicles and hence substrate availability rather than inhibition o f enzyme activity. 
Mutagenicity could be explained by microsomal binding or disruption, this was unlikely, as the 
binding did not parallel the mutagenicity/biological effect in this study. The particle with the highest 
binding was TiOj and the particle with the highest mutagenicity/biological effect was Al^O^B for 
which binding was only marginally greater than for AI2O3A and Fe2 0 3 .
From the EM observations, the S9 microsomal vesicles were not disrupted in the presence o f particles. 
This is further supported by Lakowicz who showed that a number of particles (Lakowicz et al 1980) 
did not damage liposomal integrity. The EMs showed that the particles attracted S9 vesicles in small 
’clumps’ and that they adhered lightly to the surface remaining in ’clusters’ rather than spreading over 
the surface of particles. Additionally the bacterial membrane did not fuse with that o f the microsomal 
vesicle which remained in very close association with the bacteria. However, in the samples tested 
few bacterium/particleAnicrosome associations were encountered which suggested that the BP was 
metabolised on the surface of the particle by the adhered vesicles and that the resulting mutagens were 
then released into the agar aqueous media. One can speculate that from the number of samples 
counted with the triangle association (Plates 3.7 and 3.8) this may explain mutagenicity, but not the 
enhanced mutagenicity seen with the coated particles. The microsomal binding may be explained from 
the EM observations o f the particles, in that TiO^ particles seemed to be associated with more clusters, 
almost to the point o f being engulfed by them (Plates 3.6 and 3.7), whereas aU the other particles 
seemed to have ’clumps’ associated with their surfaces.
The major correlation seems to be that of the surface area (Table 3.1) o f the particles in which AI2O3B 
has the larger surface area and highest mutagenicity.
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One can speculate that the physical form in which BP is present on the particle surface and hence its 
presentation to the microsomal enzyme complex (or cell) may contribute to its bioavailability, whether 
the form is readily available monomeric (soluble) or the majority of BP locked up in a polymeric 
(crystalline) fonn as in the case of BP microcrystals in PBSA. The coating of the particle may 
produce a mixture of states in which the BP is present in both monomeric and polymeric states.
AI2O3B may have a greater monomeric state due to its greater surface area and AI2O3A may have a 
greater crystalline state. However Lakowicz (1978) observed that a low surface area asbestos adsorbed 
BP in a monomeric form more than a high surface area silica. This would suggest that the chemical 
nature o f the particle surface and BP interaction, was the key factor and the particle may encourage 
ciystalline fonnation of BP on the surface of the particle and hence affect its biological effects.
However, surface chemical properties could not explain the different mutagenicities o f the two 
aluminas. AU the BP coated particles had more mutagenic potential than that o f BP microcrystals 
and an increase in mutagenicity was associated with an increase in concentration of adsorbed BP.
This enhancement of mutagenicity may be explained by the work o f Lakowicz and Bevan (1979)<^'n<^ 
Lakowicx e t (1980) in which they demonstrated enhanced uptake of BP into microsomes when BP was coated onto 
the particulates surface. The physical state in which the BP was present on the surface o f the particle 
may modulate its availability to the microsomal enzymic system. Alteration in BP availabiUty to the 
microsomes coupled with possible alteration in metabolic profile may explain enhanced mutagenicity.
The next stage in this study involved the investigation of the above, in an attempt to explain the 
observed mutagenicity.
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4. BIOAVAILABILITY
4.1 BIOAVAILABILITY OF PAH AND PARTICULATES
The movement of PAH into the cellular targets of the lung lining can be summarised as follows:
Air lung Interface
ALL ECL
K - the rate of release of PAH from the particle into the target cells 
RI_L - Respiratory lining layer 
ECL - Epithelial cell layer
Figure 4.1 Schematic representation of PAH release and uptake
The above representation shows the PAH’s being carried into the lungs by respirable particulates 
which are deposited into the RLL, where the PAH’s are released and taken up by the local target cells. 
However, a number of important factors have to be taken into consideration. These are
a. Solubility of PAH in aqueous and lipid phase
b. Surface nature of the particulate carrier
c. Type of carrier (size and surface area)
d. Enhanced uptake of PAH into biological membrane by particulates
e. Local biological environment
f. Metabolism
g. Burden - localised dose received by lung
h. Cellular involvement
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i. Clearance of PAH and particulates from the lung
j. Localised damage - scarification
In this section only points a-f will be considered with regards to bioavailability of PAH and 
particulates. The other aspects will be covered in chapter 6 .
a. Solubility of PAH into Aqueous and Lipid Phase
The main composition of the respiratory lining layer (RLL) (the secretory layer that flows over the 
epithelial cell layer) has been reported to be 2-3% glycoproteins, 0.3-0.5% lipids, 0.1-0.5% proteins
eitl
and about 95% water (L^pez-UndrierO;, 1980) in which the lipid content, constitutes a continuous layer 
on top of the cellular layer from the alveolar region up to the trachea (Ueda,, 1984). The lipid content 
forms either separate laminar layeis, or is dispersed as micellar liposomes within the aqueous phase.
PAH’s having a low solubility in water (MacKay^, 1977; Davis 1942) and high solubility in lipid 
(Patton  ^1984), may be an important contributory factor to in vivo behaviour of PAH.
When considering the two phases of the lung lining, two processes may occur simultaneously.
BP coated particulate Respiratory lining layer
(Micellar)
Epithelial layer
K1 - Rapid 
K 2 - Rapid
Figure 4.7, Schematic representation of lipid involvement in BP 
release and uptake
- I l l  -
BP coated particulate Respiratory lining layer
•<2
BP . 
aqueous
Epithelial layer
^  ^ - Slow release in heterogeneous aqueous layer
K 2 - Rapid absorption by alveoloar macrpohages or epithelia
Figure 4.3 Schematic representation of aqueous involvement in 
BP release and uptake
An important contributory factor is the affinity of the lipid in its lamella or micella forms to be 
adsorbed to the surface of the particulate carrier, which will enhance its eventual redistribution 
throughout the lungs RLL.
The effect of all these processes would bejfependen/^n the eventual dosage that the target cell 
receives. The aqueous mechanism suggests there would be a low but continuous concentration of 
PAH, while the lipid mechanism would suggest a short but concentrated pulse of PAH, being 
delivered.
b. Surface Nature of the Particulate Carrier
*6 <*Z
Lakowicz^(1978; 1979) suggested that fibrous mineral particles could be co-carcinogenic as a result 
of their ability to adsorb PAHs and to transport them into the target cell.
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An important factor is the ability of particulates to adsorb and release BP. This may be due to the 
particulates surface chemistry and its interaction with the biological environment.
Silica is lattic&of SO2 and its surface has may silanol groups that are believed to confer its biological 
activity (Shi ^ 1989). Another silicate asbestos has a filamentous structure held together by cations 
(Mossman^l981). The cations content of the asbestos contributes to its chemical properties and
ttA-
biological activity (Langer 1984).
The preparation of the particulate and presence o f a biological fluid would modulate the activity of 
these silanol groups and cations. The nature of the interactions with various classes o f xenobiotic 
would depend on the interaction between the surface chemical groups and those o f the xenobiotic.
The large relative intensities of the monomeric emission of BP on the asbestos samples as compared 
to the silica observed by Lakowicz (1978; 1979), are probably indicative of the superior ability to 
adsorb BP in the monomeric state which may be attributed to the chemical surface nature o f the 
particulates favouring an environment that stabilizes the monomeric BP formed rather than the 
crystalline form.
The observed relative intensities of the monomeric emission of BP is surprising in the light o f the 
surface areas o f these particles, in which the surface area o f silica and asbestos (chrysotile and 
anthophyUite) particulate was 381, 26.8 and 11.8 m^g respectively.
However the surface topography cannot be ruled out, as silica (structure with shaip edges as opposed 
to filamentous nature o f asbestos) would be more o f a crystalline structure which could produce an 
ideal crystal seeding platform for BP, so that BP would then be present in a more excitomer form 
(crystalline).
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Carbon particles (India ink, carbon black) have also produced conflicting results in carcinogenesis
(td. etd.
studies (Stenback^l976 and Davis 1975). This could be related to the preferential desorption from the 
particles o f the loaded PAH, as these particles adsorbing ability may exceed that of the desorption 
capability o f the homogenous lipid/aqueous lining layer of the bronchioles.
c. Tvpe of Carrier
The thickness o f RLL has been estimated to be about 5pm above the tips o f the cilia (Lippmaa & 
Schlesinger, 1984). Fibres assume importance as being the particles likely to have one dimension 
exceeding the thickness o f the RLL. Several experiments have demonstrated the very strong 
adsorption o f phospholipids from lung surfactant onto asbestos fibres (Light & Wei 1977; Jaurande -^-  ^
1980 ). This coating o f a particle produces a continuous layer, which breachmj the RLL, causing a
eha.1
sharp pulse o f PAH to be deposited into the epithelial layer (Gerde^l989a).
In addition, the clearance of particulates from the lung produces staging areas in which the particulates 
gather in sufficient quantity that could cause breaching of the RLL. At these staging areas the 
mechanisms o f clearance are exchanged (macrophage to ciliated cell, at the alveolar-bronchiole region) 
which is a prime site o f neoplasia (Schlesinger and Lippf^»^1978).
Lakowic^(1980) showed that particles o f comparable surface area and size distribution had different 
uptake values.
d. Enhanced Uptake of PAH into Biological Membrane bv Particulates
Lakowicz and co-workers studied the effect o f particulates on the uptake of PAH into lipid membranes 
(phospholipid bilayer vesicles and microsomes) (Lakowicz^l978; 1979; 1980). " A number of
particles were investigated (asbestos, Fe^O ,^ silica, Al^Og, TiOj and carbon particles). In these studies
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BP was used in various states, being aqueous crystalline, solvent dissolved and particulate adsorbed. 
A fluorescence spectroscopy technique was used to monitor the transfer of BP from the 
microcrystalline, or particle associated states into the various lipid membranes used.
It was observed that particulate adsorbed BP exhibited enhanced uptake into membranes compared to 
BP in the microcrystalline state. Additional experiments revealed that the mechanism of particle- 
enhanced uptake of BP was a rate-limiting solubilisation of BP into the aqueous phase followed by 
a rapid uptake o f solubilised BP into the membranes.
eJt<X
Investigations by Bevan (1981) on PAH with vaiying water solubilities helped to verify the above 
mechanism. In these experiments he compared dibenzo(c,g)carbazole (320p,g/litre) with other PAH 
having lower solubilities o f less than 3|Xg/litre (dibenzo-(a,h)-anthracene, benzo-(gdi,i)-perylene and 
3-methylcholanthrene). Under the conditions used, >60% of the dibenzo(c,g)carbazole was solubilised 
in the aqueous phase in the presence of particles prior to the addition of the membrane vesicles 
(dipalmitoyl phosphatidyicholine-DPPC), whereas <1% of the other PAH was solubilised. Due to the 
large solubilised PAH fraction, the particles would not be expected to have an effect on uptake but 
an effect would be expected with the lower solubilised PAH.
As a result of particle-enhanced uptake, it was to be expected that PAH adsorbed to particles would 
be delivered rapidly to cells. Consequently, the effective dose o f the PAH is increased and the 
incidence o f carcinogenesis would also be expected to increase.
e. Local Biological Environment
Within the RLL the inhaled particulates are in a lipid, glycoprotein and mainly aqueous environment. 
Particles and any associated PAH that were phagocytosed would find themselves in the acid 
environment of the lysosome. Uptake would still occur, but from within the cell. PAH release rate
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from the lysosome, activation in the endoplasmic reticulum via the cytoplasm, would be modulated 
by the lysosomal environment
Changes in the noimal lung function produced changes in the localised environment. Conditions such 
as lung fibrosis, emphysema and oedema, produced changes in lung architecture and respiratory lining 
layer, as a result o f cellular damage, release o f cellular components and changes in permeability. 
These changes could affect the release o f PAH from the particulates and affect both particulate and 
PAH clearance from the lungs. Additionally irritation of the airway could produce an increase in 
cellular secretions, again contributing to the localised environment that the particulate and the adsorbed 
PAH found themselves embedded in.
When particulate matter is phagocytosed by the alveolar macrophages, lysosomes fuse with these
etal
vacuoles. The pH has been shown to drop (Bassoe 1983) within these structures producing an optimal 
environment for the action of digestive enzymes contained within the lysosomes. BP coated particles 
being phagocytosed would be introduced into this low pH environment. This change in pH could 
influence BP transfer, which would affect the BP availability.
The changes in RLL lipid, protein and aqueous content and trace element (Mg^ ;^ Ca^ "^ ’ etc) may alter 
the localised response o f cells, to the toxin insult.
f. Metabolism
The nature of BP metabolism has been discussed in some detail in the Introduction (see section 1.7). 
The mechanism of particulate enhanced PAH carcinogenesis has not been fuHy elucidated. The 
effective dose that the cell could be exposed to may vary, due to the various processes involved in 
PAH elution within the lung. An altered BP availability can alter the metabolic profile (Nemoto et 
al 1978) and produce a range of different products that have different carcinogenic/mutagenic effects
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(See section 1.7). Also, in the case o f phagocytic elution, the substrate for the target cells metabolism 
may have been changed to a procarcinogen or the ultimate carcinogen (Autrup 1978a). Studies by
eireH ^  <^ 2.
Bevan^(1985) and Leung (1988) demonstrated that not all the BP transferred was metabolised.
Areas o f Investigation
With these main points in mind the following studies were made
1. Solubility o f BP in an aqueous phase and S9 fraction phase
2. BP transfer into : 5-9 mix : at pH 7.4 and pH 4.5
3. Fluorimetric determination of BP on the surface of the particulates.
4. Metabolism of BP under the conditions used for the Ames test and transfer.
4.2 RESULTS
Particulate details o f BP coating concentrations and radiolabel used are presented in 
Tables 4.1 and 4.3.
4.2.1. BP Solubüitv in Aqueous Solutions
Figure 4.4 shows a fluorescence scan of BP in HgO. There were two main peaks (405nm 430nm) 
which were associated with dissolved (monomeric) BP and a broad peak (450-5lOnm), which was 
associated with the crystalline state (excitomer) of BP. The 405nm monomeric peak does not increase 
in intensity with increased BP beyond the maximum solubility point o f BP in H^O.
The solubility in water, derived by this method was 5pg/litre which compares well with the published 
value of 4.2pg/litre (lARC, 1973).
- 117-
FIGURE 4.4 - BP Solubility in Aqueous Solutions
units
A05nn 
X u n its
blOnra
4 - 5 6 7 8 9  430 . 405 350
BP Concentration (|ig/ .1)  ^ ' Wavelength (nra)
Solubility limit of BP in water as detemiined by change in fluorescent intensity (at excitation wavelength 296nm and emission 
wavelength 405nm) against increased BP concentration.
The fluorescence emission spectra of increasing concentrations of BP in water (right side of figure) shows the differing 
contribution that the BP monomeric peaks (405 and 430 run) and excitomer peak (510 run) have, as BP concentration increases, 
lire concentrations represented are (a) 500, (b) 200, (c) 10, (d) 5 and (e) 3 pg/l. As the concentration of BP increases above the 
solubility limit of BP there is a stabilization of the 405 run peak (which is associated with monomeric BP) and an increase in 
the ^ 10 nm peak (which is associated with crystalline BP).
FIGURE :4 .5  -  BP S o lu b il i ty  in  S9MiX
u n i t s
protein concentration (rfg/ml)
Figure 4.5 shows a plot of changing fluorescence intensity against increasing S9 mix protein concentration, for a fixed 
concentration of BP (0.5pg/ml). A plateau of fluorescence was reached after 0.15mg/ml of 89 mix protein, which was associated 
with the complete dissolution of BP in the 89 mix. The subsequent decrease in fluorescence was associated with increased 
turbidity of the sample.
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The solubility for BP in PBSA and KCI-PO4 buffer determined by this method were 6,3 and 6.5p,g/litre 
respectively.
The addition o f 2.5% v/v o f DMSO in the aqueous media, increased the solubility o f BP up to 3 fold 
(H2O, 13.3; PBSA, 18.2 and 89 mix buffer 17.3|ig/litre).
4.2.2. Solubility of BP in Microsomal Suspension
It was considered that the fluorescence measurements of the monomeric BP could be influenced by 
the microsomal concentration. A determination of its solubility in a measured microsomal/aqueous 
concentration was therefore determined in order to eliminate this influence. A concentration of 
0.5|xg/ml of BP produced a plateau in fluorescence intensity beginning at 0.15mg/ml (Figure 4.5) of 
microsomal protein.
The concentration of 0.3mg/ml of microsomal protein was selected for the BP transfer experiments 
(with BP at 0.5|igAnl), as this concentration was sufficient to ensure that the microsomes did not limit 
the quantity o f BP that could be transferred from the particulate surfaces.
4.2.3. Particulate Adsorbed BP Fluorescent Scans
When investigating the fluorescence intensity of BP microcrystals in the absence and presence of  
particles, relative to BP microcrystal alone (taken as 1.0), the intensities o f these crystals in the 
presence of alumina A, alumina B, TiÛ2 and FejOs were 1.05,1.2,0.9, and 0.2 respectively. Increased 
intensities may have been associated with increased turbidity. The reduced intensities associated with 
Fe203  and TiOj may be associated with adsorption processes.
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A comparison of relative fluorescence intensities o f particle-adsorbed BP and the attenuation corrected 
intensities with aqueous dissolved BP, o f particulates with similar loadings (4.2-4.9|Xg/2.5mg of  
particles) are shown in Figure 4.6-4.10. The most intense monomeric emission was for BP adsorbed 
to the high surface area alumina B, with alumina A, TiOj and FcgOg in decreasing monomeric 
intensities.
The scans o f coated particles in Figure 4.11 - 4.14 show the development of both monomeric and 
excitomer peaks over an increase in BP loading. The scans were taken with BP at a concentration of
0.5|xg/ml.
The scans o f AI2O3 A and TiOj showed that as the BP loading increased there was an increase in the 
excitomer peak, which was accompanied by a drop in the baseline interference due to the reduction 
in the particulate concentration.
The presence of both monomeric and excitomer peaks were seen with AI2O3 B, as the BP loading 
increased there was a depressional shift in the fluorescence intensities across the wavelengths scanned.
The scans o f Fe203  showed a predominant monomeric peak, but at the highest BP loading used, the 
excitomer peak appeared. The ratios (see Table 4.1) of area under the scans of monomeric BP peak 
over total, show that the majority of BP coated was in a crystalline form. The area under the scans 
for the BP coated particles were in the order of AI2O3 B > AI2O3 A > TiÛ2 > Fe2 0 3 . The ratios o f 
monomeric peak over total were in the order o f Fc203  > AI2O3 B > Ti0 2  > AI2P 2  A.
Fe203  and Ti0 2  adsorbed BP scans were weaker compared to BP adsorbed to the other particles which 
may be due to the large attenuation factors and adsorption in the same spectral region associated with 
each of these particles.
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FIGURE 4.6 Normalised (405mm) s p e c t r a l - s c a n  o f  BP on v a r io u s  p a r t i c l e s .
F l u o r e s c e n t  U n i t  (Fu)
Alumina A 
Alumina B 
TiOg 
Fe2Û3
M i c r o c r y s t a l s '
Emission w aveleng th  nm 430 405 350510
FIGURE 4.7  S p e c t r a l  scan o f  BP on Alumina B
- BP adsorb  Alumina 
• BP d i s s o l v e d  in  b u f f e r
-  - 2 8
430 405EM nm
Figure 4.7 -  4.10
Fluorescence emission spectra of aqueous suspensions of particles containing adsorbed BP. These spectra contain components which are due 
to BP which is bound to the particles and BP which is dissolved in the aqueous phase. Concentrations of BP used (that was coated on 
particles) was 0.5 pg/ml. For BP loadings on particles used for scans are shown in table 4.1.
Legend for Figure 4.6
Figure 4.6 shows the normalised fluorescence emission spectra of BP coated particulates (at 4.2 ng of BP/2.5mg of particulates). The spectra 
show the differing contribution that the BP monomeric peaks (405 and 430 nm) and excitomer peak (510 nm) have as BP concentration 
increases. The normalised spectra were obtained by setting each BP coated particulate 405 nm emission peak to the same fluorescent 
intensity.
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■ r lüUKL.4 .ü r i u o r e s c e n t  s p e c t r a l  scan or  DK on r e r r i c  ux iae
F l u o r e s c e n t  u n i t  (Fu)
BP adsorbed  FeoO
2 7 .2
BP d i s s o lv e d  in b u f f e r
Emission wavelength 
(EM'-nm)
430 405 350
FIÇURE 4 .9  F luo re scenc e  s p e c t r a l  scan o f  BP on Titanium dioxide
BP adsorbed Tio
BP d i s s o lv e d  in  b u f f e r
430 450 350EM nm
FIGURE 4.10. F ju o re sen ce  s p e c t r a l  scan o f  Alumina A.
Fu
- BP adsorbed Alumina
BP d i s s o l v e d  in b u f f e r
EM nm
350430 405
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FIGURE 4 . 1 1  Fluorescent Scans of Al^O^A
Flu u n its
40
(Wavelength nm)
580 510 430 405
(Wavelength nm) 20
430 405 350510580
(Wavelength nra)
BP coating concentrations
1. 476pg of BP/g of particles
2. 1649pg of BP/g of particles
3. ^756/jg of BP/g of particles
* BP coated particulate
+ Uncoated particulates
The scans were performed with BP at a.concentration of 0.5jJg/ml
FIGURE k .-,1 2 Fluorescent Scans of Al20-,B
Flu units
60
-M
580 510 430 405
(Wavelength nm)
LEGEND
BP coating concentrates
---------- 1045/ig of BP/g of particles
---------  355Ajjg of BP/g of particles
9439ug of BP/g of particles 
* uncoated particles 
+ KC1-P04 buffer at pHT.A
The scans were performed with BP at a concentration of 0.5/ig/ml
FIGURE A.13 Fluorescent Scans of FegO^
Flu units
—  30
20
580 510 430 405 350
LEGEND
BP coating concentrations
----------- 399/Jg of BP/g of particles
----------------- 1694
2 9 4 9
* Uncoated particulates
The scans were performed with BP at a concentration of 0.5/Jg/ml
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FIGURE 4.14. Fluorescent Scans of TiO,
Flu un its
___40
350
430580 510
(Wavelength nm)
------10
350
430580 510
(Wavelength nm)
-3 5 0
430 405510
(Wavelength nm)
580
LEGEND
BP coating concentrations
1. 809 pg of BP/g of particles
2. 1666 pg of BP/g of particles
3. 5438 pg of BP/g of particles
* BP coated particles 
+ Uncoated particulates
The scans were performed with BP at a concentration of 0.5pg/ml
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TABLE 4.1. Ratio and Area Under the Scans.
Particulate BP Loading 
W g )
*Ratio
405nm/Total
©Area under scan 
(cm^)
AI2O3 A 1649 0.135 95
AI2O3 B 1960 0 .2 2 117
FG2O3 1694 0.275 25
TiOz 1666 0.144 43
* - area under scan of 405nm peak/area under complete scan, 
o - calculated between uncoated particles and BP coated particles.
4.2.4. Metabolism
4.2.4.1. Ames Concentration
The determination of metabolic profile and extent of metabolism of BP added to the 39 mix o f the 
mutagenicity assay, required duplication of conditions of the mutagenicity assay. BP, with or without 
the particles, was preincubated for 20 minutes with S9 mix and the reaction was terminated with the 
addition of acetone. The resulting solution, was ethylacetate extracted for BP and BP metabolites and 
then examined by HPLC.
A comparison of the metabolic profile of the various BP concentrations added in DMSO, shows a shift 
in the percentage o f metabolism (Table 4.2). The BP concentrations of Sjxg and 1.5|xg showed similar 
metabolic profiles and percentage of metabolism, whereas 0.5|xg showed extensive metabolism, 
reflected by the high percentage of activity in the polar metabolites and aqueous aliquots.
By comparison with the 5|Xg dose of BP in DMSO, the aqueous crystals o f BP (BPM) exhibited little 
metabolism, the majority of activity was in the BP aliquot.
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The most notable difference between the particle in aqueous (PBSA) and solvent (DMSO) vehicle was 
the extent o f metabolism. The DMSO solutions exhibited similar metabolic profiles and over 60% of 
the BP was metabolised with each particle type. In PBSA there was generally a low percentage of 
metabolism (< 5%) although AI2O3 B showed increased metabolism (14.9%) compared with the other 
particulates.
A comparison of BP in DMSO and particulate coated BP in DMSO shows similar metabolic profiles 
and percentage metabolism. Comparing BP crystals (BPM) to the BP coated particulates, there was 
more extensive metabolism.
4.2.4.2. Transfer Concentrations
A comparison of BP concentrations in DMSO showed that 0.25|Xg and 0.75jxg exhibited similar 
percentages o f metabolism, which was greater than that of 2.5pg dose. The percentage o f radioactivity 
in the aqueous aliquot decreased with a decrease in BP concentration.
BP in DMSO showed extensive metabolism compared to that of BP microcrystals in PBSA (BPm).
Particulates coated with BP in DMSO showed extensive metabolism over their PBSA equivalents, but 
less than BP in DMSO without particulates. In addition, the coated particulates in PBSA showed more 
metabolism than BP microcrystals, with AI2O3 B being more extensively metabolised than the other 
coated particulates.
4.2.5 BP Transfer
The transfer o f BP from the particulate surface and its solubilisation in the microsomal lipid bilayer 
was followed by changes in fluorescence intensity at 405nm, the wavelength associated with dissolved
et at
(monomeric) BP (Lakowicz 1980).
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TABLE 4.2. Ethyl Acetate Extractable Metabolite Profile of BP Using The Mutagenicity Test.
Metabolites BPd BPd BPd BPM Ap Ad Bp Bd Fp Fd Tp Td
dose(ixg) 5 1.5 0.5 5 5 5 5 5 5 5 5 5
BP 19.3 18.7 4 96 98.3 38.8 70.8 2 1 .2 94.8 14.1 96.5 35.4
30HBP 16.1 14.4 3.1 0.4 - 16.1 2 .8 15.7 2.3 14.3 - 16.6
9 0  HBP 1.9 - - - 2 .1 0.7 2.3 - 2 - 2 .8
7,8 diolBP 16.9 13 7.8 0.7 - 9.4 - 15.6 - 10.4 - 1 0 .6
4,5 diolBP 1 0 .6 1 0 .2 0 .8 - 1 0 .2 - 1 2 .2 - 9.4 - 9.5
9,10 diolBP 9.5 15.4 1 2 .6 - - 8.5 3.4 13 - 15.2 - 8.3
Tetrol 5.9 6 .1 5.5 - - 4.1 2.3 4.7 - 8 - 3.1
+ Polar 10 .8 10.7 41.8 0.7 - 6 12.3 9 - 22.7 1.3 5.8
% Metabolism 80.7 81.3 95.5 4 1.7 61.2 14.9 78.8 5.2 85.9 3.5 64.6
% Aq. Phase 7.4 2 .8 25.3 7.6 3.6 7.4 8 11 1 .8 1 1 .8 0.35 5.5
Recovery 75 93 66.4 108 87.3 73 98 74.7 70 74.5 57 87.5
BPd#  - Benzo(a)pyrene in DMSO.
# - The quantity of BP added in |xg per 0.5ml S9 mix (dose per plate in the Mutagenicity test). 
BPd - Benzo(a)pyrene in PBSA.
Tetrol - 7,8/9,10 Tetrol BP.
Ap AI2O3 A in PBSA Ad
Bp AI2O3 B in PBSA Bd
Fp Fe2Û3 in PBSA Fd
Tp Ti0 2  in PBSA Td
AI2O3 A in DMSO 
AI2O3 B in DMSO 
Fe203  in DMSO 
Ti0 2  in DMSO
Polar - Radioactivity that was collected before Tetrol aliquots.
- Not detected.
% metabolism was defined as the total BP ethylacetate extractable metabolitesAotal ethyl extractable 
phase (expressed as a percentage).
% aqueous was defined as activity in remaining in the aqueous phase after ethylacetate extraction/total 
recovered activity from all Auctions (expressed as a percentage).
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TABLE 43. Metabolism Profile of BP at Transfer Concentrations
Sample % Metabolised % Total 
Ethylacetate 
phase
% Aqueous 
Phase
% Recovery
BPD(2.5pg) 26.2 99.4 32 131.4*
BPD(0.75pg) 80.3 53.1 19.7 72.8
BPD(0.25pg) 92.6 63.1 8.9 72
BPM(2.5pg) 0.5 93.9 1 .8 95.7
AI2O3 A(PBSA) 0.5 51.2 0.9 52.1
AI2O3 B(PBSA) 21 65.6 6 .1 71.6
Fe203 (PBSA) 1 39.3 1.1 40.4
TIO2 (PBSA) 9.3 59.8 1.3 61.1
Al2 0 3A(DMS0 ) 35.4 83.9 3.3 87.2
AI2O3 B(DMSO) 42.2 69.3 3.3 75
Fe203(DMS0 ) 40.9 89.1 19.9 108.9*
Ti02 (DMSO) - - - -
The concentration of BP used was 0.5|xg/ml in 0.3 mg/ml o f microsomes incubated for 20min at 37°C 
in a shaking water bath. DMSO concentration was 2.5%7v
- loss due to collector jamming. The collector jammed on one sample tube resulting in the tube 
overflowing, with the loss of sample.
* higher than expected radiolabel counts. May be due to ’uneven* coating of sample. The higher BPq 
value could not be explained.
% metabolism was defined as the total BP ethyl acetate extractable metabolites/total ethyl extractable 
phase, time 1 0 0 , to give a final percentage.
'^^ C-BP coated particulate loadings (pg o f BP/pCi/g o f particulate)
AI2O3 A 
AI2O3 B 
Fe203 
Ti0 2
BPd - BP added in DMSO 
BPm - BP added in PBSA
2172.2/121.9/1
1855.2/81.1/1
1681.8/98.3/1
2183.8/137.8/1
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4.2.5.1. BP Transfer at pH 7.4.
The transfer of BP into the microsomes, possibly involves the partitioning o f BP into the hydrophobic 
regions o f the microsomes. The data are expressed as the percentage o f BP transferred against time. 
It was assumed that total transfer (solubilisation of BP in microsomal membranes) was obtained at the 
end of the experiment, based upon the verification by Lakowicz using radiolabelled BP (Lakowicz, 
1980). An excess o f microsomes was added to ensure that the amount o f BP used in experiments 
could be completely solubilised.
Figure 4.15 shows that BP dissolved in DMSO (final concentration o f 2.5% DMSO in suspension) was 
rapidly transferred when compared to BP microcrystals added in buffer after the addition of S9 
fraction.
The transfer rate of BP from alumina A and B, Ti0 2  and Fe203  coated particles added in DMSO were 
similar to BP microcrystals added in DMSO with particles (Figure 4.21). The transfer rate o f BP 
coated on alumina B added in buffer was higher than that observed for any of the other coated 
particles added in buffer, this being similar to BP added in DMSO particulates (Figure 4.20).
Ti0 2  and Fe203  BP coated particles added in buffer had higher transfer rates than that o f BP 
microcrystals in buffer, while AI2O3A was similar.
As the BP loading increased on the AI2O3 A (Figure 4.16 and 4.17) and AI2O3 B (Figure 4.18 and 
4.19), the transfer rate and percentage transferred in 30 minutes in PBSA was reduced, while the 
aluminas in DMSO remained similar to that o f BP in DMSO.
AI2O3 A loadings had similar transfer rates to that o f BP^ (Figure 4.19). AH loadings o f BP coated 
AI2O3 B had greater transfer rates than BP^ (Figure 4.18).
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LEGEND FOR FIGURES 4.12 TO 4.20
The concentration of BP used for transfer was 0.5 ng/ml.
Sample Alumina A
(pg of BP/g of particles)
Alumina B
(pg of BP/g of particles)
Alumina 1 476.3 1045
Alumina 2 1649.9 3554.8
Alumina 3 4756 9439.5
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gee page 135a for additional legend information
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Additional legend
The result presented in Figure 4 .4  are of a single determination .
The result presented in Figure 4.5 are an average ± standard deviation of three determinations of 
duplicates.
The result presented in Figure 4.7-10 are of single determinations.
The result presented in Figure 4.11-14 are a single scans with fixed point fluorescent emissions from 
two determinations of triplicates.
The result presented in Table 4.2 and 4.3 are of single determinations.
Following table shows the number of determination for figures 4.20-4.23,4.15.
pH 7.4 pH 4.5
Particle PBSA DMSO PBSA DMSO
Alumina A 4 3 3 3
Alumina B 4 3 3 3
Ferric oxide 3 3 1* 1 *
Titanium dioxide 3 3 2 * 2 *
BP 3 3 2 * 2 *
* Results presented as an average ± range, while remained are average ± standard deviation.
Alumina A  figure 4.16 samples in PBSA 4 determinations of duplicates.
Alumina A  figure 4.17 samples in DMSO 2 determinations of duplicates.
Alumina B figure 4.18 samples in PBSA 5 determinations of duplicates.
Alumina B figure 4.19 samples in DMSO 2 determinations of duplicate
Legend for Figure 4.15 - 4.23.
'Rates of BP transfer into S9 vesicles. BP wasldded in either DMSO or PBSA to give a final 
concentration of 0.5pg/ml. The concentration of DMSO in buffer was 2.5% (v/v) after 
addition of BP in DMSO solution. For the surface covering o f BP in figures 4 .1 6 -4 .19  see 
additional legend page 133 and for figures 4.20 -,4.23 see table 4.1 (column 2) on page 127. 
EiMSO was not present when BP was added in particulate adsorbed state and as microcrystals. 
S9 vesicles (0.3mg of protein/ml) were added to initiate the transfer process.
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4.2.S.2 BP Transfer Comparison of pH 7.4 and pH 4.5
The transfer rates were similar for pH 7.4 and pH 4.5 when the coated particles were added in DMSO 
(4.17-4.20). However, when added in PBS A, AI2O3 A and FejOj had a greater transfer rate in pH 4.5 
than pH 7.4. The reverse was observed with AI2O3 B and TiOg (Figure 4.20-4.23). The BP in DMSO 
and PBSA showed no significant difference between transfer rates at pH 4.5 and pH 7.4 (Figure 4.15).
4.3 DISCUSSION
ttal
The transfer o f BP from particles into lipid membranes has been investigated by Lakowicz (1979, 
1980 ) and Bevan (1985). When BP was adsorbed to Fe2 0 3 , asbestos, alumina (with N- 
ethylcarbazole) and Ti0 2  there was an enhancement of the rate of transfer of BP into lipid membranes, 
as compared to transfer from the microcrystaUine state. These results suggested that transfer into 
microsomes should occur and hence mutagenic activity might be seen as discussed in the previous 
chapter.
The transfer rates o f BP in DMSO + particles into microsomes (minus cofactors to prevent
ol
metabolism) were very rapid, similar observations were obtained by Bevan^(1985) when using acetone 
as the organic solvent and a subceUular system. The transfer in aqueous media from AI2O3 A, Ti0 2 , 
F%P3 was much lower, very little transfer occurring and this being only slightly more than firom BP 
microciystals. However AI2O3 B showed a higher transfer rate than any other particulate.
Other investigators have reported increased rates o f BP transfer with cellular systems when BP was 
adsorbed onto particles. Cellular uptake of BP into hamster tracheal epithelial cells in culture
otdl
(Mossman 1983) was enhanced when adsorbed onto asbestos.
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An explanation of this transfer of BP to microsomes, suggested by Lakowicz 4  1980 ), was that 
soluble PAHs were rapidly taken up by membranes and that the rate limiting step for transfer of BP 
(PAH) was the solubilisation of BP into the aqueous phase which was followed by a rapid transfer of 
solubilised BP into the membranes. As the content of organic solvent increased, the solubility o f BP 
also increased (BP in HjO was 5(ig/l and BP in H^O with DMSO at 2.5% v / \  was 13.3|0,g/litre). This 
would explain the increase in the transfer rates associated with BP in DMSO (+ particles).
The observed differences between the particles transfer in aqueous media, could be explained by the 
fluorescent surface scans, which revealed the extent of available BP (monomeric) for effective transfer 
(and metabolism).
The fluorescence scans revealed the various states of BP in the aqueous media. The two alumina’s 
showed maiked differences in scan even though they were chemically similar, which could be 
attributed to their different surface areas. The lower surface area, showed a predominant crystalline 
appearance as the loading increased which would be expected, as the area became covered with BP 
which then nucleated in a crystalline structure. This would indicate that the alumina A had become 
a large ’BP particulate’ with Al^Og A as its core.
AI2O3 B scans were very similar as the loading increased, which suggested that there was insufficient 
BP available to coat the entire surface o f the AI2O3 B. The presence o f the crystalline peak, may be 
associated with pockets of BP that have nucleated into BP crystals.
The TiOj and Fe203  were more difficult to inteipret as they adsorbed in the same region as the BP 
fluorescence. However, as the loading increased the crystalline peak became apparent. As the transfer 
rates were very similar to AI2O3 A it suggested that the particulates had similar attributes, a more 
crystalline state. This would be more likely to be true for Fe20 3 . However Ti0 2  presented a different 
situation, as the majority of Ti0 2  particles fonned aggregates, it could be suggested that the BP
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’cemented’ these aggregates, so coating the particulate unevenly and with a high BP crystalline 
content.
The particles seemed to have little effect on the metabolism of BP when added in DMSO to a 
microsomal metabolising system, when compared to each other. There appeared to be no difference 
in the type and balance o f metabolites produced and no significant inhibitory effects on the cytochrome 
P-450 system by the particles. However, when added in PBSA (thereby forming an aqueous and 
microsomal medium) there was a marked quantitative difference in metabolism, suggesting that the 
particles affected the bio-availability (transfer of BP to the microsomal metabolising system). The 
profiles again were similar but much reduced compared to an organic solvent (DMSO) system. BP 
on AI2O3 B was more extensively metabolised than on any of the other particles tested.
A comparison between the BP added in DMSO showed that at the lowest dose of BP added, the 
percentage of metabolism was low, but the extent of metabolism was high, as initiated by the high 
activity detected in the veiy polar and aqueous phases. This was also seen for the BP^ phases, 
although the majority o f BP was not metabolised.
It must be mentioned that the amount of solvent added to the Ames test produced a high solvent 
percentage (10% v/v). This greatly increased the amount of dissolved (monomeric) BP, available for 
transfer and metabolism.
When looking at the percentage of metabolism of BP at the transfer rate concentration, with a much 
reduced solvent content (2.5% v/v), the percentage o f metabolism was reduced at the higher dose, 
while at the lowest dose over 80% of the available BP was metabolised.
The comparison of BP^ with PBSA particles (AI2O3 A, Fe203  and T102) show a percentage of  
metabolism in a similar order of magnitude. However, AI2O3 B proved to be more extensively
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metabolised. A comparison of BP transfer and percentage of metabolism (transfer concentration) 
revealed that not all the BP transferred was metabolised. When particulates were added in DMSO, 
over 80-99% o f the BP was transferred; however only 35-42% o f the BP added was metabolised, 
which was approximately 50% of that transferred.
The transfers, when using PBSA, matched the percentage of metabolism. AI2O3 B particulates having 
the highest transfer rate also had the highest metabolism, the order o f transfer and metabolism being 
AI2O3 B >Ti0 2  > Fe203  > AI2O3 A. However, the percentage metabolism of the BP transferred in the 
case of AI2O3 B and TiOg was approximately 25%, while AI2O3A and Fe203  was approximately 5%. 
The similar surface areas for AI2O3 A and Fe203  may explain these observations, but AI2O3 B and TiÛ2 
was not as clear cut The aggregate nature of Ti0 2  may be the key to this observation.
/o. percentage o f  £>P
There was a. significant difference^ t^ ansFerecL between BP added in DMSO and PBSA. There was 
no significant difference between BP coated particles added in DMSO, this may be accounted for by 
the concentration of solvent (DMSO) in the media, which would raise the quantity of dissolved BP 
available for transfer.
However there was a change in BP transfer rates from the BP coated particles added in PBSA at pH 
7.4 compared to pH 4.5. At pH 4.5 order of transfer was alumina B > alumina > A >Fe203  > Ti0 2  
(in order o f decreasing rate) while at pH 7.4 alumina B > Ti0 2  > Fe2 0 3  > alumina A. Alumina B and 
Ti0 2  rates were reduced, while alumina A and Fe203  were increased at pH 4.5, when compared to that 
at pH 7.4. These changes may be associated with particle surface chemistry or S9 vesicle lipid/protein 
changes. These results indicate that the pH has an influence on the availability o f BP.
In these studies, the presence of DMSO increased the amount o f BP solubilised in the aqueous media. 
In the case o f AI2O3 B the fluorescence scan showed it had a large proportion of BP in the monomeric 
state. Assuming that the solubilisation of BP into the microsomal lipid was high, then the transfer rate
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would be a function of the quantity of monomeric to crystalline BP. It would seem from these results 
that particles mainly affected the rate of BP transfer (bioavailability) into the S9 vesicles and eventual 
metabolism to active mutagens.
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5. EFFECTS OF PARTICULATES AND BP ON PHAGOCYTIC CELLS
5.1 MACROPHAGES
The present consensus on the origin of pulmonary alveolar macrophages (PAM) is that there are at 
least two sources: peripheral blood monocytes that migrate into the lung and local mononuclear 
phagocytes that replicate in the alveoli or interstitium. In a murine model proposed by Blusse . -- 
sT at: (1979 & 1983), it was demonstrated that in steady state and acute inflammation the vast 
majority of PAM derive from peripheral blood monocytes.
Adamson and Bowden (1980) demonstrated that following tracheal instillation o f carbon particles the 
increase in the alveolar macrophage was biphasic. An initial increase was due to the rapid influx of 
monocytes, but at a later time point increased mitotic activity in the interstitium was observed, 
suggesting a role for local cell replication.
The turnover time for PAM in a murine model has been estimated at about 21-28 days (Godleski 
1972). At the end of this period there is an efflux of cells via the mucociliary escalator (Brain 1970). 
It is also believed, that a subpopulation exists that may cross the alveoli epithelium, returning to the
t- 6^ 4?
interstitium or possibly entering the lymphatics (Lauweyns 1977).
5.2 BRONCHIO-ALVEOLAR LAVAGE
Most macrophages are isolated using a lavage method, which usually involves washing the isolation 
area with saline or culture medium to wash loosely attached cells.
Bronchio-alveolar lavage fluid in a healthy non-smoking individual has a population o f 1-10x10® cells 
and in a smoker this number is increased about four-fold (Harris et al 1970). The extent to which
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cells harvested by lavage are representative of the actual cell population within the alveoli is debatable. 
Undoubtedly, the alveolar cells are a mixture of the macrophages from successive generation o f the 
airways. In addition, cells harvested using successive washes with normal saline may represent a 
subset of cells that are loosely adherent either because of senescence or other unknown factors. In 
animals, the cell yields are greatly increased when the lavage fluid contains ethylenediaminetetra acetic 
acid (EDTA) to decrease cell adherence (Holt 1979). The first aliquots of lavage have been 
demonstrated to contain the largest and least active macrophages in terms of superoxide anions (O2") 
and hydrogen peroxide (HjOj) production, and with subsequent aliquots the cells became smaller and
if-él
more active (Snvder^l982). Animal studies looking at resident PAM have demonstrated heterogeneity
J:at (J-Â
of morphological and cytochemical properties (Dauber 1983; Zwilling 1982), and tumoricidal capacity, 
chemotaxis and O2 radical release. The smaller denser cells are morphologically similar to blood
monocytes and more active in these terms, suggesting that they have recently migrated to the lung and
ùt 6/6 2^.
were relatively less mature (Hohan 1983; Elias^l985).
PAM rapidly adhere to glass or plastic. After a 10 min exposure to these surfaces attachments o f the 
spherical cells by pseudopodia have been observed. Within one hour the cells were flattened and
at
spread over the surface with smooth pseudopodia (Quan^l977).
The physiological effects of the adherence have only recently been considered. This is particularly 
important because virtually all the studies of PAM have looked at the cells following an adherence 
procedure. In the alveolus, by contrast, the cells are found in the surfactant-rich alveolar fluid, making 
contact with the epithelial lining of the alveolar septum by means o f pseudopodia (Kamer 1958).
5.3 STRUCTURE OF PAM
PAM are representative of large tissue macrophages with a well-developed vacuolar apparatus and
<sb ol et fL
more than the usual number of mitochondria (Cohen 1971; Lenzin/ 1980).
- 142-
The most prominent cytoplasmic organelle is the dense granule or secondary lysosome. These 
structures contain phagocytosed, degraded or stored extracellular material.
In the ’h o f o f the nuclei, PAM have multifocal accumulation of golgi cistemae and many associated 
small vesicles. The Golgi apparatus seem to be involved with the packaging of acid hydrolases into 
small vesicles prior to their transport and fusion with endocytic vesicles and secondary lysosomes. 
The Golgi is also involved in the formation of vesicles for secretion. Peripheral folds in the ribosomal 
endoplasmic reticulum are prominent in keeping with routine protein synthesis with occasional 
polysomes present.
The plasma membrane is utilised to form endocytosis vesicles, both pinocytosis and phagocytosis 
vacuoles move centripetally in the cytoplasm, eventually taking up residence in the peri-Golgi zone. 
Here they are converted to secondary lysosomes and commence the process o f ultracellular digestion.
Internalised macromolecules are exposed to a wide variety of endo- and exo-hydrolysis that dismantle 
most biologically important molecules within the confines of the macrophage lysosomes at pH4-4.5. 
Molecules are degraded to the small molecular weight units (amino acids, monosaccharides and
■cf'al
nucleosides) before being released to the cytosol (Cohen^l969; Ehrenreich^ 1969). Indigestible 
materials remain within the vacuolar apparatus for the life of the cell and may, upon cell death, be 
distributed to new populations of phagocytes.
5.4 FUNCTION OF PAM
5.4.1 Particle Clearance
Macrophages keep the surfaces of the lungs clean and sterile. They ingest inhaled pathogens
&  i t  4^ at '
(Goldstein^l974; Green^l979) and particles (Brain 1985) as well as endogenous effective cells and 
even ’worn-out’ surfactants (Eckert 1983).
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Like other phagocytes, PAM are rich in lysosomes, subceUular organeUes 0.5pm or less in diameter. 
Among the enzymes known to be present in lysosomes are proteases, acid ribonuclease, p-
U'oL
glucuronidase, acid phosphatase, lysozymes, B-galactosidase and phospholipases (Cohen 1963; Leake
v h  a t < / aL
1964; Sorber^ 1974; Yarborough^l967; Franson^l973). The lysosomes attach themselves to the 
phagosomal membrane surrounding the ingested pathogen. Then the lysosomal and phagosomal 
membrane becomes continuous and the lytic enzymes kiU and digest the bacteria.
Another anti-pathogenic action of macrophages occurs via the oxygen-dependent cytotoxic systems. 
Although best described in neutrophils (Babior 1980; Klebanoff 1980), phagocytosis triggers increased 
oxygen consumption and the generation of active oxygen species such as superoxide (O2 ), hydroxyl 
radical, singlet oxygen and H2O2. These highly reactive oxygen derivatives modify macromolecules 
of pathogens. Lipids, proteins and nucleic acids may be modified by peroxidase and haUde-mediated 
oxygen-dependent reactions (Klebonoff 1980). Macrophages protect themselves from the active 
oxygen species by antioxidant such as vitamin E, ascorbic acid and the glutathione redox system 
catalyses and dismutases.
In addition to phagocytosis of pathogens, macrophages also takes up non-living, insoluble particles and 
debris into membrane-bound vesicles in the cytoplasm. This rapid endocytosis of insoluble particles 
prevents particle (pathogen) from penetrating the alveolar epitheUa and faciUtates alveolar bronchiolar
tif a l
transport (Sorokin 1975).
5.4.2 Secretion and Immunological Regulation
Macrophages have many functions besides phagocytosis of particles and invading microorganisms 
(bacteria, viruses). They secrete a variety of substances that interact with multi-enzyme cascades (such 
as complement) and also with cells such as lymphocytes, fibroblasts, neutrophils and other
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macrophages (Table 5.1 gives an indication of involvement). Thus, the macrophage both responds to 
and regulates its external environment.
TABLE 5.1. Secretory and immunological factor associated with macrophages
ASSOCIATED FUNCTION PRODUCT
Complement C1-C5
Coagulation factors Thromboplastin
Prothrombin
Enzyme Inhibitors Plasmin inhibitors
Binding proteins Transferrin
Fibronectin
Bioactive lipids Arachidonate metabolites 
Prostaglandins
Reactive species of oxygen Superoxide anion 
Hydroxyl radical
Chemotactic factors For Neutrophils
Other Enzymes Lysozymes
Proteases
Regulation of protein synthesis CoUagenase
Macrophages are involved in the presentation of antigens and interact with the helper/inducer set of 
T-lymphocytes. Finally, interaction between macrophages and lymphocytes are modified by exposure
et <il
to inhaled particles such as tobacco smoke (De Shazo^l983).
5.5. PATHOPHYSIOLOGY OF MACROPHAGES
In addition to protecting the host, macrophages also participate in the pathogenesis o f lung disease. 
As macrophages are actively phagocytic, inhaled toxic, radioactive, or carcinogenic particulates become 
concentrated within pulmonary macrophages. What begins as a diffuse exposure becomes highly 
localised and non-uniform. Areas o f high concentration are formed which may also result in 
metabolism of chemicals to more toxic forms. When macrophages adhere to the airway epithelium
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they may therefore increase epithelial exposure to inhaled toxic materials. More importantly, this close 
association with the bronchial epithelium can lead to transbronchial transport of inhaled particles and 
subsequently re-ingestion by pulmonary connective tissue macrophages (Watson et al 1979). These 
cells, like those in the alveolar and airway compartments also segregate, retain and peihaps metabolise 
carcinogenic and other toxic particles. This may contribute to progressive damage by concentrating 
and storing potent toxic particles for long periods.
Macrophage function can be compromised by environmental insult and pathological changes. Such 
diverse agents as silica, immuno suppressives, ethanol intoxication, cigarette smoke, air pollution, 
oxygen toxicity and hypoxia can depress the ability o f pulmonary macrophages to protect their host 
Diesel exhaust may depress the phagocyte activity (Castranova et al 1985), lead oxide (PbO) disrupts 
mitochondria and forms precipitate complexes within the endoplasmic reticulum, nuclear chromatin 
and cytoplasm (De Vries et al 1983).
In other cases of high concentrations of inhaled particles, the phagocytic machinery may become 
saturated even in the absence of cellular cytotoxicity. Additionally, activity changes may be brought 
about by the change in the macrophage milieu as in oedema or an altered acid based balance (Tuiino or-ix 
1974).
There are situations in which pulmonary macrophages not only fail but contribute directly to the 
pathogenesis of pulmonary disease. These conditions of oedema, emphysema and fibrosis involve the 
damage or disruption of homeostatic balances of connective tissue, collagen and elastin, which help 
maintain alveolar, airway and vascular stability. This is achieved via the action of hydrolytic enzymes, 
their modulator and other secretory products (leukotrienes). Additionally, reduction in immunological 
surveillance and radical production (i.e. chronic inflammation) can contribute to cancer.
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5.6. THE ROLE OF MACROPHAGES IN CYTOTOXICITY
Phagocytosis of the particles followed by a cytotoxic effect on the PAM is believed to be the first step 
in the fibrogenic process and effects of various particulates on macrophages, from several experimental 
animals have been reported (Kaw 1977). Cytotoxic effects of silica particles on macrophages have 
been demonstrated by release of various cytoplasmic enzymes, e.g. lactate dehydrogenase (LDH), 6 - 
glucuronidase (glu) and acid phosphatases (AP) (Morgan 1978, Lock 1987).
The possible mechanisms of silica cytotoxicity includes phagocytosis induced release o f factors that 
disrupt the lysosomal membranes releasing their contents into the surrounding cytoplasm, which in turn 
could damage other organelles or rupture the cell membrane, releasing cellular contents. Added to
this, is the purely mechanical action of the particulate ’punching’ holes in the cellular apparatus
da l
(Johnson ^ 1983).
The cytotoxic effect is delayed when serum is added to the medium or when some other polymers 
(PVPNO, polyvinyl-pyridine-N-oxide) are added before, during or after incubation with silica 
(Sakabe et al 1967). This effect may be explained, by the protective effect that the polymer has by 
coating the particle surfaces. Delayed cytotoxicity would be related to the digestion time taken by the 
macrophages to remove the protective coating. As all inhaled particles have to pass through the 
respiratory lining layer that ’wets’ the surface of the respiratory tract, they become coated with 
endogenous materials. Thus the use of serum in culture may help to simulate the in vivo situation.
Already mentioned are the additional factors that macrophages contain (see Table 5.1), which may 
contribute to environmental changes within the lung producing conditions such as oedema, emphysema 
and fibrosis. It has been shown that phagocytosis-stimulating agents also elicit prostaglandin 
production by macrophages (Cook 1933), triggering an inflammatory response.
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The macrophages natural cytotoxicity can turn against the cellular environment that it is intended to 
protect. The addition of quartz to PAM in vitro, induced a substantial increase in lipid peroxidation 
compared to non-treated macrophages. Release of superoxide has been shown to be a central step in 
the killing o f invading organisms by macrophages. Various particles induce oxidant production in 
alveolar macrophages. All particles tested, with the exception of glass fibres, caused a stimulation of 
the oxidant production.
5.7. METABOLISM
Human pulmonary macrophages (HPM) have a limited capacity for metabolising xenobiotics, such as 
benzo(a)pyrene to proximal and ultimate mutagens (Autrup et allTIH , Harris e ta l 1912, Marshall et 
al 1979). Bond^(1983a) demonstrated that BP adsorbed to diesel particles, was released with its 
metabolites into the surrounding culture media that the macrophages resided in. The long retention 
of diesel particles in the lung of rats recorded by Sun^(1982), suggest that the HPM could bioactivate 
BP to mutagenic intermediates that could be released into the environment or translocated to other 
regions o f the lung or body. HPM metabolism of BP was considerably enhanced in smokers when 
compared to non-smokers (Cantrell et al 1973).
King et al (1983) demonstrated that rabbit lung macrophages were able to remove up to 98% of the 
mutagenic activity, as measured in the Salmonella mutagenicity assay, from engulfed particles (fly 
ash). This demonstrated the ability of macrophages to release and/or metabolise not only PAH, but 
also nitro-arenes. However, Palmer and Creasia (1984), demonstrated that the uptake and retention 
of DMBA by macrophages can be influenced by the characteristics of the ingested particulates. 
Smaller quantities of DMBA and its metabolites were recovered from cultures of macrophages with 
ingested carbon particles than from those with FejOa and AI2O3 particles.
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5.8. AREA OF INVESTIGATION
To complement the bacterial and subceUular work, ceU culture was used to evaluate the cytotoxic 
contribution of the particulates per se and when coated with BP that may contribute to the overaU 
effect of particulate-PAH enhanced carcinogenicity. This system was closer to the in vivo situation 
than the other techniques so far employed.
Once the culture technique was established in an established ceU Une (P388D1), the technique was to 
be applied to more relevant ceU types such as PAM and peritoneal macrophages (PM).
The ceU Une chosen was a continuous ceU Une derived from murine lymphoma which has been 
reported to have many macrophage-Uke characteristics (Dawe & Potter 1957, Koren et al 1975). 
P388D1 was isolated from a methylcholanthrene-induced lymphoid neoplasm (P388) o f a DBA/2 
mouse. P388D1 is a ’derived* culture line of P388. P388 cells were transferred back to a mouse, the 
resulting tumour was then cultured to produce the P388D1 ceU Une. This tissue culture line has been 
characterised with respect to its macrophage-like characteristics (Koren et al 1975). (1) they resemble 
macrophage morphology, (2 ) they phagocytose polystyrene beads, (3) they contain non-specific 
esterases, (4) they adhere to glass and plastic, and (5) they forni rosettes, with sheep red blood ceUs.
Previous work with the P388D1 macrophage-like ceU line has shown it to be a favourable model of 
macrophage function (Daniel et al 1980, Wright et al 1980, Wade et 4 1980) and hence, that
of possible lung toxicity. The advantage of P388D1 ceUs, unlike primary macrophage cultures is their 
capacity for replication, which makes isolation easier, standardization and long term culture more 
manageable. The index of cytotoxicity used was the release from the ceUs of cytoplasmic lactate 
dehydrogenase (LDH) and lysosomal enzymes, B-glucuronidase (Glue), B-galactosidase (Gal) and N- 
Acetyl-glucuronidase (NAG) with protein determination of attached cells at the end of the culture 
period. The ceUs were dosed with both particulate and BP coated particulates.
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In addition Chinese Hamster Ovary cells (CHO) and Chinese Hamster lung cells (V79) were used. 
CHO and V79 have been widely employed in a variety of in vitro test systems. CHO cells have been
d i t  d  a[
used to evaluate a wide variety of environmental pollutants (Garrett ^ 1981,1983 and Tan ^1982). 
Chinese Hamster V79 cells have been used extensively in cytotoxic studies o f fibrous and non-fibrous
doL
particulates (Brown^l980) and as the target cell for mediated mutagenicity. An adaption o f the 
FRAME cytotoxicity test (Knox et al 1986) to permit addition o f S9 fraction metabolising system and 
determination of protein content by binding of Kenacid blue dye (Benford et al 1988) or Neutral red 
accumulation (Borenfreund and Puemer 1985) was used to determine cytotoxicity of BP coated and 
uncoated particulates.
As cells in continuous cultures have been found to be deficient in the capability to activate 
premutagens and precarcinogens, a subceUular fraction obtained from Aroclor induced rats was used. 
The supernatant ftom centrifugation of the crude homogenate at 9000g (S9 fraction), was buffered and 
added with cofactors (NADP and G6P) to the cultured cells.
5.9 RESULTS
5.9.1 P388D1 Cvtotoxicitv
The uncoated FejOj was not significantly cytotoxic as indicated by LDH, Gal, Glue and NAG release, 
to the P388D1 ceUs over the dose range tested (Figure 5.1). AI2O3A and AI2O3B (Figure 5.2 and 
Figure 5.3) showed only sUght cytotoxicity at lOOOjxg/ml. There was a slight rise in enzyme release 
at lOOOjxgAnl. However Ti0 2  was cytotoxic at 300jxg/ml (Figure 5.4).
As expected silica DQ12 was found to be very cytotoxic at concentrations of 30-100 ligAnl 
(Figure 5.5). This was used as a positive control in subsequent experiments.
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Figure 5.1
The results are expressed as mean ± range, for two determinations of triplicates. See additional legend
for more information (page 164).
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Figure 5.2:
The results are expressed as mean ± range, for three determinations of triplicates. See additional legend
for more information (page 164).
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Figure 5.3:
The results are expressed as mean ± range, for three determinations of triplicates. See additional legend
for more information (page 164).
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Figure 5.4:
The results are expressed as mean ± range, for two determinations of triplicates. See additional legend
for more information (page 164).
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Figure 5.5
The results are expressed as an average ± range for two determinations of triplicates. See additional 
legend for more information.
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Figure 5.6
The results are expressed as an average ± range for two determinations of triplicates. See additional
legend for more information (page 164).
Alumina A, B and FcgOs BP coated particles at low and high BP coated doses caused no increase in 
cytotoxicity over the controls. However the BP coated TiOg particles showed significantly reduced 
cytotoxic effects compared to TiOg alone (Figure S.lOj. Increasing the dose o f dust to 1000 )xg/ml, 
showed no increase in cytotoxicity for Fc203  and Alumina B (Figures 5.7-5.9). The cytotoxicity when 
compared to previous experiments, using uncoated dusts, TiOg showed a slight reduction in 
cytotoxicity. However as these were only single experiments, more would be required to draw a more 
significant conclusion. It was difficult to form an even suspension of BP coated Ti0 2  in McCoys 
medium, visual inspection showed larger than normal clumps of Ti0 2 . This may account for the 
reduced cytotoxic response, by limiting the amount of TiÛ2 phagocytosed and cell to Ti0 2  surface 
contact.
BP in DMSO (Figure 5. 6  ) was found not to be cytotoxic even at doses of 250|Lig/ml (at doses above 
50pg/ml it precipitated out of solution and the precipitate was seen to be phagocytosed).
AU uncoated particles showed cytotoxicity with increased dose when using Neutral red uptake as the 
indicator of cytotoxicity, while Alumina A and Fe2Û3 showed similar but reduced cytotoxicity at the 
same dose (Figure 5.11). Cytotoxicity was as expected with DQ g^ (Figure 5.12). Latex particles seem 
to have produced minimal cytotoxicity, which was not dose related (Figure 5.12).
5.9.2 Cvtotoxicitv in P388D1 ceUs with metabolic activation
Metabolism of BP was demonstrated with S9 concentrations of 0.5 to 1.5 mg of protein/ml (see 
Section 4.2.4). At these 89 concentrations,‘fcPA  and BP were both cytotoxic to P388D1 cells, as 
assessed by Neutral red uptake (Figure 5.13 and 5.14). However CPA at lOOpigAnl only showed 
minimal cytotoxic with 0.5mg of protein/ml o f 89 (Figure 5.14).
t  Cyclophosphamide (CPA) was used as a positive control, requiring metabolism to produce its cytotoxic effect 
(Shrana et al 1984, Homer et al 1985). CPA is an indirect mutagen that is mutagenic only after activation by 
suitable metabolising system (liver microsomes) (Connors et al 1974). Initially CPA is metabolised to 
4-hydroxyCPA which may then breakdown by elimination of acrolein from its tautomeric form, 
aldophosphamide to yield phosphoramide mustard a known cytotoxic agent. In competition with this process is 
the conversion of the 4-hydroxyCPA into known in vivo metabolites, each of which has low cytotoxicity (4-keto 
CPA and carboxyphosphamide).
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The results are presented as an average ± standard deviation of three determination of triplicates.
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figure 5.13
The results for 0.5 and 1.5mg/ml S9 are expressed as average of triplicates, while 1.0 mg are 
expressed as an average ± range of 2  determinations of triplicates.
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figure 5.14
The results are expressed as an average ± range of two determinations of triplicates. See additional 
legend for more information (page 164).
S9 alone produced no significant cytotoxicity in P388D1 cells at protein concentrations o f 0.5 to 1.5 
mg of protein/ml (Table 5.2). The S9 at Img of proteinAnl was chosen for future use as it was the 
minimum concentration required to produce an effect, without adverse cytotoxicity.
Preliminary investigations indicated that BP coated Fe203  and TiÛ2 were not toxic in the presence of 
S9, over the range ( l-6 pg of BP) tested (Figure 5.15) using Neutral red uptake as the indicator of 
toxicity. Whereas both Alumina A and B showed cytotoxicity with increased loading o f BP (Figure 
5.15). The cytotoxicity of the BP coated particles was less marked than when BP (5|xg/ml) was added 
in DMSO (Figure 5.15). However, as these were only single experiments, more would be required 
to draw a more significant conclusion.
5.9.3 V79 Cytotoxicity
DQi2 as expected, produced cytotoxicity with increasing dosage. Latex particles showed minimal 
effects compared to control (Figure 5.16 and 5.17). Similar results were obtained with Neutral red 
(Figure 5.17) and Kenacid blue (Figure 5.16) determinations, although it appeared that Neutral red was 
the more sensitive.
All particles tested, showed only slight cytotoxicity at the highest dose used (3mg/ml), using Neutral 
red and Kenacid blue as the indicator of cytotoxicity (Figure 5.18 and 5.19). Similar results were 
obtained with Neutral red and Kenacid blue as indicators of cytotoxicity.
5.9.4 CHO Cytotoxicity
DQi2 showed cytotoxicity as expected, which increased with dose (Figure 5.16). Latex particles 
showed slight cytotoxicity (Figure 5.17). All particles with the exception of Alumina A showed slight
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TABLE 5.2 P388D1 Cytotoxicity* treated with S9
S9 mg/ml % Control
0 (n=4) 1 0 0
0.5 (n=3) 99.9 ± 9.9
1.0 (n=4) 96.4 ± 1.4
1.5 (n=4) 95.6 ± 4.8
* as determined by neutral re^uptake.^n^is number of determinations.
The P388D1 cells were incub^tS^for 3 hours at 37°C in humidified 5 %C0 2 :9 5 % air atmosphere. 
A d d it io n a l L ^ e n d  
Culture without S9 
P388D1 and PM
Cells were seededo-sxlO^ cells/ml. Incubated overnight and dosed with the particulates for 16-18hr, 
before assaying for LDH (Lactate dehydrogenase) ,6 -Gal( B-Galactosidase),6 -Gluc (6 -Glucuronidase), 
NAG (N-AcetylGlucronidase), Protein determination of attached cells, neutral red uptake and/or 
kenacid blue.
CHO, V79 and P388D1
Cells were seeded at 4x1 O'* cells/ml in culture well trays. The culture was then dosed with the 
appropriate concentration of particulate in media. The dosed cultures were then incubated for 3 days 
in humidified 5% C0 2 :9 5 % air atmosphere, before assaying for Neutral red and Kenacid blue.
Culture with S9
Method was as previously described, but with the following additions: To the BP coated particulates 
and cultured cells was added Img of protein/ml final concentration of S9. The resulting culture was 
then incubated for 3hrs, after which the media was removed and the cell washed and fresh culture 
media added. The resulting culture was then incubated for 3 days and then assayed for neutral red 
uptake and/or kenacid blue (2.17.3, 2.17.4).
PM isolation and dosing
The peritoneal macrophages were isolated from the peritoneal cavity of mice. This involved the 
injection of culture media (serum free) into the peritoneal cavity, gentle massage and the removal of 
the media. The cells were then precipitated by centrifugation and a viability determined and the cell 
were plated at 0.5x10*  ^cells/ml in 1 nil culture trays for dosing with particulates (2.17).
Legend information for figures
Labeling used in figures
A
B
F
T
:Al203 A  
:Al20, B
iFezOg
:TiO,
:Benzo(a)pyrene 
iCyclophosph— amide 
:DQ,'silica
BP 
CPA 
DQ12,D 
LDH iLactate dehydrogenase
6 -Gluc :6 -Glucuronidase 
6 -Gal :6 -Galactosidase 
NAG :N-AcetylGluco^a.ivi»/ii4.o5e
[continues on page 165]
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Cytotoxicity of B P co a te d  P articu la tes
% Neutal Red 
1001 with P388D1 and S9
90-
80 v:
70-
60 -
50-
40 1111111111 i 11II1111111111111 n 11111111111111111111111111111111 n III 1111111111111111111111111III Him
0 1 2 3 4 5 6 1o
Key
A
BP dose (ug)
ngure 5.15
The results are presented as an average of a single determination of triplicate samples. 
Additional legend text continued
Doses BP coated particles f<x Figure 5.7 (ug of BP)
Particles number A B F T
Part 0 10 10" 0 ' 0
1 0.14 0.31 0.12 0.25
2 0.5 1.1 0.51 1.0
3 1.4 2.8 0.89 1.6
Doses BP coated particles for Figure 5 - ,  .8, .9, .10, .20, 22(f*^ of Bf).
Particles number A B F T
Part 0 ',0_ 0 _ . 0 0
1 0-5 10 0.4 o.i
2 0.7 2.3 0.6 1.7
3 1.6 3.5 1.7 3.3
4 2.8 5.4 2.2 3.4
5 4.8 9.4 2.9 5.4
Particles were added in culture media. Control, was cells dosed only with PBSA.
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% Kenacid Blue Cytotoxicity of CHO and V79
160-] Dosed with DQ12 and Latex
Key
140-
DQ12
1 2 0 - CHO
V79
Latex80-
CHO
60-
V79
40
2 0 -
^  Particulates (ug/mi)01 10 1 0 0
ngure 5.16
The results are expressed as an average of a single determination of triplicates.
% Neutral Red Cytotoxicity of CHO and V79
Dosed with DQ12 and Latex
Key140-
DQ12
1 2 0
CHO
1 0 0
V79
Latex
CHO60-
V79
40-
2 0
01  10 30 1 0 0Particulates (ug/ml)
igure 5.17
The results are expressed as an average of a single determination of triplicates. See additional legend
for more information (page 164).
cytotoxicity at doses above ImgAnl with Kenacid blue as the indicator of cytotoxicity (Figure 5.19). 
Using Neutral red as the cytotoxic indicator, all particles showed slight cytotoxicity at doses above 
ImgAnl (Figure 5.18). As the V79 and CHO experiments were of single determinations, more 
experiments would be required to draw a more significant conclusion. The dose of Img/ml was 
chosen for study with BP coated samples, using S9.as the metabolism system.
5.10 CYTOTOXICITY OF V79 AND CHO WITH S9
BP in DMSO, was cytotoxic to both CHO and V79 cells, after incubation with 89 (Figure 5.20). BP 
coated particles showed only slight cytotoxicity at the highest BP coating in both V79 and CHO cells 
compared with uncoated particulate controls.
The cell dosing technique and subsequent washing did not lend itself well to particulate samples. If 
the washing procedure was too vigorous, it would result in the loss of attached cells by the mechanical 
action of the particulate suspension. Great care was taken to reduce the cell loss during washing.
5.11 CYTOTOXICITY PERITONEAL MACROPHAGES (PM)
¥
As expected DQ12 was found to be very cytotoxic at doses above 30pg/ml (Figure 5.21). This was 
used as a positive control.
All the uncoated particles (AI2O3 A, B, Fe203  and Ti0 2 ) showed increased cytotoxicity with increased 
dose (Figure 5.21).
BP coated Alumina A, B Fe203  and Ti0 2  showed no increase in cytotoxicity over
particulate controls (Figure 5.22). The cytotoxicity observation for PM in most cases were based on 
single experiments, more testing would be required to further substantiate the above observations.
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% LDH Release Cytotoxiclty in Peritoneal Macrophages
120-1 Keydosed with particulates
— DQ12
100-
80-
  F
60-
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20 -
100030003o 100
Dose of Particuiates (ug/mi)
ugure 5.21
The results are presented as an average for a single determination of triplicates.
Cytotoxicity of P^Macrophages 
Dosed With Particulates
% LDH leakage 
60-, Key
Control • no paitieulales
Patt0-1000uQ/mlof 
uncoaled paid ulalee
50-
40-
30-
20 -
10 -
: figure 5.22
The A and B dose groups are presented as an average of two determinations of
triplicates, while the F and T are the average of a single determination of triplicates.
See additional legend for more information (page 164).
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5.12 DESCRIPTION OF PHOTOGRAPHS
5.12.1 Scanning Electron Microscopv of Cells in Culture
All cell types (P388D1, PM, V79, CHO) used in the SEM and TEM samples, were overnight cultures 
of ceU seeded at 0.5 x 10^  cell/ml and dosed with particles (DQ12, latex beads, Al203A,B, FejOa and 
TiOg) at a concentration of lQG}Xg/ml for 16-18 hours. The samples were then washed, fixed and then 
prepared for SEM or TEM (See Methods 2.18).
5.13 DISCUSSION
An increase in mutagenicity was associated with an increase in concentration of adsorbed BP. This 
was not so with cytotoxicity. The presence of BP did not affect cytotoxicity except in the case of 
TiOj which may have been due to the physical effect of BP causing clumping of the TiOj and so 
reducing the amount of phagocytosis and particulate to cell contact.
The main contributoiy factors to the cytotoxicity seem to be the particle cell inter- and intra-actions 
rather than the adsorbed BP. This was further supported by the fact that BP in DMSO
at doses of 25(W m l had no significant cytotoxic effect, as measured by LDH leakage, suggesting that 
the BP exerts cellular effects that do not result in gross cellular toxicity in the P388D1 cell line.
As expected DQ12 was cytotoxic at low doses, the other particles tested, with the exception o f TiOg, 
showed no significant cytotoxicity, TiOj showed increased cytotoxicity at higher doses (>1 0 0 |xg/inl).
The effect seen for silica (DQ^j) was expected from previous work. Haemolysis of erythrocytes when 
challenged with silicated dust (Singh 1983) and the release o f LDH and lysosomal enzymes from 
alveolar and peritoneal macrophages (Morgan et al 1980) have all been demonstrated.
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1Plate 5.1 SEM showing P388D1 in culture
The majority of the population are rounded cells ’standing’ on extended pseudqpodia. Other members of the population are flattened, but 
show ruffled surface tvilh PTfending pseudopodia.
Plate 5.2 SEM showing a close up of a P388D1
The surface of the cells reveal a large number of folds (ruffles), with many extending pseudopodia.
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Plate 5.3 SEM showing P388D1 and AI 2O 3 association
The main cellular and particulate interactions are shown here;-1) The left cell shows extensive ^agocytosis of A1%0;B particles, much of 
the cell surface is smooth, with few extending pseudopodia. 2) The right hand cell shows its ruffled and pseudopodia, with large numbers 
of AI2O3B particles ’stuck to its back’.
Plate 5.4 SEM showing P388D1 and FegOg association
The FcjOj particles are present in large aggregates (F ->). The P388Dls appear to be using the particulate aggregate more as a surface 
support than trying to phagocytose the individual particles.
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21KV
Platèr*5.-5 SEM showing P38 8D1 and Fe 2 0 3 association
The central P388D1 ceU appears to be either sitting on the underlying Fe^O; particles or endeavouring to engulf them.
Plate 5.6 SEM showing PM and TiÛ2 association
The TiO% exist in small aggregated pockets that appear to stick to the cell surface.
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Plate 5.7 SEM showing PM and DQ 12 association
The DQij has aggregated together and ’stuck’ to the cell surface. The cells show a more pronounced ’spidery’ appearance due to the 
presence of the particles.
Plate 5.8 SEM showing PM and AI 2O 3 association
AI2O3 aggregate (A -») sitting side by side of the cells.
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Plate 5.9 SEM showing PM and FegO^ association
PMs sitting on either side of the Fe^O, aggregate show no ül effects of particulate presence, as extending pseudopodia and ruffling can be 
observed.
Plate 5.10 SEM showing PM and FegOs association
The engorged PM shows a distaided appearance due to the presence of the Fe^O; particulate.
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Plate 5.11 SEM showing PM and AI 2O 3 B association
Three central PM ceUs are coated by the Al^OjB particles. The central cells (—>) surface ’bumping’ suggest that it contains two other 
particles.
i
Plate 5.12 SEM showing PM and Latex beads association
The PM culture shows no morphological changes expected with cytotoxic particles. The Latex beads are dotted throughout the culture, the 
majority being present on the cell surface.
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5.12.2 Transmission electron Microscopv
$ 'ï-
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Plate 5.13 TEM showing P388D1 in culture
M88D1 cells in culture. The main features of a macrophage-like cell are observed (large nucleus, cellular vesicles and extending 
pseudopodia). This compares favourably with mouse peritoneal macrophages (Plate 16)(magnification 4k).
i’-' .
P ^ t e ^  showing P388D1 and Latex ^ e a d s  
association
Shows P388D1, with extensively phagocytosed latex particles that reside, within the lysosomal system, distributed throughout the cellular 
cytoplasm. This compares favourably with the mouse peritoneal macrophage (Plate 18)(magnification 7k).
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Plate 5.15 TEM showing P388D1 and 59 vesicular 
association
Plate 15 shows that theP388Dl suffers no gross cellular changes compared to control (Plate 13) when dosed with S9 (ImgAnl). S9 vesicles 
can be seen surrounding the cell and associated with the cellular surface (S->), Also vesicles can be seen within a cellular 
’vacuole’(V—»)(magnification 12k).
Plate 5.16 TEM showing PM and Latex bead 
association
To the right shows latex beads (L) in a forming pocket of cytoplasm, possibly prior to phagocytosis. While the bottom (L) shows the 
cytoplasmic presence of phagocytosed latex beads ( magnification 15k)
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Plate 5.17 TEM showing CHO and S9 vesicular 
association
Plate 5.18 TEM showing V79 and S9 vesicular
association
Similar observations can be made with CHO (Plate 17, magnification 12k) and V79 (Plate 18, magnification 12k) cells. Both these cell types 
show S9 vesicles between cells, with extended pseudopodia, surrounding the vesicles, possibly prior to being engulfed by the cell. However 
no vesicles were observed within either cell type.
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The in vitro cytotoxicity of silica correlates with known, in vivo effects, alveolar proteMeeo^and 
fibrotic nodule formation, increased release of LDH and lysosomal components into lung lavage fluid 
from animals exposed to silica (Gross et al 1984 and Sjoerstand^l984). TiOa synthetic amphoras 
samples are usually used as negative controls in cytotoxicity testing (Wright et al 1980) although at 
higher doses in testing it does produce a cytotoxic effect (Davies 1980). The apparent in vitro 
cytotoxicity does not correlate with the in vivo ‘inertness’, i.e. lack of fibrogenic action (Moores et 
al 1980). The reason for this lack of biological effect is unclear. FCzOg (haematite) was found to be 
non-cytotoxic even at high dose (doses at which TiOg had a cytotoxic effect). This ‘inertness’ was 
expected, as no cytotoxicity was observed with alveolar macrophages (Davies 1980) and intra-tracheal 
inoculations o f haematite in vivo produced no fibrogenic changes (Jasural 1972; Sîenhacï^etal; 1976). 
Again the non-cytotoxic nature of the alumina was expected from in vitro data in V79-4 and A549 
(Brown^l980), even though these particulate samples had different crystalline structures (Alumina 
A-a, Alumina B -7).
Findings by Zitting et al (1979), showed crystalline lattice structure of TiOg to be an important factor 
in haemolytic activity.
The absorption of BP to the particles had no apparent cytotoxic effect on the P388D1 cell line, except 
with TiOz particles. When coated the BP may block potential cytotoxic surface cell interactions. The 
coating o f known cytotoxic particles (silica and asbestos) with serum and polyvinyl pyridine-n-oxide 
is known to reduce and delay the cytotoxic effects of these particles (Sakabe et al 1967; Mossman v-'iT- 
198s). However this effect has not been shown to occur in particulate adsorbed PAH. The absence 
of effect of BP on P388D1 could be explained by the lack of metabolism (Plant et al 1985).
The non cytotoxic effects seen with BP coated particles and PM, may be related to the low metabolic 
capacity of cells in culture (Greim 1986). Cantrell^(1973), showed increased AHH activity in smokers
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ove-r; non-smokers. A pre-treatment of the mice with BP before isolation of macrophages, may have 
increased the likelihood of observable cytotoxicity.
A comparison of cytotoxicity between P388D1 and peritoneal macrophages, showed the peritoneal 
macrophages to be more sensitive to the cytotoxic effects of the uncoated particulate than P388D1. 
The only exception being the uncoated TiOz having comparatively reduced cytotoxicity at the highest 
dose tested compared to P388D1.
The cytotoxicity compared favourably between all cell types tested, in that as the dose of uncoated 
particles increased so did the cytotoxicity, as measured by the various endpoints (enzyme release, 
protein and Neutral red accumulation). The Neutral red uptake appeared to be the more sensitive 
method with P388D1. This may have been related to the P388D1 being rich in lysosomes.
The use of S9 as the activation system with BP coated particles, gave conflicting results between the 
cell types. CHO and V79 showed no cytotoxicity while P388D1 showed cytotoxicity in both alumina 
A and B. When BP was dosed in DMSO, cytotoxicity was seen. This may be related to there being 
sufficient BP available to result in metabolism to cytotoxic species. P388D1 (with 89) dosed with BP 
in DMSO produced more cytotoxicity compared to BP coated particles of an equivalent amount. This 
could be interpreted as insufficient BP being released from the particulate surface, to be metabolised 
to cytotoxic species, or that the S9 affords some protection against the cytotoxic species. A possible 
extension in incubation time may have increased the observed cytotoxicity.
The electron microscopic observation of the particles supported the enzyme release data. No cytotoxic 
changes in morphology were observed. The particles were seen to act more as a ’support base’ for 
culture than cytotoxic species.
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The observed difference between the CHO and V79 cell and P388D1, when using S9 with BP coated 
particles, could be explained in part by the electron microscopic observation. With the presence of 
S9, the CHO and V79 showed limited interactions. A close association between S9 vesicles and ceU 
membrane was observed, while P388D1 S9 vesicles were taken into the cell.
It was observed that S9 vesicles coated the surface of the particles (see Section 3.8.4) and when these 
coated particles were phagocytosed they carried with them an activation system (S9). Once within the 
cellular structure, one would expect the BP metabolites to be readily accessible to cellular 
macromolecules.
- 184
6. IN VIVO/IN VITRO STUDY OF HAMSTER LUNG
The technique most widely used for the investigation of tumorigenesis in lung tissue is that of 
intratracheal instillation (Saffiotti e t . al 1968; Henry et al 1973). This technique was developed to 
administer measured quantities of PAH to animals via a route resembling human exposure by 
inhalation. It was developed because the production and maintenance of a homogenous particulate 
inhalable atmosphere is technically difficult. The additional problem of variable dosage received by 
the animals, would lead to variable responses which would require larger dose groups to compensate.
Early experiments using intratracheal instillation to investigate the lung carcinogenicity o f PAH, such 
as DMBA, BP and tobacco smoke were unsuccessful and where tumours were produced (laiymx, 
trachea and oesophagus), these were not histologically similar to those produced in man by tobacco 
smoking (Della Porta et al 1958; Saffiotti et al 1965; Gross et al 1965).
Pylev (1961, l962ab)and Shabad (1962) instilled DMBA with india ink powder which produced a high 
tumour incidence (up to 30%) in rats, which were found to be histologically similar to those o f man.
The particulate-PAH co-instillation was further developed by Saffiotti et al (1968). The principal 
animal used for the intratracheal instillation was the Syrian Golden hamster although rat and mouse 
have also been used. The hamster was found to be more resistant to chronic inflammation and had 
a low incidence of spontaneous lung tumours (Pylev 1961, IBéZaypvoss et al 1965). Additionally the 
tumours produced are histologically similar to man, mainly arising from the tracheobronchial 
epithelium (Harris et al 1971, 1973; Mohr 1979; Fort et al 1973).
The method used by Saffiotti et al (1968), used a mixture of BP and ferric oxide. Briefly, it involved 
the once weekly instillation of a 1:1 mixture of BP/Fe203  (3mg:3mg) produced by prolonged grinding. 
This produced 100% tumours in surviving animals after 15 weekly instillations, with the majority of
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tumours being of histological importance (tracheobronchial, squamous, epithelial, and 
adenocarcinomas).
6.1 BENZO(a)PYRENE AND PARTICULATES
Saffiotti et al (1968) found that successive, weekly instillation produced more tumours in hamsters 
than a single intra-tracheal instillation. A mixture of 3mg BP to 3mg Fe^Og was found to be most 
effective. A dose response was observed with increased co-instillation o f equal amounts ofFegOg and 
BP (up to 2mg) (Saffiotti et al 1972). However, when BP/FejOa at 3mg was mixed with additional 
F^Ps and co-instilled no increase tumour incidence was observed (Sellakumar et al 1973). This 
observed effect may be explained by the fact that the percentage o f BP coated F^Og remained 
constant.
Sellakumar et al (1976) perforated studies to determine if  enhanced tumorigenesis observed upon 
exposure to Fe2Û3 and BP resulted from a tumour-promotor relationship. Sellakumar observed a large 
number of tumours when using BP/Fc203  (71%). However, when BP was dosed before or after only 
13% was observed, which was similar to BP alone. It was therefore concluded that Fe203  was not a 
promoter or initiator in BP induced neoplasia but that F ^P 3 association was required.
Other particulate matter has been used in conjunction with BP. These include asbestos, silica, alumina, 
titanium dioxide, magnesium oxide, lead oxide, talc and carbon black.
BP with chrysotile asbestos enhanced tumorigenesis in hamsters, while amosite produced no 
enhancement above that when BP alone was instilled (Miller et al 1965). The difference may be ex- 
plained by the way in which BP was adsorbed to the various types of asbestos (Harrington^l965o). 
Some of the particles used with BP produced varying degrees o f synergism upon co-instillation.
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Stenback (1979) studied TiOj in combination with BP and observed similar numbers o f respiratory 
lesions to those induced by BP with FezO .^ Moreover, a greater incidence of tumorigenesis was 
observed when silica and BP were administered together than when BP alone was used (Stenback 
1979). Studies employing Al^Og did not show as great a synergism as those with FegOg and BP, 
though some enhancement of tumorigenesis was observed (Stenback et al 1976, Farrell and Davis 
1974^,
Other particulates and BP have shown enhancement of tumorigenesis though a direct comparison with 
F^Og + BP was not made. Administration of PbO and BP (Kobayashi and Okamoto 1974) and BP 
in combination with talcum powder in hamsters resulted in an increased incidence o f tumorigenesis
nt al
(Stenback 1978).
Studies with carbon black and BP have produced an area of conflict. Pylev (1961 ,19 2^ab)and Shabad 
(1962) using india ink (carbon suspension) observed enhanced tumorigenesis with DMBA in rats. 
Additionally Stenback^(1976) and FarreU and Davis (1974k) using hamsters, observed BP-carbon to 
give enhanced and similar tumorigenesis to that o f FegO^/BP. However, Davis et al (1975) observed 
that BP-carbon reduced BP tumorigenesis. An explanation for these discrepancies could be due to the 
size of the particle used, its effective clearance from the lung and the dose o f BP that is released from 
the particle onto the surrounding pulmonary environment (Henry and Kaufinan 1973). Additionally 
there is a wide variety of carbon black particulates available.
6.2 BP DOSED ALONE AND TUMORIGENESIS
The BP particulate system for inducing tumorigenesis was based on the fallacy, that BP alone was not 
carcinogenic upon instillation, as it could not readily penetrate into the lung and could not be retained 
sufficiently long to be taken up into the lung tissue.
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However, investigators have produced tumours using small doses of BP (Img) instilled for long 
periods (from 52 weeks to a lifetime dosing) (Feron et al 1980; Hilfrich et al 1973), using an 
assortment of dosing vehicles (saline, gelatine, carboxymethylceUulose and com oil). Additional
ei o2
studies by Feron et al (1980), Henry et al (1973) and Stenback^(1978) produced tumours with varying 
sizes of BP (up to 10pm). AH these instillations were performed in such a way as to alter the 
clearance rate o f the particulate BP from the lung.
This manipulation may be a major contributory reason for particulate BP carcinogenesis. However, 
particles > 10pm are normally deposited in the nasopharyngeal region and not the bronchio-alveolar 
region.
6.3 CLEARANCE AND RETENTION OF PARTICULATE SIZE
The various routes of clearance have already been discussed (see Introduction section 1.2.6); the 
particles that are deposited upon the ciliated airways will be cleared rapidly from the lungs. However, 
those particulates deposited below the ciliate airway (beyond the terminal bronchiole), may become 
a reservoir, prolonging localised exposure and a source for subsequent translocation to other tissues 
via the bloodstream.
Brody et al (1982) observed translocation of inhaled silica in rats, from the alveolar duct surfaces; to 
alveolar type I cells within 24 hours; to interstitium within 3 days and over 66% of the macrophage 
contained silica (even after a 24 day period). Additionally, particulates accumulated at the terminal 
bronchioles, possibly due to sedimentation of inhaled particulates, caused by the stopping o f bulk 
airflow (which occurred at the bronchioles).
F eriif (I9 7 8 ) studied the involvement o f lymphatic drainage (TiOj contents o f Hilar nodes) in rats. 
Particles deposited on the alveolar epithelium produced a macrophage response, which partially
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contained the particulates. However free particulates may be translocated and reach the interstitial
eiaL
space and the lymphatic system quite fast (within a few hours) (Ferin^l97S). The penetration into the 
interstitium and lymphatics, could be due, in part, to absorption of the carrier fluid and heavy 
deposition (Brain 1 9 7 0 ). Thus, it is difficult to interpret in terms of the amount o f BP that is 
transferable to the lung tissues. Additionally, the rate at which the particles (with which BP was 
co-instilled) are cleared from the respiratory tract are not usually considered.
Saffiotti et al (1970, 1964 and 1965) made a number of observations concerning the retention of BP 
when co-instilled with FegOg.
1. 80%-90% of the BP dosed was cleared from the lung in 7 days regardless of the number of
instillations performed previously.
2. Low concentration of BP/Fe^Og were cleared faster than high concentration.
3. Rate of BP clearance was the same with different doses of FegOg.
4. When BP/FegOg was prepared by grinding or solvent nucléation, similar size particles were
cleared from the lung at the same rate.
5 . Qearance rates increased as particle size decreased.
However, most of the Fe2Û3 was retained in the lungs over the course of these experiments (Saffiotti d 4  
1970).
The intratracheal instillation of two different sizes of BP particles into hamsters demonstrated that 
instillation of the larger particles (64% greater than 10pm) resulted in greater tumorigenesis than
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instillation of the smaller particles (98% less than 10pm), where the larger particles produced 6  times
i t  ah
as many respiratory lesions (Stenback^l978). This correlated with the clearance rates, larger particles 
were retained for a longer period of time, 75% remaining in the lungs 6  hours after instillation, 
compared to 17% for the smaller particles (Stenback 1978).
When BP was administered to hamsters together with FezOg and AlgOg with particle sizes o f 0.1-5,0.5- 
1,2-5 ,5-10 and 15-30pm there was no observed differences between BP clearance rates as a function 
of particle size (95% clearance of AlgOg was within llhr-14 days and FejOg was 14-23 hrs). However,
the clearance rate o f BP from the particle associated state were slow compared to the clearance o f BP
(lot
administered without particulates (Henry^l974, 1975).
As a general rule the particulate clearance from the lungs is much longer than that of the associated 
xenobiotics (Henry^l973; Saffiotti 1970).
Lehnert and Morrow (1985) determined the effective clearance half-time for radiolabelled ferric oxide 
(^^e) from the lung of hamsters to be 24.5+2.5 days and the biological clearance half-time to be 
52.5+5.5 day. Additionally, Matsumo et al (1986) concluded that clearance of coal fly ash from rats 
was very slow as after a 10 month clearance period there still remained approximately 50% o f the fly 
ash (as measured by aluminium content).
The transfer through other compartments via macrophage conveyance may account for this extended
elaZ
retention. Brody^(1982), isolated macrophages collected after a 42 day clearance period from rat 
exposed to respirable silica, showing that 28+4% of these macrophages contained silica.
A postmortem comparison of cancer patients and their marked controls by Churg et al (1985), 
concluded that cancer patients retained more particles than non-cancer patients.
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6.4 DISTRIBUTION OF BP METABOLISING ENZYMES IN THE LUNG
DaW «^4  ^ (1982,1983) detected measurable levels of microsomal P450 reductase in the nasal
epithelial membrane of dog, rabbit, guinea pig and hamster. Cytochrome P450 levels of rat nasal 
epithelium was 1.6 times that of lung [per mg protein] (Hadley ^ 1982). Monooxygenase in nasal 
turbinates of dogs and rat catalysed the activation of BP (Bond 1983a,cjto bacterial mutagens in 
Salmonella typhimurium (Bond 1983b). Additionally rat nasal epithelium metabolised BP to 
dihydrodiol, quinones and phenol at 10  times the rate of lung microsomes.
Kaufman et al (1973) incubated hamster trachea with ^H-BP then isolated DNA from the tracheal 
epithelial cells and found it contained covalently bound ^H-BP. Binding was enhanced when trachea
e t  al
was taken from hamsters previously exposed to BP-Fe2 0 3 . Additional studies (Mass^l978) in hamsters 
have shown that the tracheal epithelium is the target tissue for the development of tumours by PAH 
such as BP.
Tracheal organ culture and isolated tracheal microsomes catalysed the binding of ^H-BP to DNA in 
vitro. HPLC analysis revealed a variety of metabolic products (phenols, quinones, tetrols and diols 
7 ,8 -dihydrodiol the penultimate carcinogen).
When cloned hamster tracheal epithelial cells were incubated with ^H-BP, adducts with DNA were 
formed (Eastman 1983). The cell formed the proposed carcinogen 7,8-dihydro-7,8-di-hydroxy-BP-9,10 
oxide which reacts with deoxy-adenosine, deoxy-cytosine and deoxy-guanosine (see Introduction). The 
DNA-carcinogen adducts were partially repaired during the course of the incubation. In addition to 
these biochemical events it was reported that incubation of rat tracheal organ culture in media 
containing BP produced morphological alterations consistent with hyperplasia, metaplasia and other 
general cytotoxic features. Following intratracheal administration of BP-FcjOg to rat and hamster there
eJb d
was a striking species difference in lesion distribution (Schreiber^l975a,t^, In hamster, squamous
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metaplasia of the trachea and large bronchi were observed, while in rat squamous nodules of the 
bronchio alveolar region developed. These differences correlate with penetration and persistence of 
BP-Fc203  in hamster epithelium but not in the rat. An additional reason for this could be that when
ikot
BP was incubated in tracheal organ cultures (Mass 1984), binding to DNA was 17 times greater in 
hamster than in rat. Harris et al (1976) used pieces of human bronchi and incubated them with ^H-BP 
for one week. ^H-BP and its metabolites were found to bind to cellular macromolecules and to DNA 
isolated from bronchial mucosa. The main cells involved were ciliated and mucous cells.
Autrup et al (1978a)reported that cultured human bronchial epithelium in vitro converted ^H-BP to 7,8 
dihydroxy-7,8,dihydro-BP. Aryl hydrocarbon hydroxylase was found to be induced when
benz(a)anthracene was present in cultured bronchial epithelium, which in turn produced increases o f
etal
%-BP DNA adducts (29x) (Kahng 1981).
Human alveolar macrophages have a limited capacity to metabolise PAH compounds to proximal and 
ultimate mutagens (Autrup^l978k J'rump et al 1978). When diesel particles were recovered after being 
engulfed by rabbit macrophages in vitro, organic extracts of the particles had lost 97-98% of their 
mutagenic activity, showing that macrophages were able to release and/or metabolise not only PAH 
but also nitro-arenes which were responsible for most of the mutagenic activity of diesel particles 
(King et al 1983).
The role of metabolic activation of xenobiotics in lung injury seems mainly to involve the attack of  
a reactive electrophilic intermediate on bronchiolar, non-ciliated (Clara) epithelial cell, alveolar type
ddl
I and II or vascular endothelium (Bend^l985, Boyd 1976).
The above mentioned studies indicate that there are cell types distributed throughout the respiratory 
tract with the capacity to metabolise BP to active intermediates. The reason for certain portions of 
the respiratory tract being more susceptible to tumour formation may be related to their metabolic
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capabilities. Most studies have focused on the cytochrome P450 dependent metabolism rather than
et o2
non-oxidants. Bond ù d  ,(1988) and Dahl (1983) demonstrated that several non-oxidative enzymes 
including epoxide hydrolase, UDP-glucuronyl transferase and glutathione transferase were present in 
nasal tissue and lower respiratory tract. The activity in the tissues of these enzymes was greater than 
the tissue’s Aryl hydrocarbon hydroxylase activity. It is unclear what the balance of ’activating’ and 
’inactivating’ enzymes are in the different portions of the respiratory tract. This balance would be a 
major determinant of chemical carcinogenicity.
6.5 UNSCHEDULED DNA SYNTHESIS (UDS) IN CULTURED CELLS
It has been established for some time that cells can remove portions of DNA damage in one strand 
of the double helix and replace the excised portion with undamaged DNA nucleotides. This process 
is called excision repair and restores the original integrity of the DNA molecules. This is distinct from 
semi-conservative replication that is confined to the S-phase of the mammalian cell cycle.
Rasmussen and Painter (1966) first reported the incorporation of ^H-thymidine into the DNA of  
cultured mammalian cells during the repair of damage induced by ultraviolet irradiation. The method 
involved culturing cells on glass slides, exposing them to a DNA-damaging agent in the presence of  
medium containing high specific activity ^H-thymidine, and observing the radiolabel incorporated 
during UDS into cells that were not in S-phase. This was done by way of a photo emulsion that 
detects the B-emission from the tritium. Using autoradiographic methods (as opposed to liquid 
scintillation counting) it is possible to distinguish between those cells in S-phase and those undergoing 
excision repair.
The ability of substances to induce UDS in cultured cells is now widely used to assess the genotoxic 
activity of compounds in mammalian systems. The assay is a measure of the amount of repair 
produced and monitors neither the original lesion nor the fidelity or consequence of repair.
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6.5.1 Qassification Type of Genotoxicants
Many chemicals have been studied (Schulte-Hermann et al 1983) and it has been proposed that there 
are three useful classifications for hepatocarcinogens (Butterworth et al 1985; Lowry et al 1987). The 
three types are
Type 1 agents that are genotoxic in the liver in the whole animal as evidenced by the induction of  
DNA repair, identification of DNA adducts and other indicators o f reactivity with DNA.
Type 2 agents which show no induction of primary genotoxicity but cause liver hyperplasia upon 
prolonged administration. An S-phase response is seen, with a maximum at about 24 hours after a 
single treatment. No cytotoxicity is produced as evidenced by unchanged liver-specific enzymes in 
the serum.
Type 3 agents which show no induction of primary genotoxicity but are cytotoxic to the liver as 
evidenced by specific enzymes in the serum. Regenerative liver growth is produced, evidenced by an 
increase in S-phase response with a maximum at about 48 hours after a single treatment
This classification may equally be applied to extrahepatic tissues, although the time response for S- 
phase may vary depending upon tissue (cell type).
6.5.2 Chemical Exposure and UDS
Many t>pes of mutagens/carcinogens capable of inducing DNA damage can be detected by UDS 
(McCann et al 1975; Williams^l982).
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Carcinogenesis is a multistage, multifactoral process. The induction of either DNA damage or DNA 
replication is likely to be necessary, but not a sufficient component of the carcinogenic process. 
Agents that induce acute hyperplasia are not necessarily carcinogenic (Furstenberger et al 1981; 
Marks et al 1979; Mufson et al 1979; Slaga et al 1976). Hyperplasia is an early response of the 
respiratory epithelium to physical and chemical injury (Becci^l978, Griesemer^l976). The elevation
cJ-al
of restorative cell proliferation (Gordon 1977) may be important in both initiation (Cayama et al 1978;
tkoL
Columbano^l981) and promotion (Argyris 1980; Argyris and Slaga 1981; Kinzel et al 1984; 
Furstenberger et al 1985) o f chemical carcinogenesis.
6 .6  UDS IN LUNG TISSUE
Surprisingly little work has been reported on UDS in respiratory tissue. The majority o f work that has 
been performed concerns the upper respiratory tract, the nasal-olfactory region to the bronchiole 
region, due to the large number of cancers that occur at these sites in humans (Jett et al 1983). The 
work mainly involved in vitro systems using isolated cells of the nasal turbinates, trachea and 
bronchial epithelia. These cellular epithelia have been isolated from human, hamster and rat. All 
show varying degrees of xenobiotic specificity of positive UDS response (Bermudez et al 1984; 
Doolittle .1983, 1984; Formce 1982; Grafstrom et al 1983; Schiff 1983, 1985; Working et al 1986).
Doolittle (1985) showed an increase in UDS for human bronchial epithelial cells when exposed to BP.
Even less work has been performed with cells of the peripheral lung (bronchioli to alveolar) although 
Deilhaug^(1985) demonstrated UDS repair in isolated clara, alveolar type II cells and macrophages of 
rabbit lung.
One drawback of these in vitro methods is that the isolation of cultured lung cells do not readily 
permit identification of the particular ceU type involved in a positive response. However, identification
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can be obtained, although by lengthy procedures, involving histochemistry, immunochemistry and 
cryocytology (Plopper 1987).
6.7 SUMMARY REASONING
The large number of genetic and/or epigenetic mechanisms required to turn a cell into the beginnings 
of a malignant tumour (the eventual expression of the cancer usually follows a long latency period, 
up to as much as 20 years (Calms 1975)), makes early detection of lung cancer very difficult.
Accordingly, identification of chemicals with carcinogenic potential is very difficult. Traditional 
animal cancer bioassays must run over the lifetime of the animal. Most protocols require a preliminary 
acute toxicity determination, a 90 day chronic study and a 2 year cancer study with an additional year 
of pathology evaluation data analysis and report writing, all of which is costly.
A UDS assay in the whole animal offers a reasonably quick means to measure the extent o f possible 
initiation and/or promotion of unknown xenobiotics in the tissue of interest.
As previously discussed, the majority o f air pollutants are associated with particulate emissions of  
respirable size, which have a host of associated xenobiotics. These responsible dusts are deposited 
throughout the length of the respiratory tracts, from which the xenobiotics dissociate into the 
surrounding area.
Work by Saffiotti et al (1968), Henry et al (1975) and Pyi'ev (1973) has shown that BP instilled with 
particulates increased neoplasia and reduced the latency period in Syrian golden hamsters (also mice 
and rats), the main types of neoplasia being seen in the trachea and bronchioles with limited number 
of lesions in the peripheral parts.
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The heterogeneity of the respiratory tract metabolism can be related to its diverse cell types (Breeze 
et al 1977) which are distributed throughout its lengths, each of which, will probably have unique
et é-
metabolising capabilities within their positions (Bond 198 Sa^erabjit-Singh^1983). The animal studies 
using particulates, produced results after many weeks of continuous dosing, while the metabolism 
studies using isolated organ and cultured cell systems, can produce results in a few weeks. However 
the cells are removed from their co-ceUular symbiosis into an alien environment.
Using the UDS assay and duplicating as closely as possible the work of Saffiotti et al (1968) and a 
modification of the organ culture technique of Placke and Fisher (1987), it was hoped that UDS could 
be produced in the hamster lungs after intratracheal instillation with BP-FeiOa. These methods enabled 
the integrity of the lung infrastructure to be kept as complete as possible and maintain the cellular 
cooperation within this heterogenous tissue, enabling regional effects o f the dosed xenobiotic 
particulate suspension to be observed. Additionally, the normal process of absoiption transportation 
metabolism, detoxification and binding o^DNA were allowed to take place. Autoradiography was em­
ployed to locate the incorporation of ^H thymidine and distinguish between UDS repair and S-phase 
cells.
6 .8  Area of Investigation
The following study was based on the study performed by Saffiotti^(1968, 1972) and Henry^(1973). 
This involved the intratracheally instilled BP coated ferric oxide particles to produce respiratory 
tumours in the Syrian golden hamsters.
In these studies, the endpoint used was an increase in the tumour incidence over controls. In this 
study the endpoint used was the incorporation of radiolabelled ^H-thymidine, measuring the possible 
extent of genome damage (possible initiation) over controls.
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A single intratracheally instilled dose of BP (9.8+2.3mg), Fe^Og ( 1 5 .6 4 4 .5 mg) and BP-FegOg (BP 
1 3 .2 +3 .2 mg:Fe203  10.1+1.9mg) in 0.25ml of saline was given to 14 week old male Syrian golden 
hamsters (103.6+7.4 [n=32]), with a saline control, UDS was measured for each sample at various time 
points 12hr, 1 day, 3 day and 5 days after exposure.
6.9 RESULTS
6.9.1 UDS
A count for nuclear and cytoplasmic grains was made (Tables 6 .1-6.3) on the controls and BP-F6203 
dose groups, on time points 12hr, 1 day and 3 days. On examination of the other dose groups and 
time points, it was decided that counting for UDS grains would be unsuccessful as no grains were 
seen. However large numbers of S-phase cells denoted by heavy labelling were seen and these were 
counted.
6.9.2 S-Phase
The percentage of S-Phase cell is shown in Figures 6 .1-6.3
6.9.3 Tracheal S-Phase Cells
The BP and FezOs dose groups (Figure 6.1) showed only minimal changes compared with control. 
The BP-Fe203  combined coated dosing showed a marked increase in S-phase cells 1 day after dosing 
(7.13%).
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The following Tables 6.1 to 6.3 are à summary of UDS responses across pulmonary regions 
at different times after a single intratracheal dose of saline and BP-FegOg.
TABLE 6.1 Twelve hour time point
Dose Group Pul. Region NG CG N etN G
saline Trachea 0 0 0
Bronchiole 0 0 0
Peripheral 0 0 0
BP-Fe^Os Trachea 0 0 0
Bronchiole 0 0 0
Peripheral 0 0 0
TABLE 6.2 One day time point
Dose Group Pul. Region NG CG Net NG
saline Trachea 0 0 0
Bronchiole 0 0 0
Peripheral 0 0 0
BP-FegOg Trachea 0 0 0
Bronchiole 0 0 0
Peripheral 0 0 0
TABLE 6 3  Three day time point
Dose Group Pul. Region NG CG Net NG
saline Trachea 0 0 0
Bronchiole 0 0 0
Peripheral 0 0 0
BP-Fe^Oa Trachea 0 0 0
Bronchiole 0 0 0
Peripheral 0 0 0
Two slides counted per dose group. Fifty cells counted for each pulmonary region^pu/.
NG Nuclear grains counted
CG Cytoplasmic grain count
Net NG Net nuclear grain count (Net NG = NG - CG)
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6.9.4 Bronchioles
BP and FegOg showed no major increase over controls although there can be seen a general increase 
in S-phase cells with time. However BP-FejOa again produced an increase in the S-phase cells seen 
(at 1 day produced 1 .2 %), although not as large an increase as was observed in the trachea.
6.9.5 Peripheral
BP, Fe203  and BP-Fe203  doses showed no change over the controls. At the 5 day time point, with 
aU samples tested there was a marked increase in the S-phase cells detected. This increase affected 
both the controls and the 3 dose groups used. This increase could not be accounted for.
6.9.6 Dose Observation
The distribution of an instilled dose was estimated using vegetable dye in saline. The lung was 
examined to show distribution to be mainly tracheal-bronchial, with limited peripheral staining.
6.10 DISCUSSION
The results and observations obtained for UDS may give a misleading conclusion. No repair was 
observed. This could be explained by the fact that no DNA damage was observed caused by 
insufficient xenobiotic insult or that the label was diluted by a large cellular nucleotide pool, or that 
the test was not sensitive enough. The exact amount o f repair synthesis would depend on 1) the 
particular mutagen/ carcinogen, 2) the type of DNA repair process that operates on the damaged area, 
3 ) the size of the repair patch that would be cut out to remove the damage prior to subsequent 
resynthesis.
- 200 -
Trachea S f  hase Cells
12
10
8
«
4
2
0
0 12h lOay 5Day3Day
Time (hr-days)
Key
—  BP
—  Ferric
—  BPfFe
ugure 6 .1
p«««.oe sj>te» Bronchiole S-phase Cells
2.5
1.5
0.5
0 12h IDay 3Dey 5Day
key
 BP
—  Fiirte 
 BPfFe
figure 6.2
Peripheral S f  hase Cells
0
5
4
3
2
1
0
0  12h 1 Day 3Day SDay
key 
 BP
—  Panic
—  BPfPe
"igure 6.3
The results are expressed as the average ± standard range of two animals per dose group, cell 
were counted from a slide per animal. The control value is all saline controls for each 
time point combined.
The ability to detect UDS is further influenced by more obvious factors such as whether the cells 
under study (and tissue slices), take up and incorporate (^H)-thymidine readily, the concentration and 
specific activity of the (%-thymidine and the efficiency of the method used to detect the radiolabel.
However the most likely cause of this non-detection of UDS is the effective dose administered and
the subsequent tissue dose exposure and exposure time. The dose of BP added was 10-15mg of BP
d'ctt
or/and FezOg. Henry^(1973) produced tumorigenesis with a single dose of 37.5mg, while Saffiotti 
(1968), using a dose o f 3mg:3mg BP to Fe2 0 3 , used a repeated 5 weekly instilling regime resulting 
in a total dose of 15mg BP and 15mg of FOiOj to produce a more significant effect
The small single dose administered may have been insufficient to have over-burdened the various 
clearance and cellular metabolising defence mechanisms (muco-ciliaiy escalator, deactivation 
metabolism and DNA-repair). The dose delivery system used had its limitations, in this instance it 
was only able to effectively deliver a dose of approximately 30mg. Improvements in syringe and 
cannula design might have allowed an increase in effective dosage.
Although no effective UDS was measured, the label did penetrate the pulmonary matrix, as heavily 
labelled S-phase cells were observed throughout the lung slices.
An additional point with regard to the method used was that the infrastructure of the lung slices was 
intact and that the tissue isolation method, was not as disruptive as other in vivo/in vitro methods, 
which used proteases to separate cells (Doolittle et al 1984). As the infrastructure o f the lung sample 
was intact, its cutting for slide preparation would produce cuts, that may have sections o f nucleus 
present. This produces an inherent reduction in sensitivity as only a section of the nuclear area is seen 
for counting. As the interfintra relationships were still intact, this may have benefited cellular defence 
systems. In additional to these factors is the influences of the in vivo systemic system, in that the 
clearance of the dosed BP and FejOa to another location would have reduced the local effective dose.
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Forth (1984) demonstrated that instilled BP being cleared from perfused rat lung appeared within 3 
minutes in the perfusate. This cleared BP becomes a source for extra-pulmonary metabolism. The 
liver plays a major role in detoxification and removing BP and metabolites before the full cardiac 
output returns to the capillaiy beds o f the lungs. Foith^(1984) showed that in a recycling system 
involving the lung and liver, the liver offered protection to the lung, reflexed in the reduced pulmonary 
BP binding. Additionally, BP-FegOg, cleared from the lung via the muco-ciliary escalade and then 
swallowed in the sputum, undergoes a two stage metabolic pass; that of the gastrointestinal tract and 
a pass through the liver, in which the first pass effect of the liver will have removed the majority of  
BP and its metabolites, via biliary clearance (Weyand.^1986). This illustrates the influence that the 
route of xenobiotic exposure can have on an effect in a specific tissue.
However, entrohepatic circulation may play a role in giving an additional toxicological risk. Tomquist «/«Z 
(1985) demonstrated the increase binding of BP, when the perfusion media was recycled through the 
lung, without the protective influence o f the liver. BP that escapes the first pass effect o f the liver 
may then produce a higher toxicological risk to the lung capillary beds, which may be greater than that 
of the parent compound.
An attempt was made to determine if  the BP and particulates induced the levels of enzymes involved 
in the metabolism of BP. However, this was imsuccessful, due to storage difficulties. A change in 
the metabolising systems activity would help to explain the biological effects seen.
An important factor in the activation of xenobiotics that could cause DNA damage, increased repair 
or binding adducts is the extent of activation over inactivation present in the target area. The 
distribution of P450 isoenzymes may have important implications in site specific toxicity 
(Minchin 1983). The use of inducers such as methylcholanthrene or B-naphthofiavone results in a 
marked increase in the metabolism of BP to phenols, dihydrodiols and quinones (Tomquist 1985, 
Levin 197 g).
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(1985) demonstrated low levels of UDS repair in cells from the respiratory tract 
(macrophages type I and II and Clara cells), which may be explained by the high concentration of 
detoxification enzymes present in the cellular extracts.
It was noted that large numbers of cells within the preparation were in S-phase (recognised by their 
heavy labelling). This high observation over the lack of UDS may be associated with the physical
irritational effects of the particulates used (BP and FeaOj). Inhalation, instillation and abrasion have
mb
produced fibrosis and hyperplasia at the sites of application (Shami^l985, Stenback, Argyris^ 1981). 
This, coupled with the ability of selective pulmonary cell types (Clara, type n, epithelial), have the 
capacity for proliferation, being a pro-genitor cell for cellular regeneration (Brody 198%). This could 
help to explain some of the observed S-phase, but not all, as no doublet nuclei were observed in the 
preparations studied.
The intratracheal cannulation of the airway when instilled with FezOg-saline can cause mechanical 
denudation of the trachea epithelium which elicited an epithelial cell proliferation followed by an 
epidermoid metaplasia in the wounded area (McDowell^l979). Intratracheal instillation in hamsters 
are reported to cause hypeiplasia and metaplastic changes in the tracheal epithelium (Becci^l978,
(jhai
Harris^l971). In addition, particle instillation can cause a rise in ceU proUferation in the hamster 
bronchiolar epithelium (Nettesheim 1972, Shami^l982b). Bronchiol alveolar hyperplasia has been 
described in the lungs of hamster, rats and mice after exposure to a variety of different substances 
(Nettesheim and SzakM 1972, Schrieberl975, Kennedy and Little 1978, Shami 1982; 1984).
The development o f this lesion has been associated with proliferation of alveolar type II and 
bronchiole ceUs after injury (Nettesheim and Szakal 1972, Witschi^l977, Evans 1982).
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The S-phase counted in the peripheral lung section, may be related to the influx and/or increased 
activity of localised macrophages, which have the ability to proliferate, metabolise BP and for DNA 
repair (Autrup et al 1978a.^Deilhaug et al 1985).
An influx of inflammatory cells in the lung is a common response to many types of particulate
Arti
deposition (Bowden and Adamson 1978; 1984, Kavet^978, Beck 1982). Alveolar macrophages and 
PMN contain hydrolytic enzymes and form toxic oxygen flee radicals, both of which can be released 
extracellularly during phagocytosis of particulate matter (Ackerman and Beebe 1974, Weiss and 
Lobuglio 1982, Brain 1980). These inflammatory cell products have been implicated in pulmonary
damage from exposure to silica (Bowden and Adamson 1984b), asbestos (Brody , et al 1982),
O-A
ozone (Schwartz 1976) and hyperoxia (Crapo^l980). Marshall^(1987) observed a close proximity of 
inflammatory cells near the sites of bronchiolar cell proliferation and bronchiol alveolar hyperplasia, 
which suggested these cells had an involvement in the observed proliferation and hyperplasia.
Additionally, the stimulatory capacity of particulate matter, may cause increased anabolic activity of 
the cells within the respiratory tract; increased bronchial-alveolar secretions by the Goblet and type 
II cells.
The adaption to injury has been demonstrated in the lung, through a proliferative response that reduces
<Aihi vi-tAi
with time (Evans 1992; 1985, Stephens 1973) and increases endogenous macromolecules, enzymes and 
inhibitors (White and Repine 1985). Morphological changes can occur as proportions o f epithelial cell 
type can alter to form a respiratory epithelium that is less susceptible to damage. A shift from ciliated 
and type I cells to Clara and type II cells are a more resilient cell lining for the epithelium (Lum ^ 1978,
(Jr A  A  A  t b A
Castleman^l980, Evans^1985, Fujinaka 1985). This cellular resilience may be attributed to their high 
metabolic capacity.
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The cells observed to be in S-phase presence in the periphery of the lung were likely to be type I or 
type n  cells. The most likely are the type II cells, as this cell type is believed to be a precursor cell 
having high metabolic activity.
The observed response with BP being at 3 days and Fe^Og at 1 day may be related to the nature of 
the organic (BP) and inorganic (FcgOg) way in which the lung responds.
The gradual release of BP from the particulate state into the environment may have been insufficient 
in the earlier stages to overwhelm metabolic cellular defences. However the sustained release may 
with time overtax the system.
The inorganic FczOg would have caused a larger and prolonged irrational effect and recruitment of 
cellular defence to the site of exposure. This effective recruitment and release of endogenous factor 
and the cytotoxic capacity of the macrophages, may be the observed result
that
The combination of BP FegOg results may have been the combined effect of the above. Shami^(1985) 
compared exposure of rats to a nose only inhalation of BP-gallium oxide and SO2 with gallium oxide 
and SO2. More frequent proliferation in airway and alveolar regions with hyperplasia and hypertrophy 
affecting the terminal bronchioles was observed with the BP dose group. The interpretation was 
regenerative repair response after lung injury, the action of BP was as a carcinogen or a toxin, 
producing greater toxic injury to the lung.
The results described do not fully demonstrate the potential of the system for use in studies on the 
mechanism by which carcinogens interact with pulmonary tissue and its possible use for a screening 
test for direct and indirect damage to cellular DNA. Additional work is necessary to explore the 
usefulness of this system.
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Possible improvements would be
1. Induction of Local P4S0. As the lung contains different iso-enzymes of cytochrome P450, 
induction of the P450 iso-enzymes likely to favour production of genotoxic products would 
increase the ’sensitivity’ of the technique. Additionally, depletion of other protective systems 
such as glutathione would enhance the above.
2. Use of Isolated Perfused Lung. The two approaches would be (a) dosing and perfusion, (b) 
culturing replacement.
(a). Dosing and Perfusion. Dosing with particulate and PAHs into the isolated lung 
lumen, which is being perfused by a regulatory system or continuous flow perfusion 
system. This technique would allow monitoring o f PAH release from the particulates 
into the perfusate.
(b). Culture replacement. A perfusion step would replace the labelled culture step. The 
perfusate medium would contain the radiolabel marker, in this case ^H-thymidine. 
This would produce a better distribution and penetration of radiolabel throughout the 
lung matrix, as it would be using the pulmonary vascular system and reduce the 
traumatization of the lung, prior to histological or autoradiography investigation.
3. Better Slicing Technique. The lung slicing was performed by hand and produced variations 
in cut angle and thickness. An automatic tissue sheer would give more regularity to the cut. 
Additionally, the use of different angles of cut would produce more information on the areas 
of susceptibility. To complement this, the use of differentiated histological stains can be used 
to reveal further information on cell type and connective tissue. Further samples can be used 
in TEM or SEM investigation to give information at a cellular level.
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4. Use of Additional Radiolabels. The addition of other radiolabelled precursors, such as 
proline (incorporation into collagen), leucine (general cellular turnover), palmitic acid (lipid 
synthesis) and arachidonic acid (macrophage usage in inflammatory response), can give 
additional information on the anabolic and catabolic processes occurring in the lung and cells 
resulting from cellular insult.
The in vivo/in vitro method holds a great deal o f potential but much work on characterization and 
validation wiU need to be performed before the technique can be routinely used.
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7. GENERAL DISCUSSION
The results of BP uptake experiments are similar to those obtained by other investigators (Bevan 1985, 
Lakowicz 1979; 1980), in that the adsorption of BP to particulates enhanced the transfer o f BP into 
membranes as compared to uptake from microcrystaUine states.
The uptake rates when BP was added as a DMSO solution have not been determined before, though 
it is clear that uptake is very rapid. This compares favourably with Bevan^(1985), using acetone. This 
rapid uptake could be explained by solubilised PAHs which are rapidly transferred from an aqueous 
phase to membranes, whereas uptake of PAH for particle-adsorbed or microciystaUine states was 
dependent upon the rates of solubilisation of PAH in the aqueous phase. The solubility o f BP in
eJ-oL qJ-A
aqueous solution is approximately 4.2pg/ml (Davis^l942, McKay^l977), but as determined in this 
study, the presence of 2.5% of DMSO increased the solubility of BP three fold. This increased 
solubility of BP in medium containing DMSO may account for increased transfer rates o f BP into 
microsomal membranes.
Other investigators also have reported increased rates of BP uptake into membranes when particle- 
adsorbed states are compared to microcrystalline states. For example, adsorption of BP to crocidolite 
asbestos (Kandaswani^l983) or amosite asbestos increased rates of transfer of BP into rat liver 
microsomes. Similarly, chrysotile enhanced the rate of uptake of BP into human fibroblasts in cell
culture (Chang^l982) and adsorption of BP to crocidolite and chrysotile asbestos enhanced cellular
A-XI
uptake into hamster tracheal epithelial cells (Eastman^1982; 1983, Mossman^l983). Bevan (1985) 
reported that AHH, EH and 0-dealkylation activity was inhibited by the presence of chrysotile or iron 
oxide. This was in contrast to observations in this study, in which no inhibition of enzyme activity
t/ rtf
was seen. KandaswaniJ[1983) reported 0-dealkylation inhibition by chrysotile. This inhibition may 
be related to the poisoning of the enzymes’ active sites by cations released from the asbestos surface.
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Bevan^(1985) attributed the lack of effect o f enzyme inhibition on profiles of BP metabolites to the 
multiplicity of the cytochromes P450 and the distinct catalytic activity towards the substrates 
metabolised (BP and 7-ethoxyresorufin). Inhibition of epoxide hydrolase may not alter metabolic 
profile because the formation of epoxide substrates may be rate-limiting.
Metabolism of BP and determination of metabolic profile has been extensively studied (Holder drÀ]V5c
it- A. (J-X.
Fujino^l978, Levin^l982). As expected, at low BP concentrations (|ig), the majority o f metabolites 
were more polar than BP 9,10 diol. Similar results were obtained by Holder et al (19751), although 
a different inducing agent (3-methylcholanthrene) was used.
From the profile of BP metabolites produced under the various conditions, the predominant effect of 
particulate was to alter the percentage metabolised (Table 7.1) and the extent of metabolism (see 
Section 4.2.4). These observations would seem to be the result of the transfer rates of the adsorbed 
BP (Table 7.1), which show varying amounts of available BP for metabolism.
Results o f the mutagenicity testing also supported the hypothesis that the predominant effect o f  
particulates in these experiments was on rate of BP uptake. These results are consistent with those
X'X- ttX.
reported by other investigators (Bevan 1985, Szyba 1983). Lack of mutagenicity of iron oxide in the 
Ames test is consistent with the Bevan^(1985) report, though the mutagenicity of AlgOg and TiOj has 
not been previously investigated.
From these results, it is clear that particulates alter bioavailability of BP for metabolism to mutagenic 
species (Table 7.1). Changes in the availability of BP altered the metabolism profile of BP, showing 
a shift to more polar metabolites, epoxides and diols, which have a more pronounced biological effect 
on cellular components. The effect on BP availability was related to the percentage o f BP transferred, 
in that those BP coated particulates with the highest percentage transfer had the highest percentage o f  
metabolism and mutagenicity, in this instance AlgOg B (Table 7.1). This is in contrast to Bevan
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(1985), in which and asbestos both exhibited the same amount of metabolism (62%), while the 
microciystaUine BP was 16%.
l/at
Findings by Leung^(1988) with BP adsorbed to diesel particles indicated that not all the BP released 
from the particulate adsorbed state is metabolised. In this study 3% of the adsorbed BP was 
transferred into microsomes, of this only 1-2 % was metabolised.
Leung (1988) showed that the release of BP from the diesel particle was not related to its metabolism 
by microsomes, since the rate and the amount of the BP associated were the same with or without 
NADPH in the incubation medium. This suggests that microsomal enzymes do not metabolise BP on 
the surface of the particulate. Biotransformation presumably would proceed after the BP has been 
dissociated from the particle.
eJ-at
Metabolism and uptake of BP microcrystals in experiments conducted by Bevan (1985) were more 
extensive than reported here. This may be explained by the difference in microcrystal preparation. 
Bevan (1985) created microcrystals from evaporation of solvent, while in this study they were created 
through solvent and water mixing. This may produce the two distinct crystal structures o f BP 
(Monodinic (needle like crystals, usually formed from solvent evapouration), Orthorhonilic (plate like 
crystals, usually formed from low temperature sublimation (the most common form))), which may 
possess different dissolution properties and hence transfer rates.
The BP coating concentration used in this study for mutagenicity, metabolism and uptake were within 
the same order of magnitude (Range 1600|xg/g-2100|xg/g of particles), while Bevan (1985) used a 
loading on ferric oxide and asbestos o f 2600-14000|Xg/g. This may account for the differences 
observed between our studies.
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7.1 SPECULATION ON THE NATURE OF MUTAGENICITY RELATED TO UPTAKE 
MECHANISMS
At the in vitro level used in this study a simple model that represents the expression of mutagenic 
activity in the microsome/particulate suspension can be represented schematically as follows
BP
k1
[Particle or Solvent]
BP
[aqueous]
K3 BP
k4 [microsomal]
Expression ^  
(colony)
metabolism ^  detoxrficaton
\ l /
activation
M /
Bacterial genome- ^  non expression
Figure 7.1: Schematic Representation of event s involved in BP mutagenicity
(J'ai
in which the Kj is the rate limiting step as Kg is rapid (Lakowicz 1978, 1979, 1980)..
Bevan ^ (1981) studied the effects of particulates on membrane uptake of PAH other than BP 
(dibenzo(a,b)anthracene, benzo(g,h,i)perylene, 3-methylcholanthrene and dibenzo(c,g)carbazole). AH 
but dibenzo(qg)carbazole showed enhanced uptake. The uptake o f dibenzo(c,g)carbazole was rapid 
with or without particles; it had the highest solubility and more than 60% of the dose would have been 
in a dissolved state (less than 1% for the other xenobiotics). As solubilised PAHS are rapidly taken 
up by membranes, it would be expected not to show enhancement.
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BP has a solubility in water of 4.2|Xg/Iitre (Davis^l942), at concentrations normally used for 
carcinogenicity testing. Not all the BP is soluble in the aqueous medium used for dosing, which 
would mean that the majority of BP would exist in aggregates in an aqueous suspension.
The BP as it exists on the surface of the particulates must also be considered. The method of 
preparation would greatly govern its state, whether it be adsorbed BP molecules or an aggregate of  
BP molecules associated with the particulates or aggregates as a co-suspension which are not bound 
to the particulates.
Grinding (SaffiottU968) and precipitation (Henry^l974,1975) would seem to produce aggregates both
Ü-4.
bound and associated with the particulates, while a solvent evaporation method (Lakowicz^ 1978), 
which was used in this study, would produce a high adsorbed BP molecular content with the presence 
of some aggregate BP.
The particles’ influence on the transfer equilibrium may be due to the foUowing:-
(1) increase in the available solubilised BP in the aqueous phase
(2) increase in the ease of solubilisation/dissolution of the BP into the aqueous phase.
The addition of particles to the aqueous phase may increase the solubility o f BP, similar to the effect 
of adding a suitable solvent such as acetone or DMSO to water, which will increase the dissolution 
of BP, though the modifications of the solution properties (by reducing solvent (water) polarity or 
’chelating* the BP molecule). The particulate surface moieties may change the micro environement 
between the water/particulate boundry to produce a suitable environment for ’chelating’ the BP 
molecule. A more favoured alternative is that the particle’s surface enables adsorbed BP to be 
released in a monomeric form, which may be due to reduction of the dissolution energy required to 
dissolve a crystalline structure.
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The data shows that BP is adsorbed to the particulate in different proportions of monomeric (dissolved) 
and polymeric (crystalline) states (See Section 4.2.3).
The AI2O3B showed a predominant presence of monomeric BP than the other particles, which 
suggested that the enhanced transfer may be related to the presence of the monomeric BP.
When considering the availability and mutational expression of BP in the mutagenicity test, Figure 7.1 
demonstrates the key elements involved in the eventual mutagenic expression.
The rate-limiting factors would be those previously discussed, but with the addition of K5, the enzymic 
conversion of BP to active metabolites that would then diffuse into the surrounding medium to 
encounter a bacterium and cause a inheritable mutation response (His’ - 4  His'*').
This assumes that the particles do not associate with any other components of the model. However, 
from the electron microscopic observations, it was seen that the particles interacted with the 
microsomes, in which microsomal ’clumps’ were associated with the particulate surface. This would
change the previously mentioned model to the following:-
BP ^
Expression ^  
(colony)
[Particle ]
BP
[microsomal / Lipid]
metabolism. ^  detoxificaton
activation
M /
Bacterial genome- ^  nonexpressin
Figure 7.2: Alternate schematic representation of BP mutagenicity
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The rate-limiting factor in this model would be K3, the metabolism to mutagens. As the solubility of 
BP in lipid is high Kj would not be rate-limiting. The particle has become a ’catalytic’ support for 
the S9 vesicle (enzymes system)(see EM of S9 vesicles and particulates Section 3.8.4).
The binding of microsomal vesicles to the surface gave no indication of correlation with mutagenicity 
and transfer rates. The 89 vesicles however, remained intact even when they were closely associated 
with the particulate surface. One can speculate on the nature of this association. If reversible then 
the transfer rate may be a product o f the number of collisions between the particle surface and 89 
vesicle; the larger the surface area the more possible collisions. Immobilisation of the two components 
would give an indication of this effect.
The factor that seems to influence the surface coverage of the BP was the surface area. AI2O3B had 
the largest surface area compared to the other particulates which had similar surface areas and 
mutagenicities at the similar BP surface loadings (Table 7.1).
Alumina A and B are chemically similar but the structural lattice of the particulate are very different. 
While alumina B is rounded and porous, alumina A is angular and ’ciystal-like’ (EM Plate 5.1-5.3 and 
5.8). This would explain the spectrum of BP as alumina A would act like a seeder o f crystallisation. 
BP in this form may have a high dissolution energy. It would seem that the surface nature o f the 
particle is an important contributory factor.
The enhancement of the biological effect seen in the mutagenicity test, of particulate adsorbed BP may 
be associated with the particulate becoming a ’catalytic’ platform for 89 vesicular ’clumps’, holding 
enzyme and substrate in close association, and with the bacterium.
The variation between inter-particulate mutagenicity was not as great as would be expected from the 
metabolism studies (Table 7.1). The BP coated alumina A, ferric oxide and titanium dioxide produced
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varying quantities o f BP metabolites, but had very similar mutagenicity. One would assume that there 
would be a more pronounced ranking of BP coated particulate mutagenicity. This discrepancy may 
be accounted for by the continued activity o f the S9 in the agar overlay after dosing.
In addition, the metabolic activation system used wiU be a contributing factor to the observable 
mutagenicity and metabolism, as the tissue used to produce the S9 will have a differing balance of 
’activation’ and ’deactivation’ and inhibitory effects of the particulates. However in this study 
inhibition was not a contributory factor on observed metabolism or mutagenicity (Table 7.1).
An influencing factor on the enhanced particulate transfer, is the loading of the particulate BP coating. 
The in vitro BP coating concentration (1600-2100p.g/g) indicates that a short pulse of BP is delivered 
while, at high concentration (alumina A and B comparisons, in Section 4.2.5.1), as loading increased 
there was a reduction in transfer rate. This questions the delivery of dose and the possible effect this 
will have on tumorigenesis.
PAHs occur in low concentrations in the general environment, typically in the low ppm range (Dais-y 
et al 1986). Even though PAHs are highly particle-associated, they only achieve low surface coverage 
on the carrier particles. Thus, humans may be continuously exposed to low concentrations o f PAHs.
Most studies have been performed using large amounts of PAHs administered with particulates. Two 
different levels o f PAHs have been used for animal exposure. In past experiments, the purpose of 
which was to induce cancer in animals by intratracheally instilling BP (Saffiotti et al 1968; Henry et 
al 1975), the amounts administered were many orders of magnitude greater than human smokers 
immediate exposure to PAHs after smoking (Gerde and Scholander 1987). Later more realistic
ihcd
amounts were administered by inhalation (Sun 1982, 1989).
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The coadministration of BP with inert carrier dust was in the presence of large aggregates of dust in 
the lungs of the animals. Several days after instillation, these aggregates contained crystalline BP 
(Kennedy and Little 1974). When 0.9mg of BP precipitated onto ferric oxide, 90% was cleared within 
50 hours (Henry et al 1975), whereas 8 and 5mg BP precipitated onto the same type o f carrier was 
cleared in 14 days (Schreiber et al 1975f),
This contrasts with inhalation studies using reduced doses, resulting in 90% clearance o f BP within 
30 minutes after exposure had been completed (Sun 1982). No metabolised BP remained in the lungs
e/<ft
for more than 1 day (Sun^l989).
The difference in residence time of BP, between the two types of studies described above, indicates 
a change in the way that BP was released from the particulate surface.
Gerde ^(1991) indicated from theoretical results that increased retention of PAH, observed when large 
amounts of PAHs are co-instilled with an inert carrier dust into the lungs o f animals, can be explained 
by the formation of large aggregates of carrier dust that entrap crystalline PAHs. Therefore, the 
increased frequency obtained when an inert carrier dust was co-instiUed with PAH, may thus be 
explained in part by aggregates of dust containing PAH prolonging retention.
Therefore retention may be important when large aggregates are instilled. A sustained low release 
means that critical metabolite levels may be reached before the PAH are cleared from the lung, while 
at low doses, critical doses of metabolites are more likely to be produced from PAH released shortly 
after the deposition.
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7.2 SPECULATION ON PARTICULATE-BP ASSOCIATION IN PULMONARY
CARCINOGENESIS
Many animal studies have revealed that administration o f both particulates and PAH results in 
increased tumorigenesis as compared to administration of either particulates or PAH alone. The 
mechanisms frequently proposed for this enhanced PAH carcinogenesis by particulates are
(a) The particulate functions as a carrier to enhance the penetration of the PAH into the lungs
d-al
(Saffiotti^l964, 1965, 1968).
(b) The PAHS are retained in the lungs longer by virtue of their association with the particulates
if-A. a,h
(Pylev 1962, Shabad 1962).
(c) The particulates enhanced the release/uptake of PAH into the surrounding tissue (Saffiotti
ij-a i
1970, Creasia 197f).
Particle effects RLL
Cell
Figure 7.3: Schematic representation of PAH release/uptake after particulate deposition in the
lung
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‘The surface reaction (Kl) involved either dissolution from crystalline PAHs or desorption from the 
surface or honeycomb structure of the particle that the PAH is adsorbed to.
In general, this is very rapid, except when the binding energy is high. In this case hydrocarbon will 
be ’tied’ almost permanently to the surface (Rivin and Atkin 1987) and will probably become 
biologically inactive (Sun 1989). High binding energies are associated with carbonaceous particles 
in particulate (Rivin and Atkin 1987).
Diffusion o f PAHs through pores (K2) may occur within a single porous particle or within interparticle 
spaces of particle aggregates. This step is, of course, missing if  exposure is to crystalline PAHs.
The third step (K3) is associated with the PAH diffusing through the respiratory lipid layer and any 
cellular material in that layer.
Connective transport in the blood (K4) is rapid in the blood-bound redistribution of PAH from the
eJ-«7
lung to other organs (Sun 1982).
The delivered dose received by the lung tissue is dependent on the amount deposited and transport 
rates of the above steps. Step K l and K2 are primarily governed by properties of the deposited 
xenobiotics and the exposure conditions, while K3 and K4 are governed by the biological system.
In the in vivo situation the binding of the respiratory lining layer (RLL) would be an important factor 
that may influence the redistribution of the particulates associated PAH.
Gerde and Scholander in a series o f papers indicated the importance of the RLL (Gerde and 
Scholander 1987,1988,1989a>), A slow penetration of PAHs, rather than a slow release from their 
carrier particles, should explain their rather extensive clearance through mucociliary action during the
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first half hour or so after inhalation of these chemicals in experimental animals (Mitchell 1982; Sun 
1982).
The role of the carrier particle has been described as causing a slow release of the PAHs into the target 
tissue, thereby prolonging its carcinogenic action (Henry 1975).
An alternative explanation for the influence of the carrier particles coated with PAHs could be that 
they both cause a local overloading of the RLL and act simply as a carrier, enabling crystalline PAHs 
before dissolution to bypass the surfactant lipid phase of the RLL and come into close contact with 
the underlying epithelium.
Although the particles enhance bioavailability of the PAH to initiate a genotoxic event, other 
mechanisms may be involved in overall tumour-formation.
The nature of the in vivo effect of BP and the particulate can be treated in three ways.
1. The effect o f BP on its own
2. The effect o f the particulate on its own
3. The contribution one will have upon the other
Essentially BP is a genotoxic carcinogen, while the particulates produce their effects though epigenetic 
mechanisms.
Once a particle has been phagocytosed by alveolar macrophages, the size and chemical nature o f the 
particle may influence the dissociation of PAH, as the pH had m. effect on the 
transter rate, implying that it rnajuu a contributory factor in the release o f BP from the particulate. In 
addition, exposure of alveolar macrophages (AM) to PAH (as in cigarette smoking) will induce mixed
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function oxidases (Ptashne,^ 1974; Cantrell,^ 1973). As this enzyme system is involved in
activation/detoxification of chemical carcinogens, an induced level could enhance the formation of
ei-at
ultimate or proximate carcinogens (Trump, 1978).
Due to the phagocytic nature of the AM, it would concentrate the particles and their adsorbed BP. 
During the passage of these engorged AM up to the ciliary escalator, they may be released into the 
surrounding active proximate and ultimate carcinogenic metabolites into the surrounding media, which
Oj-at
may be taken up by the cells lining these areas (Autrup,^ 1978k). Cells that are dividing may have 
reduced metabolic activity to protect themselves against possible genotoxic agents, the release of 
proximate and ultimate mutagens from the macrophage, may have a more immediate effect. The 
extended presence o f BP from particulate involvement could be enough to produce an enhanced effect. 
The off-loading of the coated particles may lead to formation of aggregate being large enough to 
breach the RLL, allowing a large ’effecter pulse’ of BP to be delivered to the cells below (Gerde, 
1987).
The particles tested in the in vitro cell culture system, produced no significant cytotoxicity, except 
at very high doses (3mg/ml). The BP coated particles showed little enhanced cytotoxicity, most of 
the observed cytotoxicity being due to the high particulate presence, rather than the metabolised BP 
(Figures 5.1-5.8).
The aggregational nature of the BP coated particulate in culture may account for the lack of 
cytotoxicity. However when the cells were dosed with BP in DMSO cytotoxicity was observed.
The BP in vitro transfer rates imply that the majority of BP is released from the particulates surface 
within a short time span (less than 30 minutes). However there is a disparity between the dose coating 
concentrations used in the in vivo and in vitro experiments. In the in vivo case a 1 : 1 proportion, of  
BP and ferric oxide, was dosed. While in the in vitro case a lower dose coating 0.016 - 0.021: 1 (BP
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to ferric oxide) was used, for mutagenicity and metabolism. Gerde^(1991) indicated that a large 
majority of work does not take this fact into consideration. The high doses added would have 
extended release being the preferred method of BP dosage, while the lower doses normally received 
being lower in the real world, would have BP delivery in a short effecter pulse.
The implication that, at an initial stage, from the pulse release effect of BP and the high dose of 
particulate, an additive increase in cytotoxicity would be expected. This toxic insult may be sufficient 
to initiate genotoxic damage but also the stimulus for regenerative or adaptive cellular growth. The 
presence of the particle may further enhance the effects upon the cells of the bronchial alveolar branch 
by increasing permeability of these carcinogens to enter the cells or cause scarification of the 
surrounding lung tissue, making these areas more susceptible to tumorigenesis (Bereblum, 1944;
eJhoL
Harrington, 1974). M a/1986) demonstrated that particulates adsorb lung surfactants and as a result 
increase the surface tension. These changes may be the initial steps in the development o f  
pneumoconiosis. When the lungs responded to inhaled particles by increasing surfactant production 
(Heppleston and Young 1972), it may be trying to prevent the particulate induced increase in surface 
tension, which reduces the lung compliance leading to dysfunction and localized hypoxia. The hypoxia 
condition stimulates localised macrophages to release factors which increase neutrophil recruitment 
The neutrophils may release cytotoxic factors leading to localised damage.
The in vivo-in vitro study showed that instillation produced an increase in S-phase cells. This cell 
proliferation, be it as a result of cytotoxicity leading to regenerative growth or adaptive cell changes 
or irritational propagation in the lung, is a contributing factor o f ferric oxide and BP instillation. The 
elevation of cells in S-phase could not be predicted from their individual instillation. It was interesting 
to note that the trachea was more affected than other areas o f the lung under study. This may be due 
to the distribution of the dose and also the effect of clearance via the mucociliary route, which would 
result in the trachea receiving a higher exposure.
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In the light o f Gerde^(1991), the in vitro finding may not apply to the in vivo dosing o f BP and ferric 
oxide in this study. However the lack of UDS detection may be due to the BP clearance within the 
first 12 hours and that the first time point missed the short BP toxicological effecter pulse, at which 
metabolite concentrations may have been sufficent to produce genotoxic damage.
In addition, the particles may also affect the normal clearance mechanism of the lungs, thereby 
increasing residence times of inhaled particles and particulate associated carcinogens (Henry and 
Kaufman 1973). Also, the effects o f PAH and particles on the suppression of the humoral and
•c^  A
cytotoxic immune defense mechanisms of the lung in tumour surveillance (Sibbett, 1986; Urso,  ^1986) 
are additional factors to be considered.
Taking the two elements per se (particles and BP) the mutagenicity test gave a good indication of 
potential genotoxicity, but gave no indication of the epigenetic mechanisms of the particulate, as the 
particulates were negative when tested. The mutagenicity could be explained by the observed tranfer 
rates and metabolism. The complimentary experiment with the cell culture system gave an indication 
of the cytotoxic element The particles alone and with BP coating had limited effect. This may have 
been due to lack of transfer and metabolism. The in vivoHn vitro study indicated that cell proliferation 
may be an important contributory factor in tumorigenesis.
7.3 AREAS REQUIRING FURTHER INVESTIGATION
7.3.1 In vivoNin vitro
In addition to those already mentioned (Section 6 .10), it would be advantageous to repeat the in vivo/in 
vitro work with a reduced particulate dose and coating concentration and to include time points soon 
after dosing. Additionally, looking at metabolic pararmeters that reflects "metabolic stress" exerted 
on the cells of the respiratory lining. The induction of relevant metabolising enzymes would be of 
interest.
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7.3.2 In vitro
It would be advantageous to dose more metabolically active cells derived from the epithelium of the 
trachea or bronchioles with particulate/BP. A Modifiction to determine the nature of the S-phase 
element would be to added media from cells cultured with the particulates, or lysates derived from 
macrophages and monitor cellular turnover.
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